ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3,1,Stress urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4,1,Headache,Headaches NEC,Headaches,Nerv,N
5,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
7,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
10,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
10,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
13,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,1,Amaurosis,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
14,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
15,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
16,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
17,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
18,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
19,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
20,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
20,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
20,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,4,Seizure anoxic,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
20,5,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
21,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
21,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
22,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
23,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
23,2,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
24,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
24,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
24,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
25,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
26,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
27,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
28,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
29,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
30,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,1,Headache,Headaches NEC,Headaches,Nerv,N
31,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
33,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
34,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
34,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
34,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
35,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
37,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
39,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
40,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
40,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
40,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
40,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
41,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
41,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
42,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
43,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
43,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
44,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
45,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
46,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
46,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
47,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
47,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
48,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
49,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
51,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
52,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
53,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
54,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
56,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
57,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
58,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
59,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
59,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
60,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
60,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
60,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
61,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
62,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
63,1,Headache,Headaches NEC,Headaches,Nerv,N
63,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
64,1,Headache,Headaches NEC,Headaches,Nerv,N
64,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
64,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
66,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
67,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
67,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
68,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
69,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
72,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
73,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
74,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
75,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
75,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
76,1,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
77,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
78,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
79,1,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
80,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
81,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
82,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
83,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
83,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
84,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
85,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
86,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
87,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
88,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
88,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
89,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
89,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
89,3,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
89,4,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
89,5,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
90,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
91,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
92,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
92,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
94,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
94,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
95,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
96,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
97,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
98,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
99,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
99,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
100,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
101,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
101,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
101,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
101,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
102,1,Theft,Criminal activity,Legal issues,SocCi,N
103,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
103,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
103,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
103,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
104,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
104,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
105,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
105,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
106,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
107,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
108,1,Migraine,Migraine headaches,Headaches,Nerv,N
108,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
111,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
112,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
112,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
113,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,1,Endometrial disorder,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
114,2,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
115,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
115,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
116,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
117,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
117,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
117,3,Headache,Headaches NEC,Headaches,Nerv,N
117,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
117,5,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
117,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
119,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
120,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
121,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
122,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
122,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
123,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
123,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
123,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
124,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
125,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
126,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
127,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
128,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
128,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
129,1,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
130,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
131,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
131,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
133,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
134,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
134,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
134,3,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
135,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
136,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
137,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
138,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
138,2,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
139,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
139,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
140,1,Headache,Headaches NEC,Headaches,Nerv,N
141,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
142,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
142,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
143,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
144,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
145,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
146,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
147,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
148,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
149,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
149,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
149,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
150,1,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
151,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
152,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
152,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
153,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
153,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
153,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
153,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
154,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
155,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
157,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
158,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
159,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
159,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
160,1,Headache,Headaches NEC,Headaches,Nerv,N
161,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
161,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
161,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
162,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
163,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
164,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
165,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
165,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
166,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
167,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
168,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
168,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
169,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
170,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
170,2,Hepatitis chronic active,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
170,3,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
170,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
170,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,6,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
171,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
172,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
173,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
174,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
175,1,Breast discharge,Breast signs and symptoms,Breast disorders,Repro,N
176,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
177,1,Erythema marginatum,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
178,1,Headache,Headaches NEC,Headaches,Nerv,N
179,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
180,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
181,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
182,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
182,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
182,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
183,1,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
183,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
184,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
185,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
186,1,Headache,Headaches NEC,Headaches,Nerv,N
187,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
188,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
188,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
188,3,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
189,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
191,1,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
192,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
192,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
193,1,Otosclerosis,Middle ear disorders NEC,Middle ear disorders (excl congenital),Ear,N
194,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
195,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
195,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
195,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
197,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
197,2,Headache,Headaches NEC,Headaches,Nerv,N
197,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
197,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
198,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
199,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
200,1,Headache,Headaches NEC,Headaches,Nerv,N
200,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
201,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
202,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
203,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
204,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
205,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
206,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
207,1,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
208,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
209,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
210,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
211,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
212,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
213,1,Headache,Headaches NEC,Headaches,Nerv,N
213,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
214,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
214,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
214,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
215,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
216,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
217,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
218,1,Contact lens intolerance,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
218,2,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
219,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
220,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
221,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
222,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
223,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
223,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
224,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
225,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
226,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
226,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
227,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
227,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
228,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
228,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
229,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
230,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
231,1,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
232,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
233,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
233,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
234,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
234,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
235,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
236,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
236,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
237,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
238,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
238,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
239,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
239,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
240,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
241,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
242,1,Headache,Headaches NEC,Headaches,Nerv,N
242,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
243,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
244,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
244,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
244,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
244,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
247,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
247,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
247,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
248,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
248,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
248,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
249,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
249,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
250,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
251,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
252,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
253,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
253,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
254,1,Headache,Headaches NEC,Headaches,Nerv,N
254,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
255,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
256,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
257,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
259,1,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
260,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
261,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
262,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
262,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
262,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
262,4,Headache,Headaches NEC,Headaches,Nerv,N
262,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
263,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
263,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
264,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
264,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
264,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
265,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
265,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
266,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
267,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
268,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
269,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
269,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
270,1,Headache,Headaches NEC,Headaches,Nerv,N
271,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
272,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
273,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
273,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
274,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
274,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
275,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
276,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
277,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
278,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
279,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
280,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
281,1,Headache,Headaches NEC,Headaches,Nerv,N
281,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
282,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
283,1,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
284,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
285,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
285,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
286,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
287,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
288,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
289,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
289,2,Urticaria contact,Urticarias,Angioedema and urticaria,Skin,N
290,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
290,2,Headache,Headaches NEC,Headaches,Nerv,N
290,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
291,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
292,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
292,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
292,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
292,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
293,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
294,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
294,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
295,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
296,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
297,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
297,2,Headache,Headaches NEC,Headaches,Nerv,N
298,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
299,1,Porphyria,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
300,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
301,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
302,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
303,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
303,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
304,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
304,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
304,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
304,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
305,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
305,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
306,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
309,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
310,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
310,2,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
311,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
312,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
313,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
313,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
313,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
313,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
313,6,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
314,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
314,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
314,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
315,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
316,1,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
316,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
316,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
317,1,Deafness,Hearing losses,Hearing disorders,Ear,N
317,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
318,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
319,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
320,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
321,1,Migraine,Migraine headaches,Headaches,Nerv,N
322,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
323,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
323,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
324,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
324,2,Migraine,Migraine headaches,Headaches,Nerv,N
325,1,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
326,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
327,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
328,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
329,1,Complication of device removal,Complications associated with device NEC,Complications associated with device,Genrl,N
330,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
330,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
330,3,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
330,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
331,1,Headache,Headaches NEC,Headaches,Nerv,N
331,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
331,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
332,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
333,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
334,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
335,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
336,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
336,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
336,3,Headache,Headaches NEC,Headaches,Nerv,N
336,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
337,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
337,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
338,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
339,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
340,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
340,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
340,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
341,1,Cerebral artery embolism,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
341,2,Headache,Headaches NEC,Headaches,Nerv,N
341,3,Hemianopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
341,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
341,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
342,1,Scintillating scotoma,Visual disorders NEC,Vision disorders,Eye,N
342,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
342,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
343,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
344,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
345,1,Headache,Headaches NEC,Headaches,Nerv,N
345,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
345,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
346,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
346,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
346,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
346,4,Vulval oedema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
347,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
347,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
348,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
349,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
350,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
351,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
352,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
352,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
352,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
352,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
353,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
354,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
355,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
356,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
357,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
357,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
357,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
357,4,Headache,Headaches NEC,Headaches,Nerv,N
357,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
358,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
359,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
359,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
360,1,Hepatitis chronic active,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
361,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
361,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
362,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
363,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
364,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
364,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
364,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
365,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
365,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
366,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
367,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
368,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
369,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
370,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
371,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
371,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
371,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
372,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
373,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
374,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
375,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
375,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
376,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
377,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
377,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
377,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
377,4,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
378,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
378,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
379,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
379,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
380,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
381,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
382,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
382,2,Headache,Headaches NEC,Headaches,Nerv,N
382,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
383,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
383,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
383,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
383,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
383,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
384,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
384,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
384,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
384,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
384,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
384,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
384,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
385,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
385,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
385,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
386,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
387,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
388,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
389,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
390,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
390,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
390,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
390,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
391,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
392,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
393,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
394,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
394,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
394,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
395,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
396,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
396,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
396,3,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
397,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
397,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
398,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
398,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
398,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
398,4,Migraine,Migraine headaches,Headaches,Nerv,N
398,5,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
399,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
399,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
400,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
402,1,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
402,2,Headache,Headaches NEC,Headaches,Nerv,N
402,3,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
403,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
404,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
404,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
404,3,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
405,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
405,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
406,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
407,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
408,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
409,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
410,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
411,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
412,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
413,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
413,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
414,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
415,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
416,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
417,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
418,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
419,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
420,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
421,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
421,2,Vulval oedema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
422,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
422,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
423,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
424,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
425,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
426,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
427,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
427,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
427,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
427,4,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
428,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
429,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
429,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
430,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
431,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
432,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
432,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
432,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
432,4,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
432,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
433,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
433,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
433,3,Headache,Headaches NEC,Headaches,Nerv,N
433,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
434,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
435,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
436,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
437,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
438,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
438,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
438,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
438,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
439,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
439,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
440,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
441,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
441,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
442,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
442,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
443,1,Headache,Headaches NEC,Headaches,Nerv,N
443,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
443,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
444,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
445,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
446,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
447,1,Migraine,Migraine headaches,Headaches,Nerv,N
448,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
449,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
450,1,Headache,Headaches NEC,Headaches,Nerv,N
450,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
450,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
451,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
451,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
451,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
452,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
453,1,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
453,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
454,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
455,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
456,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
457,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
458,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
459,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
459,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
459,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
459,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
460,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
461,1,Headache,Headaches NEC,Headaches,Nerv,N
461,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
462,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
463,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
464,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
465,1,Headache,Headaches NEC,Headaches,Nerv,N
465,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
465,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
466,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
466,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
467,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
468,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
469,1,Migraine,Migraine headaches,Headaches,Nerv,N
469,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
469,3,Scintillating scotoma,Visual disorders NEC,Vision disorders,Eye,N
470,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
471,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
472,1,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
472,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
473,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
474,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
475,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
476,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
477,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
477,2,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
477,3,Headache,Headaches NEC,Headaches,Nerv,N
477,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
478,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
479,1,Retinal aneurysm,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
479,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
480,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
481,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
482,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
482,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
483,1,Migraine,Migraine headaches,Headaches,Nerv,N
484,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
485,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
486,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
486,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
486,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
486,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
487,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
487,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
488,1,Headache,Headaches NEC,Headaches,Nerv,N
488,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
489,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
490,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
490,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
490,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
490,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
491,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
492,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
493,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
493,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
494,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
495,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
495,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
495,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
496,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
497,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
498,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
499,1,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
500,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
500,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
500,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
501,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
501,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
502,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
503,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
504,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
505,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
506,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
506,2,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
506,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
506,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
506,5,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
507,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
507,2,Headache,Headaches NEC,Headaches,Nerv,N
508,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
508,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
509,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
509,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
509,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
509,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
510,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
510,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
511,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
512,1,Headache,Headaches NEC,Headaches,Nerv,N
512,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
513,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
514,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
514,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
515,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
515,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
515,3,Headache,Headaches NEC,Headaches,Nerv,N
515,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
515,5,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
516,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
517,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
518,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
519,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
520,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
520,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
520,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
521,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
521,2,Simple partial seizures,Partial simple seizures NEC,Seizures (incl subtypes),Nerv,N
522,1,Adjustment disorder with depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
522,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
522,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
523,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
523,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
524,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
524,2,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
525,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
525,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
525,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
525,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
526,1,Vulvovaginitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
527,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
528,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
528,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
528,3,Headache,Headaches NEC,Headaches,Nerv,N
529,1,Melanosis,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
530,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
531,1,Trisomy 18,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
532,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
533,1,Headache,Headaches NEC,Headaches,Nerv,N
534,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
535,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
535,2,Headache,Headaches NEC,Headaches,Nerv,N
535,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
536,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
537,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
537,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
538,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
538,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
539,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
540,1,Headache,Headaches NEC,Headaches,Nerv,N
540,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
541,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
541,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
541,3,Headache,Headaches NEC,Headaches,Nerv,N
542,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
543,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
543,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
544,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
545,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
545,2,Headache,Headaches NEC,Headaches,Nerv,N
545,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
546,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
547,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
547,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
548,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
549,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
549,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
550,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
551,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
552,1,Headache,Headaches NEC,Headaches,Nerv,N
552,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
552,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
553,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
554,1,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
555,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
555,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
556,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
557,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
558,1,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
559,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
559,2,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
559,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
560,1,Deafness,Hearing losses,Hearing disorders,Ear,N
560,2,Otosclerosis,Middle ear disorders NEC,Middle ear disorders (excl congenital),Ear,N
561,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
561,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
561,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
561,4,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
561,5,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
561,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
561,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
561,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
561,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
561,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
562,1,Headache,Headaches NEC,Headaches,Nerv,N
562,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
563,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
564,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
564,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
565,1,Tongue paralysis,Hypoglossal nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
566,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
566,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
567,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
567,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
567,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
567,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
567,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
567,6,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
568,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
569,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
569,2,Headache,Headaches NEC,Headaches,Nerv,N
569,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
570,1,Mixed anxiety and depressive disorder,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
571,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
571,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
572,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
573,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
574,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
575,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
576,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
577,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
578,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
579,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
579,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
580,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
581,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
581,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
582,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
583,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
583,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
584,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
584,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
584,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
585,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
586,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
587,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
588,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
589,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
589,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
590,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
591,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
592,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
592,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
593,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
594,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
595,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
595,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
596,1,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
597,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
598,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
599,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
600,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
600,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
601,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
601,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
601,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
602,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
603,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
603,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
603,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
603,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
604,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
605,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
605,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
606,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
607,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
607,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
607,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
607,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
608,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
609,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
610,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
610,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
611,1,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
611,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
611,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
612,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
612,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
613,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
614,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
614,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
615,1,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
616,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
617,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
618,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
619,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
620,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
621,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
621,2,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
622,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
622,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
623,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
623,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
624,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
625,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
626,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
627,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
628,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
629,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
629,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
630,1,Spider naevus,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
631,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
632,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
632,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
633,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
634,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
635,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
636,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
637,1,Migraine,Migraine headaches,Headaches,Nerv,N
637,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
638,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
639,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
640,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
640,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
641,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
642,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
643,1,Phlebitis superficial,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
644,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
645,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
646,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
647,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
648,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
649,1,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
649,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
649,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
650,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
651,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
651,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
652,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
653,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
654,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
655,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
655,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
656,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
657,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
658,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
658,2,Breast atrophy,Breast disorders NEC,Breast disorders,Repro,N
659,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
659,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
660,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
661,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
661,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
662,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
662,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
663,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
663,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
664,1,Amaurosis fugax,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
665,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
666,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
667,1,Breast engorgement,Breast signs and symptoms,Breast disorders,Repro,N
667,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
667,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
667,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
668,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
668,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
669,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
670,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
671,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
672,1,Phlebitis superficial,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
673,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
674,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
674,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
675,1,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
676,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
677,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
678,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
679,1,Rhinitis allergic,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
680,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
680,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
681,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
682,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
683,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
684,1,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
684,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
684,3,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
684,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
685,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
686,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
687,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
688,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
688,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
688,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
688,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
688,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
689,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
690,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
691,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
692,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
693,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
694,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
695,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
695,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
695,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
696,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
697,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
698,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
698,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
699,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
699,2,Headache,Headaches NEC,Headaches,Nerv,N
699,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
699,4,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
699,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
699,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
700,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
700,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
700,3,Headache,Headaches NEC,Headaches,Nerv,N
700,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
701,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
702,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
703,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
704,1,Headache,Headaches NEC,Headaches,Nerv,N
704,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
705,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
706,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
707,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
708,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
709,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
710,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
711,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
712,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
713,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
713,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
714,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
715,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
715,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
716,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
716,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
716,3,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
716,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
717,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
717,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
717,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
718,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
719,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
719,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
720,1,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
721,1,Migraine,Migraine headaches,Headaches,Nerv,N
721,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
722,1,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
723,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
723,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
723,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
724,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
725,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
726,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
726,2,Burning sensation mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
727,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
728,1,Gingival pruritus,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
728,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
729,1,Urticaria cholinergic,Urticarias,Angioedema and urticaria,Skin,N
730,1,Amaurosis fugax,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
731,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
731,2,Headache,Headaches NEC,Headaches,Nerv,N
731,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
732,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
733,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
734,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
734,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
734,3,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
735,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
736,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
736,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
737,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
737,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
737,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
737,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
738,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
739,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
740,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
741,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
741,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
742,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
743,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
744,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
744,2,Headache,Headaches NEC,Headaches,Nerv,N
744,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
745,1,Phlebitis superficial,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
746,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
747,1,Mechanical urticaria,Urticarias,Angioedema and urticaria,Skin,N
748,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
749,1,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
750,1,Migraine,Migraine headaches,Headaches,Nerv,N
751,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
752,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
753,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
754,1,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
755,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
756,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
757,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
758,1,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
759,1,Deafness,Hearing losses,Hearing disorders,Ear,N
760,1,Deafness,Hearing losses,Hearing disorders,Ear,N
761,1,Migraine,Migraine headaches,Headaches,Nerv,N
761,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
761,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
762,1,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
762,2,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
762,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
763,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
764,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
765,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
766,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
766,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
767,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
768,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
769,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
769,2,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
769,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
769,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
770,1,Embolism arterial,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
770,2,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
770,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
770,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
771,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
771,2,Migraine,Migraine headaches,Headaches,Nerv,N
771,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
772,1,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
773,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
774,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
775,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
776,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
777,1,Migraine,Migraine headaches,Headaches,Nerv,N
778,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
779,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
779,2,Headache,Headaches NEC,Headaches,Nerv,N
780,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
781,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
781,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
782,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
782,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
783,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
784,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
785,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
786,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
787,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
788,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
788,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
789,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
790,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
790,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
790,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
791,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
791,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
792,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
793,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
794,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
795,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
795,2,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
796,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
797,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
797,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
798,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
799,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
799,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
799,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
799,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
799,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
800,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
801,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
802,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
803,1,Cerebral artery embolism,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
803,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
804,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
804,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
804,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
805,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
806,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
807,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
808,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
809,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
809,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
809,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
810,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
810,2,Migraine,Migraine headaches,Headaches,Nerv,N
811,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
811,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
812,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
813,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
813,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
814,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
815,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
815,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
816,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
816,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
817,1,Breast engorgement,Breast signs and symptoms,Breast disorders,Repro,N
817,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
818,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
819,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
819,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
820,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
821,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
822,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
823,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
823,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
823,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
823,4,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
824,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
824,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
825,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
825,2,Headache,Headaches NEC,Headaches,Nerv,N
826,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
827,1,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
828,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
829,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
830,1,Breast discharge,Breast signs and symptoms,Breast disorders,Repro,N
830,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
830,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
831,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
832,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
833,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
834,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
834,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
835,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
836,1,Metaplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
836,2,Urethral disorder,Urethral disorders NEC,Urethral disorders (excl calculi),Renal,N
837,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
837,2,Headache,Headaches NEC,Headaches,Nerv,N
837,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
838,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
839,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
839,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
839,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
839,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
840,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
840,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
841,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
842,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
843,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
844,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
845,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
846,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
846,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
847,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
848,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
848,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
848,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
849,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
849,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
849,3,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
850,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
851,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
852,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
852,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
853,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
854,1,Headache,Headaches NEC,Headaches,Nerv,N
854,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
855,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
856,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
857,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
857,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
857,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
857,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
858,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
859,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
859,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
860,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
861,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
861,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
861,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
862,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
863,1,Headache,Headaches NEC,Headaches,Nerv,N
863,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
863,3,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
864,1,Headache,Headaches NEC,Headaches,Nerv,N
864,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
864,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
865,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
865,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
866,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
866,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
867,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
868,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
869,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
870,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
870,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
871,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
871,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
872,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
872,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
873,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
873,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
874,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
875,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
876,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
877,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
878,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
878,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
879,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
880,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
881,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
881,2,Headache,Headaches NEC,Headaches,Nerv,N
881,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
882,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
883,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
884,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
885,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
886,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
887,1,Endometrial hyperplasia with cellular atypia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
888,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
889,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
889,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
890,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
891,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
892,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
893,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
894,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
895,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
896,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
897,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
897,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
898,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
898,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
899,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
900,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
900,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
900,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
901,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
902,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
903,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
904,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
905,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
906,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
907,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
907,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
907,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
907,4,Headache,Headaches NEC,Headaches,Nerv,N
907,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
907,6,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
907,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
908,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
909,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
910,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
910,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
910,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
910,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
910,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
910,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
910,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
910,8,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
911,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
912,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
913,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
914,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
914,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
914,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
915,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
915,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
915,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
916,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
917,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
918,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
918,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
919,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
919,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
920,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
921,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
921,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
921,3,Headache,Headaches NEC,Headaches,Nerv,N
921,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
921,5,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
922,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
923,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
924,1,Headache,Headaches NEC,Headaches,Nerv,N
925,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
926,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
927,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
928,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
929,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
930,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
930,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
931,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
931,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
931,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
932,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
933,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
934,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
935,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
936,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
937,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
938,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
939,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
940,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
940,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
941,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
942,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
942,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
943,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
943,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
944,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
945,1,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
945,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
946,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
947,1,Migraine,Migraine headaches,Headaches,Nerv,N
948,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
949,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
949,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
950,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
950,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
951,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
952,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
952,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
953,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
954,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
955,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
956,1,Melanosis,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
957,1,Headache,Headaches NEC,Headaches,Nerv,N
958,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
959,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
960,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
961,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
962,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
962,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
963,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
964,1,Headache,Headaches NEC,Headaches,Nerv,N
965,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
966,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
967,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
968,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
969,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
969,2,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
970,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
971,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
972,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
973,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
973,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
974,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
975,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
976,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
977,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
977,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
978,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
978,2,Cervical polyp,Cervix neoplasms,Cervix disorders (excl infections and inflammations),Repro,N
979,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
980,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
980,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
981,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
981,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
981,3,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
982,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
982,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
983,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
983,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
984,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
985,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
986,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
986,2,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
986,3,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
986,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
986,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
987,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
987,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
987,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
987,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
988,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
989,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
990,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
990,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
991,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
991,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
991,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
992,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
993,1,Phlebitis superficial,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
994,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
994,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
994,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
994,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
995,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
996,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
997,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
998,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
999,1,Breast inflammation,Breast infections and inflammations,Breast disorders,Repro,N
1000,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1001,1,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
1002,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1002,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1003,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1003,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1004,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1005,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1006,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1007,1,Mesenteric vein thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1008,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1009,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1010,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1011,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1011,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1012,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1013,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1013,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1013,3,Headache,Headaches NEC,Headaches,Nerv,N
1013,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1013,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1014,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1015,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1015,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1016,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1016,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1017,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
1017,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1018,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1019,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1019,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1019,3,Headache,Headaches NEC,Headaches,Nerv,N
1019,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1020,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1021,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1022,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1023,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1024,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1025,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1026,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1026,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1027,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1028,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1029,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1030,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1030,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1031,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1032,1,Oestradiol increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1033,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1034,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1034,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1034,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1034,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1035,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1036,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1037,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1037,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1038,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1039,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1040,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1041,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1042,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1043,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1043,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1043,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1044,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1044,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
1044,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1045,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1045,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1046,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
1046,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1046,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1047,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1048,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1048,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1048,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1049,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1050,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1051,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1052,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1052,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1052,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1053,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1053,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1053,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1054,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1055,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1055,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1055,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1056,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1057,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1058,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1059,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1060,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1060,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1060,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1060,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1061,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1061,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
1062,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1062,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1062,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1063,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1063,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1064,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1064,2,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
1064,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1065,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1066,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1067,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1068,1,Breast engorgement,Breast signs and symptoms,Breast disorders,Repro,N
1068,2,Headache,Headaches NEC,Headaches,Nerv,N
1069,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1070,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1071,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1072,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1073,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1073,2,Headache,Headaches NEC,Headaches,Nerv,N
1073,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1073,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1073,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1074,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1075,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1076,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1077,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1078,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1078,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1079,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1080,1,Headache,Headaches NEC,Headaches,Nerv,N
1081,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1081,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1082,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1083,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1084,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1085,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1086,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1087,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1087,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1088,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
1089,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1090,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1091,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1092,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1092,2,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1093,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1093,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1093,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1094,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1095,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1096,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1097,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1098,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1098,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1098,3,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1099,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1100,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1101,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1102,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1102,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1103,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1103,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1103,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1104,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1105,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1105,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1106,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1106,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1107,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1108,1,Headache,Headaches NEC,Headaches,Nerv,N
1108,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1108,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1109,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1110,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1111,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1112,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1113,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1113,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
1114,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1114,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1114,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1114,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1114,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1114,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1114,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1115,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1116,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1116,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1116,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1117,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1118,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1118,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1119,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1119,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1120,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1121,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1121,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1121,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1121,4,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1121,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1121,6,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1121,7,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
1122,1,Acne,Acnes,Skin appendage conditions,Skin,N
1122,2,Deafness,Hearing losses,Hearing disorders,Ear,N
1122,3,Headache,Headaches NEC,Headaches,Nerv,N
1123,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1124,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1125,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1126,1,Migraine,Migraine headaches,Headaches,Nerv,N
1126,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1126,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1126,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1127,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1127,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1128,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1129,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1130,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1131,1,Headache,Headaches NEC,Headaches,Nerv,N
1132,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1133,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1134,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1134,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1134,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1134,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1135,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1136,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
1137,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1138,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1139,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1140,1,Temporal lobe epilepsy,Partial complex seizures,Seizures (incl subtypes),Nerv,N
1141,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
1141,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1141,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1141,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1141,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1142,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1143,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1143,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1143,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1143,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1144,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1144,2,Breast disorder,Breast disorders NEC,Breast disorders,Repro,N
1144,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1145,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1146,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1146,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1147,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1148,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1148,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1148,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1149,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1149,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1149,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1150,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1151,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
1151,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1152,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1153,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1154,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1155,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1156,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1156,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1156,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1157,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1158,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1159,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1160,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1160,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1161,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1161,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1162,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1162,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1162,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1163,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1163,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1164,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1164,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
1164,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1164,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1165,1,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1166,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1167,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1167,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1167,3,Headache,Headaches NEC,Headaches,Nerv,N
1168,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1169,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1170,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1171,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1172,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1173,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1173,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1174,1,Endometrial stromal sarcoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1174,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1175,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1176,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1176,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1176,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1176,4,Headache,Headaches NEC,Headaches,Nerv,N
1176,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1176,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1177,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1178,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1179,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1180,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1181,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1181,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1182,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
1182,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1182,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1183,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1184,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1185,1,Ischaemic skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1186,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1186,2,Hemianopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1186,3,Migraine,Migraine headaches,Headaches,Nerv,N
1187,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1187,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1188,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1189,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1190,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1191,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1192,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1193,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1194,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1194,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1195,1,Amaurosis,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1195,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1196,1,Congenital choroid plexus cyst,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
1196,2,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1196,3,Dandy-Walker syndrome,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
1196,4,Fallot's tetralogy,Multiple cardiac abnormalities congenital,Cardiac and vascular disorders congenital,Cong,N
1196,5,Hemivertebra,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1197,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1197,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1198,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1198,2,Migraine,Migraine headaches,Headaches,Nerv,N
1199,1,Headache,Headaches NEC,Headaches,Nerv,N
1200,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1200,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1201,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1202,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1202,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1203,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1204,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1205,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1206,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1207,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1207,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1208,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1209,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1209,2,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1209,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1210,1,Conjunctival irritation,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1211,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1212,1,Cerebral artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1212,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1213,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
1214,1,Amaurosis fugax,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1214,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1215,1,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,Y
1216,1,Migraine,Migraine headaches,Headaches,Nerv,N
1217,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1218,1,Benign breast neoplasm,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
1219,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1220,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1221,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1222,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1223,1,Capillary disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1224,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1225,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1226,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1227,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1228,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1229,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1229,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1229,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1230,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1231,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1232,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1232,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1232,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1232,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1233,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1234,1,Benign ovarian tumour,Ovarian neoplasms benign,Reproductive neoplasms female benign,Neopl,N
1234,2,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1235,1,Headache,Headaches NEC,Headaches,Nerv,N
1236,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1237,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1237,2,Headache,Headaches NEC,Headaches,Nerv,N
1237,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1237,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1237,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1238,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1238,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1239,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1239,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1240,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1241,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1241,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1242,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1243,1,Melanosis,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1244,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1245,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1245,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1246,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1247,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1248,1,Migraine,Migraine headaches,Headaches,Nerv,N
1249,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
1250,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1250,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1250,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1251,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1251,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1251,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1252,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1253,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1253,2,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1254,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1255,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1256,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1257,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1258,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1259,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1259,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1260,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1260,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1260,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1260,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1261,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1261,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1261,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1262,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1263,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1264,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1264,2,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1264,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1265,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1266,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1267,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1268,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1268,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1269,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1270,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1271,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1272,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1272,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1273,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1274,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1275,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1276,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
1276,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1276,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1277,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1278,1,Injection site fibrosis,Injection site reactions,Administration site reactions,Genrl,N
1279,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1280,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1280,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1281,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1282,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1283,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1284,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1285,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1286,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1286,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1287,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1288,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1288,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1288,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1288,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1288,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1289,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1290,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1291,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1292,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1292,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1292,3,Headache,Headaches NEC,Headaches,Nerv,N
1292,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1292,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1293,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1293,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1293,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1294,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1295,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1296,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1297,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1298,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1299,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1300,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1301,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1301,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1301,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1302,1,Headache,Headaches NEC,Headaches,Nerv,N
1302,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1302,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1303,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1304,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
1304,2,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
1305,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1305,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1305,3,Headache,Headaches NEC,Headaches,Nerv,N
1305,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1306,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1307,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1308,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1309,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1310,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1310,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1311,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1312,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1313,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1313,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1313,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1313,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1314,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1314,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1315,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1316,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1317,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1318,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1318,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1318,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1319,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1319,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1320,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1320,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1321,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1322,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1323,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1324,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1325,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1325,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1326,1,Herpes gestationis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1327,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1327,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1327,3,Headache,Headaches NEC,Headaches,Nerv,N
1327,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1328,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1328,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1328,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1328,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1328,5,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
1329,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1330,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1331,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1332,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
1333,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1333,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1334,1,Vulva cyst,Vulvovaginal cysts and neoplasms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1335,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1335,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1336,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1337,1,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1338,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1338,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1338,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1339,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1340,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1341,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1342,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1343,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1343,2,Headache,Headaches NEC,Headaches,Nerv,N
1343,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1344,1,Headache,Headaches NEC,Headaches,Nerv,N
1344,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1345,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1346,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1346,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1347,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1347,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1348,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1348,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1348,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1349,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1350,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1350,2,Headache,Headaches NEC,Headaches,Nerv,N
1351,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1352,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1353,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1353,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1354,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1354,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1354,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1355,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1355,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1355,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,4,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1356,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1357,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1357,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1357,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1358,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1358,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1359,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1360,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1361,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1361,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1362,1,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
1363,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1364,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1364,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1365,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1365,2,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1366,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1367,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1368,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1369,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1369,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1369,3,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1369,4,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1369,5,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1369,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1369,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1370,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1370,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1370,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1371,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1372,1,Headache,Headaches NEC,Headaches,Nerv,N
1372,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1373,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1374,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1374,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1374,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1374,4,Headache,Headaches NEC,Headaches,Nerv,N
1375,1,Drop attacks,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1375,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1376,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1377,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1378,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1379,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1380,1,Inferior vena caval occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1380,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1381,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1381,2,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1382,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1383,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1383,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1384,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1385,1,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1386,1,Epidermolysis bullosa,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
1386,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1386,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1387,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1388,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1389,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1389,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1390,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1390,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1391,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1391,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1391,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1391,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1392,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1392,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1393,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1394,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1395,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1395,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1395,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1396,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1396,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1397,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1398,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1399,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1400,1,Headache,Headaches NEC,Headaches,Nerv,N
1400,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1400,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1401,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1402,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1403,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1404,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1404,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1405,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1406,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1407,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1408,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1409,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
1409,2,Headache,Headaches NEC,Headaches,Nerv,N
1410,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1410,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1410,3,Migraine,Migraine headaches,Headaches,Nerv,N
1411,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1411,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1412,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1413,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1414,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1414,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1414,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1415,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1416,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1417,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1417,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1418,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1419,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1420,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1421,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1422,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1423,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1423,2,Migraine,Migraine headaches,Headaches,Nerv,N
1424,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1424,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1425,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1426,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1426,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1427,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1428,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1429,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1430,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1431,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1432,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
1433,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1433,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1433,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1434,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1435,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1436,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1437,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1438,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1439,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1440,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1440,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1441,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1442,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1443,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1444,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1445,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1446,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1446,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1447,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1448,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1449,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1450,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1451,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1452,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1452,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1453,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1454,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1455,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1456,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1457,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1458,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1459,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1460,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1461,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1462,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1463,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1463,2,Headache,Headaches NEC,Headaches,Nerv,N
1463,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1464,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1465,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1465,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1466,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1467,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1468,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1469,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1469,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1470,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1471,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1472,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1473,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1474,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1475,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1476,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1477,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1478,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1478,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1479,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1480,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1480,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1481,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1481,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1482,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1483,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1484,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1485,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1486,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1487,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1487,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1488,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1489,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1490,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1491,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1492,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1493,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1493,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1494,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1495,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1496,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1497,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1498,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1498,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1499,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1500,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1501,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1502,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1503,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1504,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1505,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1505,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1505,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1505,4,Headache,Headaches NEC,Headaches,Nerv,N
1505,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1506,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1507,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1508,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1508,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1509,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1510,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1511,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1511,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1511,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1512,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1513,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1514,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1515,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1516,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1517,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1518,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1518,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1519,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1519,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1519,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1519,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1520,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1521,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1522,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1523,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1524,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1525,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1526,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1527,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1528,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1529,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1530,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1531,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1531,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1532,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1533,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1534,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1534,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1535,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1535,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1535,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1536,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1536,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1537,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1538,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1539,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1540,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1541,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1542,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1543,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1544,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1545,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1546,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1546,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1547,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1548,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1548,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1549,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1550,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1550,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1550,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1551,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1551,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1552,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1553,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1553,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1553,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1554,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1554,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1555,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1556,1,Breast engorgement,Breast signs and symptoms,Breast disorders,Repro,N
1556,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1557,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1558,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1559,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1560,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1561,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1561,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1561,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1562,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1562,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1563,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1564,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1565,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1566,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1567,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1568,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1568,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1568,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1568,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1569,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1569,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1569,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1570,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1571,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1572,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1572,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1573,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1574,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1575,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1576,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1577,1,Amaurosis,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1578,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1579,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1580,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1581,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1582,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1583,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1583,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1583,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1583,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1584,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1584,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1585,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1586,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1587,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1588,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1589,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1589,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1589,3,Headache,Headaches NEC,Headaches,Nerv,N
1589,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1590,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1591,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1592,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1593,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1594,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1595,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1595,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1595,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1596,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1597,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1598,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1598,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1599,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1600,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1601,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1601,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1602,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
1602,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1603,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1604,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1605,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1606,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1607,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1608,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1609,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1610,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1610,2,Breast discharge,Breast signs and symptoms,Breast disorders,Repro,N
1611,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1612,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1613,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1614,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1614,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1615,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
1615,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1616,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1616,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1617,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1618,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1619,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1620,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1621,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1622,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1623,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1624,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1625,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1625,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1626,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1627,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1628,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1629,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1630,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1630,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1631,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1631,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1632,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1633,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1634,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1634,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1635,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1636,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1636,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1637,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
1638,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1639,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1639,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1640,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1640,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1641,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1641,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1641,3,Headache,Headaches NEC,Headaches,Nerv,N
1642,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1643,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1644,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1644,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1644,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1645,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
1645,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1645,3,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1645,4,Headache,Headaches NEC,Headaches,Nerv,N
1646,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1647,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1648,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1648,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1649,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1650,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1650,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1651,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1651,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1651,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1651,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1651,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1652,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1653,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1654,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1655,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1655,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1656,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1657,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1657,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1657,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1657,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1658,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1659,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1659,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1659,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1660,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1661,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1662,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1662,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1663,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1663,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1664,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1664,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1665,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1665,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1666,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1667,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1668,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1668,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1669,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1670,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1671,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1672,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1673,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1674,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1675,1,Headache,Headaches NEC,Headaches,Nerv,N
1676,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1676,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1677,1,Headache,Headaches NEC,Headaches,Nerv,N
1678,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1679,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1680,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1681,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1682,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1683,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1683,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1684,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1685,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1686,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1687,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1688,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1688,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1689,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1690,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1690,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1691,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1692,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1693,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1694,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1694,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1695,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1696,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1696,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1697,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1698,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1699,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1700,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1701,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1702,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1703,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1704,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1705,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
1706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1707,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1708,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1709,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1710,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1710,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1711,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1712,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1713,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1713,2,Headache,Headaches NEC,Headaches,Nerv,N
1713,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1714,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1715,1,Thrombosis mesenteric vessel,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1716,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1717,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1718,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1718,2,Headache,Headaches NEC,Headaches,Nerv,N
1719,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1720,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1720,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1721,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1722,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1722,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1723,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1724,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1724,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1724,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1724,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1724,5,Headache,Headaches NEC,Headaches,Nerv,N
1725,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1725,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1726,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1727,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1728,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1729,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1730,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1731,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1732,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1733,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1734,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1735,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1735,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1736,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1737,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1738,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1739,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1739,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1739,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1740,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1741,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1742,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1742,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1742,3,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1742,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1743,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1744,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1745,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1745,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1746,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1747,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1748,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1749,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1750,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1751,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1751,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1752,1,Migraine,Migraine headaches,Headaches,Nerv,N
1753,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1754,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1754,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1754,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1755,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1756,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1757,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1758,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1759,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1760,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1761,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1762,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1763,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1763,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1764,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1765,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1766,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1766,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1767,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1767,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1767,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1767,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1768,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1768,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1769,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1769,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1770,1,Migraine,Migraine headaches,Headaches,Nerv,N
1771,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1772,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1773,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1774,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1775,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1776,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1777,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1778,1,Migraine,Migraine headaches,Headaches,Nerv,N
1779,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1780,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1780,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1781,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1782,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
1783,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1784,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1784,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1785,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1785,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1785,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1786,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1786,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1787,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1788,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1789,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1789,2,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
1790,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1791,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1792,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1793,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1794,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1795,1,Migraine,Migraine headaches,Headaches,Nerv,N
1796,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1796,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1797,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1798,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1799,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1799,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1800,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1801,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1801,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1802,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1802,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1803,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1804,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1805,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1805,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1806,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1807,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1808,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1808,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1809,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1809,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1810,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1810,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1811,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1811,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1812,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1813,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1814,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1815,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1815,2,Headache,Headaches NEC,Headaches,Nerv,N
1815,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1816,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1817,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1818,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1818,2,Headache,Headaches NEC,Headaches,Nerv,N
1819,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1820,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1821,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1822,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1823,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1824,1,Headache,Headaches NEC,Headaches,Nerv,N
1825,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1826,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1827,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1828,1,Rash follicular,Pustular conditions,Epidermal and dermal conditions,Skin,N
1829,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1829,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1829,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1830,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1831,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1831,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1832,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1833,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1834,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1834,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1835,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1836,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1837,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1838,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1839,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1840,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1841,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1841,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1842,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1843,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
1843,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1844,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1845,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1846,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1847,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1848,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1848,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1848,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1849,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1849,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1850,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1851,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1851,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1851,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1852,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1853,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1854,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1854,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1855,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1856,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1857,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1858,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1859,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1859,2,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1860,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1860,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1861,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1862,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1863,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1864,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1865,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1865,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1866,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1867,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1868,1,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
1869,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1870,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1871,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1872,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1872,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1872,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1873,1,Headache,Headaches NEC,Headaches,Nerv,N
1874,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1875,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1875,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1876,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1877,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1878,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1878,2,Headache,Headaches NEC,Headaches,Nerv,N
1878,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1879,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1879,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1880,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
1881,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1882,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1882,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1883,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1884,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1885,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1885,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1886,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1886,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1887,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1888,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1889,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1890,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1891,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1892,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1893,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1894,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1895,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1896,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1897,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1898,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1898,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1898,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1899,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1899,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1900,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1901,1,Cervical polyp,Cervix neoplasms,Cervix disorders (excl infections and inflammations),Repro,N
1902,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1903,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1903,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1904,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1905,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1906,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1907,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1908,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1909,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1910,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1911,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1912,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1912,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1913,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1914,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1915,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1915,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1916,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1917,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1918,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1918,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1919,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1919,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1920,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1921,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1922,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1922,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1923,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1924,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1925,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1926,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1927,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1928,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1929,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1930,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1931,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1932,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1933,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1934,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1935,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1936,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1937,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1937,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1938,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1939,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1940,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1940,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1941,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1942,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1943,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1944,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1945,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1946,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1947,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1947,2,Headache,Headaches NEC,Headaches,Nerv,N
1947,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1947,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1948,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1949,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1950,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1950,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1951,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1951,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1951,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1952,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1953,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1954,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1955,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1956,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1956,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1957,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1958,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1959,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1960,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1961,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1962,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1963,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1963,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1964,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1965,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1966,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1967,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1968,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1969,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1969,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1970,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1970,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1971,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1972,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1973,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1974,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1975,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
1976,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1977,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1978,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1979,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1980,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1981,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1981,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1981,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1982,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1982,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1983,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1984,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1985,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1986,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1987,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1987,2,Headache,Headaches NEC,Headaches,Nerv,N
1988,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1989,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1989,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1990,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1990,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1990,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1990,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1991,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1992,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1993,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1994,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1995,1,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
1996,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1997,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1998,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1999,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2000,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2001,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2002,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2003,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
2004,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
2004,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2005,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2005,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2006,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2006,2,Cerebrovascular arteriovenous malformation,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
2007,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2008,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2008,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2009,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2010,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
2011,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2012,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2013,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2014,1,Fibrocystic breast disease,Breast disorders NEC,Breast disorders,Repro,N
2015,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2016,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2016,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2017,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2018,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2019,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2020,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2021,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2022,1,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
2023,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2024,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2024,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2025,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2025,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2026,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2027,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2027,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2028,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2029,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2030,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2030,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2031,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2032,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
2033,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2034,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2035,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2035,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2036,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2037,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2038,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2038,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
2039,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2040,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2041,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2042,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2043,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2044,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2044,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2044,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2045,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2046,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2047,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2048,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2048,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
2049,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2050,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2051,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2052,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2053,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2054,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2055,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2055,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2056,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2057,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2058,1,Headache,Headaches NEC,Headaches,Nerv,N
2058,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2059,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2060,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2061,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2062,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2063,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2064,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2065,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2065,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2066,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2067,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2068,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2068,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2069,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2070,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2071,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2072,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2073,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2074,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2075,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2076,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2077,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2078,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
2078,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2079,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2080,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2081,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2081,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2082,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2083,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2083,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2083,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2083,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2084,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2085,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2086,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2086,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2087,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2088,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2089,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2090,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2090,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2090,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2091,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2092,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2093,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2094,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2094,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2095,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2096,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2096,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2096,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2096,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2097,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2098,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2099,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2099,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2099,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2100,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2101,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2102,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2103,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2104,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2105,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2106,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2107,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2108,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2109,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2110,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2111,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2112,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2113,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2113,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2114,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2115,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2116,1,Porphyria non-acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
2117,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2118,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2119,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2120,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2121,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2121,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2122,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2123,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2124,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2124,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2125,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2126,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2127,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2127,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2127,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2128,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2129,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2130,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2131,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2132,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2133,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2134,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2135,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2136,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2137,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2137,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2137,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2138,1,Headache,Headaches NEC,Headaches,Nerv,N
2139,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
2139,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2139,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2139,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2139,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2140,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2141,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2142,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2143,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2144,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2145,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2146,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2147,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2148,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2149,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2150,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2151,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2152,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2153,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
2154,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2155,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2156,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2157,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2157,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2158,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2159,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2160,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2161,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2162,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2163,1,Headache,Headaches NEC,Headaches,Nerv,N
2163,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2163,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2164,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2165,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2166,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2167,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2168,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2169,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2170,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2171,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2172,1,Varicose ulceration,Varicose veins NEC,Venous varices,Vasc,N
2173,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2173,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2174,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2174,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2175,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2176,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2177,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2178,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2179,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2180,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2181,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
2181,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2181,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2181,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2182,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2183,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2183,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2184,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2184,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2185,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2186,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2187,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2188,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2189,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2189,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2190,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2191,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2192,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2193,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2194,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2194,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2195,1,Headache,Headaches NEC,Headaches,Nerv,N
2196,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2197,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2197,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2198,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2198,2,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
2198,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2198,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2199,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2200,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2201,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2202,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2203,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2204,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
2205,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2206,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2207,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2208,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2209,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2210,1,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2211,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2212,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2212,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2212,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2213,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2214,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2215,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2216,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2216,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2217,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2218,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2218,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2218,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2218,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2219,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2220,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2221,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
2222,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2223,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2224,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2225,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2226,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2227,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2227,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2227,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2228,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2229,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2230,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2231,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2232,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2233,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2234,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2235,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
2236,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2237,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2237,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2237,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2238,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2239,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2240,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2241,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2241,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2241,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2242,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2243,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2244,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2245,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2246,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2247,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2248,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2249,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2250,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2250,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2251,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2252,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2253,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2254,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2254,2,Migraine,Migraine headaches,Headaches,Nerv,N
2255,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2256,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2257,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2257,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2258,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2259,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2260,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2261,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2262,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2263,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2264,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2265,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2266,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2267,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2267,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2268,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2269,1,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2270,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2271,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
2272,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2272,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2273,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2274,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2275,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2276,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2276,2,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2277,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2278,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2279,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2279,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2280,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2280,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2281,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2282,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2282,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2283,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2284,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
2285,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2286,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2287,1,Headache,Headaches NEC,Headaches,Nerv,N
2287,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2287,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2288,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2288,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2289,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2290,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2291,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2292,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2293,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2294,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2294,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2295,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2296,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2297,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2298,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2299,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2299,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2300,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2301,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2302,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2303,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
2304,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2305,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2305,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2306,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2307,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2308,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2309,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
2310,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2311,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2312,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
2313,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2314,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2315,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2315,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2316,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2317,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2318,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2319,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2320,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2321,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2322,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2323,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2324,1,Migraine,Migraine headaches,Headaches,Nerv,N
2325,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2326,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2327,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2328,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2329,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2330,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
2331,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2332,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2333,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2334,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2335,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2336,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2337,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2337,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2338,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2339,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2340,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2341,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2342,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2343,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2344,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2345,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2346,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2346,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2346,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2347,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2348,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2349,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2350,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2351,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2352,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2353,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2354,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2355,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2355,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2355,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2356,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2356,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2357,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2358,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2358,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2359,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2360,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2361,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2361,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2361,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2362,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2363,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2364,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2365,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2366,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2367,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2368,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2369,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2369,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2370,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2371,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2372,1,Headache,Headaches NEC,Headaches,Nerv,N
2373,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2374,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2374,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2374,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2375,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2376,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2376,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2377,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2378,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2379,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2380,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2380,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2380,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2380,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2381,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2381,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2381,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2381,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2381,5,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2382,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2383,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
2384,1,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
2385,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2385,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2386,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2386,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2387,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2388,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2389,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2390,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2391,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2391,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2391,3,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
2391,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2392,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2393,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2394,1,Headache,Headaches NEC,Headaches,Nerv,N
2395,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2396,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2396,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2397,1,Migraine,Migraine headaches,Headaches,Nerv,N
2398,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2399,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2400,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2401,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2402,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2403,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2404,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2405,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2406,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2407,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2408,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2409,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2410,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2411,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2412,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2413,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2413,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2414,1,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
2415,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2416,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2417,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2417,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2418,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2419,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2419,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2419,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2420,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2421,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
2422,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2423,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2423,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2423,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2423,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2423,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2423,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2424,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2425,1,Headache,Headaches NEC,Headaches,Nerv,N
2425,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2426,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2426,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
2427,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2428,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2429,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2430,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2430,2,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2431,1,Device colour issue,Device physical property and chemical issues,Device issues,Prod,N
2432,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2432,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2432,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2433,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2434,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
2434,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2435,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2436,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2436,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2437,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2438,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2438,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2438,3,Claustrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
2438,4,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2438,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2439,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2440,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2440,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2441,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2442,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2443,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2443,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2444,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2445,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2446,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2447,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2447,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2448,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2449,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2450,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2451,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2452,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2452,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2453,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2454,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2455,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2455,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2456,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2457,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2458,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2459,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2459,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2459,3,Headache,Headaches NEC,Headaches,Nerv,N
2459,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2460,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
2460,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2460,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2461,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2462,1,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2462,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2463,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2464,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2464,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2465,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2466,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2467,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2468,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2468,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2468,3,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2468,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2469,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2470,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2471,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2472,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2473,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2473,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2474,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2475,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2476,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2477,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2478,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2479,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2479,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2479,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2480,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2481,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2481,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2481,3,Headache,Headaches NEC,Headaches,Nerv,N
2481,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2481,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2482,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2483,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2484,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2485,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2486,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2486,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
2487,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2487,2,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2488,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2489,1,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2490,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2490,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2491,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2492,1,Retinal vascular occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2493,1,Illusion,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
2493,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2494,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2494,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2495,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2495,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2496,1,Phlebitis superficial,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
2497,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2498,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2498,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2499,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
2500,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2500,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2500,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2501,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2501,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2502,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2502,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2502,3,Headache,Headaches NEC,Headaches,Nerv,N
2502,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2503,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2504,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2505,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2506,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2507,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2508,1,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
2509,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2510,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2510,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2510,3,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
2511,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2512,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2513,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2514,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2515,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2516,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2516,2,Headache,Headaches NEC,Headaches,Nerv,N
2516,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2517,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2518,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2518,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2519,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2519,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2520,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2521,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2522,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2522,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2523,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2524,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2524,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2524,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2525,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2525,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
2525,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2526,1,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
2527,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2527,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2528,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2528,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
2529,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
2530,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2531,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2532,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2532,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
2532,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2532,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2532,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2533,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2534,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2535,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2535,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2535,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2536,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2537,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2538,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2539,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2539,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2540,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2541,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2541,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2542,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2543,1,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2544,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2545,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2546,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2547,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2548,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2549,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2550,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2551,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2551,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2551,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2551,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2552,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2553,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2554,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2554,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2555,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2556,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2557,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2557,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2557,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2558,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
2559,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2559,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2560,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2561,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2562,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2563,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2564,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2564,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2565,1,Headache,Headaches NEC,Headaches,Nerv,N
2565,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2566,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2567,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2567,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2567,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2568,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2568,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2568,3,Headache,Headaches NEC,Headaches,Nerv,N
2569,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2569,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2570,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
2571,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2572,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2573,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2573,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2574,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2575,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2576,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2576,2,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2577,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2578,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2579,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2580,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2581,1,Otosclerosis,Middle ear disorders NEC,Middle ear disorders (excl congenital),Ear,N
2582,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2582,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2583,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2584,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2584,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2585,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2586,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2586,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2587,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
2588,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2589,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2589,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2590,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2591,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2592,1,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
2593,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
2594,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2594,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
2595,1,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
2596,1,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2597,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2598,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2599,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2600,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2601,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2602,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2603,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2603,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2604,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2604,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2605,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2606,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2607,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2607,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2607,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2608,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
2609,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2609,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2610,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2610,2,Headache,Headaches NEC,Headaches,Nerv,N
2611,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2612,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2612,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2612,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2613,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2614,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2615,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2616,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2616,2,Headache,Headaches NEC,Headaches,Nerv,N
2616,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2617,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2617,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2618,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2618,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2619,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2620,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2620,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2621,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2622,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2623,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2624,1,Asthmatic crisis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2625,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2626,1,Cerebral artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2627,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2627,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2628,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2628,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2628,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2628,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2628,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2629,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2630,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2631,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2632,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2633,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2634,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2634,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2635,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2636,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2637,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2638,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2639,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2640,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2641,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2641,2,Otosclerosis,Middle ear disorders NEC,Middle ear disorders (excl congenital),Ear,N
2642,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2643,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2644,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2645,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2646,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2647,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2648,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2649,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2649,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2650,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2651,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2652,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2653,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2654,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2655,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2656,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2657,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2657,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2657,3,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2657,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
2658,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2658,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2659,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2660,1,Headache,Headaches NEC,Headaches,Nerv,N
2660,2,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2661,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2662,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2662,2,Migraine,Migraine headaches,Headaches,Nerv,N
2663,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2664,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2665,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2666,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2666,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2667,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2668,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2669,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2670,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2671,1,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
2672,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2672,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2673,1,Headache,Headaches NEC,Headaches,Nerv,N
2674,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2674,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2675,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2676,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2677,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2678,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2678,2,Headache,Headaches NEC,Headaches,Nerv,N
2678,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2679,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2680,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2680,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
2681,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2681,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2682,1,Tachyphylaxis,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2683,1,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
2684,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2685,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2685,2,Migraine,Migraine headaches,Headaches,Nerv,N
2686,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2687,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2688,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
2689,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2690,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2691,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2691,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2691,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2692,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2693,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2694,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2695,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2696,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2696,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2697,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2697,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2698,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2699,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2699,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
2700,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2700,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2701,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2702,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2702,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2702,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2703,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2704,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2705,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2706,1,Endometrial hyperplasia with cellular atypia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
2707,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2707,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2708,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2708,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2708,3,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
2709,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2710,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2710,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2710,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2711,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2711,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2711,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2712,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2712,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2713,1,Bronchopulmonary aspergillosis allergic,Aspergillus infections,Fungal infectious disorders,Infec,N
2714,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2714,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2715,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2715,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2716,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2716,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2717,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2718,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
2719,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
2720,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2721,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2722,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2723,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2724,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2725,1,Migraine,Migraine headaches,Headaches,Nerv,N
2726,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2727,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
2727,2,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
2728,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2729,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2730,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2731,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2731,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2732,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2732,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2732,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2732,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2733,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2734,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2735,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2735,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2736,1,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
2737,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2738,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2739,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2739,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2739,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2739,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2740,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2740,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2741,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2741,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2742,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2742,2,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2743,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2743,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2744,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2744,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2745,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2745,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2746,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2746,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2747,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2748,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2748,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2748,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2748,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2749,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
2749,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
2750,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2751,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2751,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2752,1,Conjunctival disorder,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
2752,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2753,1,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2754,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2754,2,Phobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
2755,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2755,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2756,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2757,1,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2758,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2759,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2759,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2759,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2760,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2760,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2761,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2762,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
2762,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2762,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2763,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2764,1,Brain stem infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2764,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2764,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2765,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2766,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
2766,2,Scintillating scotoma,Visual disorders NEC,Vision disorders,Eye,N
2766,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2767,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
2767,2,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2767,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2768,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2768,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2768,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2769,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2770,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2771,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2772,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2773,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2774,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2774,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2774,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2774,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2774,5,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2774,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2774,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2775,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2775,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2776,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2777,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2778,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2778,2,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
2779,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
2780,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2780,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2781,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2782,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2782,2,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2783,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2783,2,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2784,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2785,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
2786,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2786,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2787,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2788,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2788,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2788,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2789,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2790,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2791,1,Androgenetic alopecia,Alopecias,Skin appendage conditions,Skin,N
2791,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2792,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2793,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2794,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2794,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2794,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2795,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2795,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2795,3,Headache,Headaches NEC,Headaches,Nerv,N
2795,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2795,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2796,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2797,1,Endometrial hyperplasia with cellular atypia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
2798,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2798,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2799,1,Headache,Headaches NEC,Headaches,Nerv,N
2799,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2800,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2800,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2801,1,Vulvovaginal inflammation,Vaginal and vulval infections and inflammations,Female reproductive tract infections and inflammations,Repro,N
2802,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2802,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2803,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2804,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2805,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2806,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2807,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2808,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2809,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2809,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2810,1,Headache,Headaches NEC,Headaches,Nerv,N
2810,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2811,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2811,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
2811,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2811,4,Sinus rhythm,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2811,5,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2812,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2813,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2813,2,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2813,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2813,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2814,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2814,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2815,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2815,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2816,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2816,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2817,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2817,2,Oestradiol increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
2817,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2818,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2819,1,Vulvovaginal inflammation,Vaginal and vulval infections and inflammations,Female reproductive tract infections and inflammations,Repro,N
2820,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2820,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2821,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2821,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2821,3,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2822,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2823,1,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
2824,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2824,2,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
2824,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2824,4,Nerve conduction studies abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2825,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2826,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2827,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2828,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2828,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
2829,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2830,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2831,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2832,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2833,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2834,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2835,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2836,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2837,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2837,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2838,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2838,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2839,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2840,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2841,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2842,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2843,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2844,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2844,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2845,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2845,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2845,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2846,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2846,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2846,3,Headache,Headaches NEC,Headaches,Nerv,N
2846,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2846,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2847,1,Migraine,Migraine headaches,Headaches,Nerv,N
2848,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2849,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
2850,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2850,2,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
2851,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2852,1,Antiphospholipid syndrome,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2852,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2853,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2854,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2854,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
2855,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2856,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2857,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2858,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2859,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2860,1,Headache,Headaches NEC,Headaches,Nerv,N
2861,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2862,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2863,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2864,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2865,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2865,2,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
2866,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2866,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2866,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2867,1,Headache,Headaches NEC,Headaches,Nerv,N
2867,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2867,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2868,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2869,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2869,2,Headache,Headaches NEC,Headaches,Nerv,N
2869,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2870,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2870,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2870,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2870,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2870,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2871,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2872,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2872,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2872,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2872,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2872,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
2873,1,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2874,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2875,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2875,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2876,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2877,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2878,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2879,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
2880,1,Breast cancer stage III,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2881,1,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2881,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2882,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2882,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2883,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2883,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2884,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2884,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2885,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2886,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2887,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2887,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2888,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2888,2,Smear site unspecified abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2888,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2889,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
2889,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2890,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2890,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2891,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2891,2,Headache,Headaches NEC,Headaches,Nerv,N
2891,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2892,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2893,1,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2893,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2894,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2894,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2894,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2895,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2895,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2895,3,Uterine enlargement,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
2896,1,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
2896,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2897,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2897,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
2897,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2898,1,Polypectomy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2899,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2899,2,Polypectomy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2900,1,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2900,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2901,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2902,1,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2902,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2902,3,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2902,4,Post concussion syndrome,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2902,5,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2902,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2903,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
2903,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2903,3,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
2903,4,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
2903,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2903,6,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2904,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2905,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2906,1,Neurosurgery,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
2907,1,Bloody discharge,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2907,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
2908,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2908,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2909,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2910,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2910,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2910,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2911,1,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
2912,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2912,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2913,1,Malignant mesenchymoma,Mesenchymomas malignant,Soft tissue neoplasms malignant and unspecified,Neopl,N
2914,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2915,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2916,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2917,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2917,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2917,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2917,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2918,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2918,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2918,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2918,4,Headache,Headaches NEC,Headaches,Nerv,N
2918,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2918,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2919,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2920,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2920,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2921,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2922,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2923,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2924,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2924,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
2925,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2926,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2927,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2928,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
2928,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2928,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2929,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2929,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2929,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2930,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2931,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2931,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2931,3,Headache,Headaches NEC,Headaches,Nerv,N
2931,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2932,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2932,2,Migraine,Migraine headaches,Headaches,Nerv,N
2933,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2934,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
2934,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2934,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2934,4,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2934,5,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2935,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2935,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2936,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2937,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2937,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2937,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2937,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2938,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2938,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2939,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2939,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2939,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2939,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2939,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2940,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2940,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2941,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2942,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2943,1,Migraine,Migraine headaches,Headaches,Nerv,N
2944,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2944,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2944,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2944,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2944,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2944,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2945,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2945,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2945,3,Headache,Headaches NEC,Headaches,Nerv,N
2946,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
2946,2,Duodenal atresia,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
2946,3,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
2946,4,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
2947,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2948,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2948,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2948,3,Headache,Headaches NEC,Headaches,Nerv,N
2948,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2948,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2948,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2949,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2949,2,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
2950,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2951,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2951,2,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2952,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2952,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2953,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2953,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2954,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2954,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2954,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2954,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2955,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
2956,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2957,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2957,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2957,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2958,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2958,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2958,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2959,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2959,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2960,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2961,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2961,2,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2961,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2961,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2961,5,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2962,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2962,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2963,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2963,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2964,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2964,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2964,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2965,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2965,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2965,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2965,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2966,1,Pregnancy on oral contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
2966,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2967,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2967,2,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2967,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2967,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2968,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2968,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2969,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2970,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2970,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2970,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2970,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2971,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2971,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2971,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2972,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2972,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2973,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2974,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2974,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2974,3,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
2974,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2975,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2975,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2976,1,Blood oestrogen increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
2976,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
2976,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2976,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2976,5,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2977,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
2978,1,Gastric operation,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
2978,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2978,3,Medical diet,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
2979,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2980,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2981,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2981,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2982,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2983,1,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2984,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2984,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2984,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2984,4,Illogical thinking,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2984,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2984,6,Neurosis,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
2984,7,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2985,1,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2986,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2986,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2987,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
2988,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2989,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2990,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2990,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2990,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2990,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2990,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2990,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2990,7,Migraine,Migraine headaches,Headaches,Nerv,N
2990,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2991,1,Endometrial thickening,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
2991,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2991,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2992,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2993,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2993,2,Self-medication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2994,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
2995,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2995,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2995,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2995,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2996,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2996,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2996,3,Self-medication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2997,1,Acne,Acnes,Skin appendage conditions,Skin,N
2998,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2998,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2998,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2998,4,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2998,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2998,6,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
2999,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
2999,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3000,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3001,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3001,2,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3002,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3003,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3003,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3003,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3003,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3003,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3003,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3003,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3003,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3003,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3003,10,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3003,11,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3003,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3003,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3004,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3005,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3005,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3006,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3006,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3006,3,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3006,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3007,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3007,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3007,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3007,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3007,5,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3007,6,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3008,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3008,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3009,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3009,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3010,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3010,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3011,1,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3012,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3012,2,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3013,1,Dry age-related macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3013,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3014,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3015,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3015,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3016,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3016,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3016,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3016,4,Product commingling,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3017,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3017,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3017,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3018,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3018,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3018,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3018,4,Headache,Headaches NEC,Headaches,Nerv,N
3018,5,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3018,6,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3018,7,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3018,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
3019,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3019,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3019,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3019,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3020,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3020,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3020,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3020,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3020,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3020,6,Headache,Headaches NEC,Headaches,Nerv,N
3020,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3021,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3022,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3022,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3022,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3023,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3023,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3024,1,Headache,Headaches NEC,Headaches,Nerv,N
3024,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3025,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
3025,2,Breast disorder,Breast disorders NEC,Breast disorders,Repro,N
3025,3,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
3025,4,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3025,5,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3025,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3025,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3025,8,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3026,1,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3027,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3027,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3028,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3028,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3029,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3029,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3029,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3030,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3030,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3030,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3031,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3032,1,Abulia,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3032,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3032,3,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
3032,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3032,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3032,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3032,7,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3032,8,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3032,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3033,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3034,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3034,2,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3034,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3034,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3034,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3034,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3034,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3034,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3034,9,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3034,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3034,11,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3034,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3035,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3035,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
3036,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3037,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3038,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3038,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3038,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3038,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3038,5,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3038,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3038,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3038,8,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3038,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3038,10,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3038,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3038,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3038,13,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3039,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3039,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3040,1,Gastric bypass,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3041,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3042,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3042,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3042,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
3043,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3043,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3043,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3043,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
3043,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3044,1,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3045,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3046,1,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3047,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3047,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3047,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3048,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3049,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3049,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3049,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3050,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3051,1,Breast oedema,Breast signs and symptoms,Breast disorders,Repro,N
3051,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3051,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3051,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3051,5,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
3051,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3051,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3052,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3053,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3054,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3054,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3055,1,Headache,Headaches NEC,Headaches,Nerv,N
3056,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3056,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3056,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3056,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3056,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3056,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3057,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
3058,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3058,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3059,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3059,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3059,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3060,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3061,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3061,2,Application site scar,Application site reactions,Administration site reactions,Genrl,N
3061,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3061,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3062,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3062,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3062,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3062,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3063,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3063,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3063,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3064,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3064,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3064,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3064,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3064,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3065,1,Migraine,Migraine headaches,Headaches,Nerv,N
3066,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3066,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3067,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3068,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3069,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3069,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3069,3,Quadrantanopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
3069,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3069,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3070,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3071,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3071,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3071,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3071,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3072,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3073,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3074,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3074,2,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3075,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3076,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3076,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3076,3,Adrenal adenoma,Adrenal neoplasms benign,Endocrine neoplasms benign,Neopl,N
3076,4,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3076,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3076,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3077,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3077,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3078,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3078,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3078,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3078,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3079,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3079,2,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
3079,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3079,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3080,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3080,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3081,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3082,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3082,2,Migraine,Migraine headaches,Headaches,Nerv,N
3082,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3083,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3084,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3084,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3085,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3085,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3085,3,Headache,Headaches NEC,Headaches,Nerv,N
3085,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3085,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3085,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3085,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3085,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3086,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3086,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3086,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3087,1,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3087,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3088,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3088,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3088,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3088,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3089,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3089,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3089,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3090,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3090,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3091,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3091,2,Pregnancy on contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3092,1,Oedema genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
3092,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3092,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3092,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3092,5,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3093,1,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
3094,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3094,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3095,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
3095,2,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3096,1,Headache,Headaches NEC,Headaches,Nerv,N
3097,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3098,1,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3099,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3100,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3101,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3102,1,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3103,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
3103,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3103,3,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3104,1,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
3105,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3106,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3107,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3108,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3108,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3108,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3109,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3110,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3111,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3111,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3111,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3112,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3112,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3113,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3113,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3114,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3114,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3114,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3115,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3116,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
3117,1,Hormone receptor positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3118,1,Babinski reflex test,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
3118,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
3118,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3118,4,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3118,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3118,6,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3118,7,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3118,8,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3118,9,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3118,10,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3118,11,Headache,Headaches NEC,Headaches,Nerv,N
3118,12,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3118,13,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
3118,14,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
3118,15,Limb asymmetry,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3118,16,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3118,17,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
3118,18,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3118,19,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3118,20,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
3118,21,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3118,22,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3118,23,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3118,24,Visual field defect,Visual field disorders,Vision disorders,Eye,N
3118,25,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3119,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3119,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3119,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3120,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3121,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3121,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3121,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3121,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3121,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3121,6,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3121,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3122,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3123,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3123,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3123,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3123,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3124,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3124,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3124,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3124,4,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3124,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3124,6,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
3124,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
3124,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3125,1,Migraine,Migraine headaches,Headaches,Nerv,N
3126,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3127,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3128,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3129,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3129,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3130,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3130,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3130,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3131,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3131,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3131,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3132,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3132,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3133,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3134,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3134,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3134,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3135,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3135,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3136,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3136,2,Headache,Headaches NEC,Headaches,Nerv,N
3137,1,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3137,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3138,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3138,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3138,3,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3138,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3139,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3139,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3139,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3139,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3139,5,Breast inflammation,Breast infections and inflammations,Breast disorders,Repro,N
3139,6,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
3139,7,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3139,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3139,9,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3139,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3139,11,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3139,12,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3139,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3139,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3139,15,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3139,16,Stress urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3139,17,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3140,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3141,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3141,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3142,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3143,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3143,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3143,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3143,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3143,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3143,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3144,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3145,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3145,2,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3145,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3146,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3147,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3147,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3147,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3147,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3147,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3147,6,Headache,Headaches NEC,Headaches,Nerv,N
3147,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3147,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3147,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3147,10,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3147,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3148,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3148,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3148,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3149,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
3149,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3149,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3150,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3150,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3150,3,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
3150,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3150,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3150,6,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
3150,7,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3150,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3151,1,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
3152,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3152,2,Headache,Headaches NEC,Headaches,Nerv,N
3152,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3152,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3152,5,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3152,6,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
3152,7,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3152,8,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3152,9,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
3152,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3152,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3152,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3152,13,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3152,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3153,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3153,2,Dysacusis,Hearing disorders NEC,Hearing disorders,Ear,N
3153,3,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
3153,4,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
3153,5,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3153,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3153,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3153,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3153,9,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3153,10,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3153,11,Hypoaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3153,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3153,13,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
3153,14,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
3153,15,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3153,16,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3153,17,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
3153,18,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3153,19,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3153,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3154,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3154,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3154,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3154,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3154,5,Heart valve incompetence,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
3154,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3155,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3156,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3157,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3157,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3157,3,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3158,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3158,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3159,1,Headache,Headaches NEC,Headaches,Nerv,N
3159,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3159,3,Hypoaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3159,4,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
3159,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3159,6,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
3159,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3159,8,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3159,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3159,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3160,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3161,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3161,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3162,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3162,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3163,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3163,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3163,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3163,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3163,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3164,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3165,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3166,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3166,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3166,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3166,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3166,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3166,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3166,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3166,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3166,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3166,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3166,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3166,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3166,13,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3166,14,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3167,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3167,2,Exposure via partner,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
3168,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3169,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3169,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3170,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3170,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3170,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3170,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3170,5,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3171,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3171,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3171,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3171,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3171,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3171,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3171,7,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3172,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3172,2,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
3172,3,Headache,Headaches NEC,Headaches,Nerv,N
3173,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
3174,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3174,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3174,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3174,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3174,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3174,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3175,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3175,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
3175,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3176,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3177,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3177,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3177,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3177,4,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3178,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3179,1,Diffuse alopecia,Alopecias,Skin appendage conditions,Skin,N
3180,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3180,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3180,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3180,4,Contact lens intolerance,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3180,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3180,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3180,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3180,8,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
3180,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3181,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3181,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3181,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3181,4,Lactose intolerance,Sugar intolerance (excl glucose intolerance),Food intolerance syndromes,Metab,N
3182,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3183,1,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
3184,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3184,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3184,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3184,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3184,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3184,6,Headache,Headaches NEC,Headaches,Nerv,N
3184,7,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3184,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3184,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3185,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3185,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3186,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3186,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
3186,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3186,4,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
3187,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3187,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3187,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3187,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3187,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3188,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3188,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3188,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3189,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3189,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3189,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3190,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3190,2,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
3190,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3190,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3190,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3190,6,Endometrial disorder,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3190,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3190,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3190,9,Impaired reasoning,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3190,10,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3190,11,Lid sulcus deepened,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3190,12,Madarosis,Alopecias,Skin appendage conditions,Skin,N
3190,13,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3190,14,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3190,15,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3190,16,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3190,17,Ovarian disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
3190,18,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3190,19,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3190,20,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
3190,21,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
3190,22,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3190,23,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3191,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3191,2,Foetal malformation,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
3192,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3193,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3194,1,Adnexa uteri mass,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3195,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3195,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3196,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3196,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3196,3,Headache,Headaches NEC,Headaches,Nerv,N
3196,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3196,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3196,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3196,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3196,8,Vertigo positional,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3197,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3198,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3198,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3198,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3199,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3199,2,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
3200,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3201,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3202,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
3203,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3203,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3203,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3203,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3204,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3204,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3204,3,Migraine,Migraine headaches,Headaches,Nerv,N
3204,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3205,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3205,2,Migraine,Migraine headaches,Headaches,Nerv,N
3206,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3206,2,Migraine,Migraine headaches,Headaches,Nerv,N
3207,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3208,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3208,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3209,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3209,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3209,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3209,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3209,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3209,6,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3210,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
3211,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3211,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3212,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
3213,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3213,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3213,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3214,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3214,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3214,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3214,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3215,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3216,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3217,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3218,1,Headache,Headaches NEC,Headaches,Nerv,N
3218,2,Migraine,Migraine headaches,Headaches,Nerv,N
3218,3,Visual brightness,Visual disorders NEC,Vision disorders,Eye,N
3218,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3219,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3220,1,Blood pressure inadequately controlled,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3220,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3220,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
3220,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3220,5,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3220,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3220,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3220,8,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3220,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3220,10,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3221,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3221,2,Transverse sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
3222,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3222,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3222,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3222,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3222,5,Migraine,Migraine headaches,Headaches,Nerv,N
3223,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
3223,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3223,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3223,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3223,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
3223,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3223,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3223,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3223,9,Product gel formation,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3223,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3223,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3223,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3223,13,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3224,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3224,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3225,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3225,2,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3225,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3225,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3226,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3226,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3227,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3227,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3227,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3228,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3229,1,Headache,Headaches NEC,Headaches,Nerv,N
3229,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3229,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3230,1,Basal ganglia infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3231,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
3231,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3231,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3231,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3232,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3232,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3232,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3232,4,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3232,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3233,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3233,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3234,1,Hyperinsulinaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3235,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3235,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3235,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3235,4,Headache,Headaches NEC,Headaches,Nerv,N
3235,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3235,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3236,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3237,1,Hormone receptor positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3237,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3238,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3239,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3239,2,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3239,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3239,4,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3239,5,Benign neoplasm of skin,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
3239,6,Benign neoplasm of skin,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
3239,7,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3239,8,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
3239,9,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3239,10,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3239,11,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3239,12,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3239,13,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3239,14,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3239,15,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
3239,16,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3239,17,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
3239,18,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3239,19,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3239,20,Genital swelling,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
3239,21,Headache,Headaches NEC,Headaches,Nerv,N
3239,22,Headache,Headaches NEC,Headaches,Nerv,N
3239,23,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3239,24,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3239,25,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3239,26,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3239,27,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3239,28,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3239,29,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3239,30,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3239,31,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3239,32,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3239,33,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3239,34,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3239,35,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3239,36,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
3239,37,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3239,38,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3239,39,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3239,40,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
3239,41,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3239,42,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3239,43,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3239,44,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3239,45,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3239,46,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
3239,47,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3239,48,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3239,49,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
3239,50,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3239,51,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3239,52,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3240,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3240,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3240,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
3240,4,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3240,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
3240,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
3241,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3241,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3242,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3242,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3243,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3244,1,Asthma late onset,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3245,1,Acne,Acnes,Skin appendage conditions,Skin,N
3245,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3245,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3245,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3245,5,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
3246,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3246,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3247,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3248,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3249,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3250,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3250,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3251,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3251,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3252,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3252,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3253,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3253,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3253,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3253,4,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3253,5,Headache,Headaches NEC,Headaches,Nerv,N
3253,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3253,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3254,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3254,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3255,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3256,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3256,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3256,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3256,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3257,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3258,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3258,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3259,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3259,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3259,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3259,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
3259,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3259,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3260,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3260,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3260,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3260,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3260,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3261,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3261,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3261,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3262,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3262,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3262,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3262,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3263,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3263,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3263,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
3263,4,Headache,Headaches NEC,Headaches,Nerv,N
3263,5,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3263,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3263,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3263,8,Postictal state,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3264,1,Headache,Headaches NEC,Headaches,Nerv,N
3265,1,Contact lens intolerance,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3265,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3265,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3265,4,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
3265,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3265,6,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
3266,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3267,1,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
3267,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3268,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3268,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3268,3,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3269,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3269,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3269,3,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
3269,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3269,5,Blood testosterone abnormal,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
3269,6,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
3269,7,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3269,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3269,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3269,10,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
3269,11,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3269,12,Nipple disorder,Breast disorders NEC,Breast disorders,Repro,N
3269,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3269,14,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3269,15,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3269,16,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3269,17,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3270,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3270,2,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3271,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3271,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3271,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3271,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3272,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3272,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3272,3,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3273,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3274,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3274,2,Migraine,Migraine headaches,Headaches,Nerv,N
3275,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
3275,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3275,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3275,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3275,5,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3276,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3277,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3278,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3279,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3279,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3279,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3280,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3280,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3281,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3281,2,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
3282,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3282,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3282,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3282,4,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3282,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3282,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3282,7,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3282,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3282,9,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3282,10,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3282,11,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3282,12,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3282,13,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3282,14,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3282,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3282,16,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3282,17,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3282,18,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3282,19,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3283,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3284,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3285,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3286,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3287,1,Vulvovaginal inflammation,Vaginal and vulval infections and inflammations,Female reproductive tract infections and inflammations,Repro,N
3287,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3288,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3288,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3288,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3288,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3288,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3288,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3289,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3290,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3290,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3290,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3291,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3292,1,Genital tract inflammation,Reproductive tract infections and inflammations NEC,Reproductive tract disorders NEC,Repro,N
3292,2,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3293,1,Headache,Headaches NEC,Headaches,Nerv,N
3294,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3294,2,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
3294,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3295,1,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3295,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3296,1,Administration site reaction,Administration site reactions NEC,Administration site reactions,Genrl,N
3297,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3298,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3299,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3299,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3300,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3300,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3300,3,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3300,4,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3300,5,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3300,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3300,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3300,8,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3300,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3300,10,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3300,11,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3300,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3300,13,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3301,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3302,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3303,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3303,2,Plantar fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3304,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3305,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3305,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3305,3,Migraine with aura,Migraine headaches,Headaches,Nerv,N
3306,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3306,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3306,3,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3307,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3308,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3309,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3310,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3311,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3311,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3311,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3311,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3311,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3311,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3312,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3312,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3313,1,Ovarian hyperstimulation syndrome,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
3313,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3314,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3315,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
3315,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3316,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3316,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3317,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3317,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3318,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3318,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3319,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3319,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3320,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3320,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3321,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3321,2,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3322,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3323,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3323,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3324,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3324,2,Headache,Headaches NEC,Headaches,Nerv,N
3325,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
3325,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3325,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3325,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3325,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3326,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3326,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3326,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3326,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3327,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3327,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3327,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3327,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3327,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3327,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3328,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3329,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
3329,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3330,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3330,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3330,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
3330,4,Vulvovaginal erythema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3330,5,Vulvovaginal inflammation,Vaginal and vulval infections and inflammations,Female reproductive tract infections and inflammations,Repro,N
3330,6,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3331,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3332,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3332,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3333,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3333,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3333,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
3333,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3333,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3333,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3334,1,Tongue biting,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3335,1,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3335,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3336,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3336,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3337,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3338,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3339,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3339,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3339,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3340,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3340,2,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3340,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3341,1,Acne,Acnes,Skin appendage conditions,Skin,N
3342,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3342,2,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3342,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3343,1,Narrow anterior chamber angle,"Anterior chamber structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
3344,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3344,2,Finger deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3344,3,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3344,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
3344,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3344,6,Normal tension glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3344,7,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
3345,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
3345,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3345,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3345,4,Headache,Headaches NEC,Headaches,Nerv,N
3345,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3345,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3345,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3346,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3346,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3347,1,Ovarian hyperstimulation syndrome,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
3348,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3348,2,Obsessive thoughts,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
3348,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3349,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3349,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3349,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3349,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3349,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3349,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3350,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
3350,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3351,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3352,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3353,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3354,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3355,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3355,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3355,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3356,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3357,1,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
3358,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3358,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3358,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3358,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3358,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3358,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
3358,7,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3358,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3358,9,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3358,10,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3359,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3359,2,Headache,Headaches NEC,Headaches,Nerv,N
3359,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3359,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3359,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3360,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3360,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3361,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3361,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3361,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3361,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3361,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3361,6,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3361,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3361,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3361,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3361,10,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3361,11,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3361,12,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3361,13,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3361,14,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3362,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3362,2,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3362,3,Product selection error,Product selection errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3362,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3363,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3363,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3364,1,Abnormal withdrawal bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3364,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3365,1,Allergy to chemicals,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3365,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3366,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3366,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3367,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3368,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3368,2,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3369,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3369,2,Menstrual discomfort,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3369,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3369,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3369,5,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3370,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3371,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3371,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3371,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3371,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3371,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3371,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3371,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3371,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3371,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3371,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3371,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3372,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3373,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3374,1,Headache,Headaches NEC,Headaches,Nerv,N
3374,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3374,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3375,1,Acute cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
3375,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3376,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3376,2,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3376,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3376,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3376,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3376,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3376,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3377,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3377,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3378,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
3378,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3378,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3379,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3380,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3381,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3381,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3381,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3382,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3383,1,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
3383,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3383,3,Migraine,Migraine headaches,Headaches,Nerv,N
3383,4,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3383,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3383,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3384,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3384,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3384,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3384,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3384,5,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3385,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
3386,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3387,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3387,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3388,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3389,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3389,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3389,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3390,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3391,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3392,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3392,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3392,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3393,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3394,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3394,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3395,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3395,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3395,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3395,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3395,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3395,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3395,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3395,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3395,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3395,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3395,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3396,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3396,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3396,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3396,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
3396,5,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3397,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3397,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3398,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3398,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3398,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3398,4,Headache,Headaches NEC,Headaches,Nerv,N
3398,5,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
3398,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3398,7,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3398,8,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3399,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
3399,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3400,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
3401,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3401,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3401,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3401,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3402,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3402,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3402,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3402,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3402,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3403,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3403,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3404,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3405,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3406,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3407,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3407,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3407,3,Headache,Headaches NEC,Headaches,Nerv,N
3407,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3408,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3408,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3409,1,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3409,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3410,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3410,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3410,3,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
3410,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3411,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3411,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3412,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3412,2,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3412,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3413,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3413,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3413,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3413,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3414,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3414,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3414,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3414,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3415,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3415,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3415,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3415,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3415,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3416,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3416,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3416,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3416,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3417,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3418,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3418,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3419,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3419,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3420,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3420,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3420,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3421,1,Eye paraesthesia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3421,2,Genital tract inflammation,Reproductive tract infections and inflammations NEC,Reproductive tract disorders NEC,Repro,N
3421,3,Headache,Headaches NEC,Headaches,Nerv,N
3421,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3421,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3422,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3422,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3422,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3423,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3424,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3425,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3426,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3427,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3427,2,Headache,Headaches NEC,Headaches,Nerv,N
3428,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3429,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3429,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3429,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3429,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3430,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3430,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3431,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3432,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3432,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3433,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3434,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3434,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3434,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3434,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3435,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3436,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3437,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3437,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3437,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3438,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3438,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3438,3,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3438,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3439,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3439,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3439,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3439,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3439,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3439,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3439,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3440,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3440,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3441,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3441,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3442,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3442,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3442,3,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3443,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3444,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3445,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3445,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3445,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3445,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3445,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3445,6,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3446,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3447,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3448,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3448,2,Headache,Headaches NEC,Headaches,Nerv,N
3448,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3448,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3448,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3448,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3448,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3449,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3449,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3449,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3449,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3449,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3449,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3450,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3450,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3450,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3450,4,Superficial vein prominence,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3450,5,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3451,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3451,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3451,3,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3451,4,Sweating fever,Viral infections NEC,Viral infectious disorders,Infec,N
3451,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3452,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3452,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3453,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3453,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3453,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3454,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3454,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3454,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3454,4,Coccydynia,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
3454,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3455,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3455,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3455,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3455,4,Headache,Headaches NEC,Headaches,Nerv,N
3455,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3455,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3455,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3455,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3456,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3456,2,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3457,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3457,2,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
3457,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3457,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3457,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3458,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3458,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3458,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
3458,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3458,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3459,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3459,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3459,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3460,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3460,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3460,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3461,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3461,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3461,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3461,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3462,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3463,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3464,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3464,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3464,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3464,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3465,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3465,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3466,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3467,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3467,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3467,3,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3467,4,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3467,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3467,6,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3467,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3467,8,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3467,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3467,10,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3467,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3467,12,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3467,13,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3467,14,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
3467,15,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3467,16,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3468,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3468,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3468,3,Migraine,Migraine headaches,Headaches,Nerv,N
3469,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3470,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3470,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3470,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3470,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3470,5,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3471,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3471,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3471,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3471,4,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3472,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3472,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3472,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3472,4,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3473,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3473,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3473,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3473,4,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3473,5,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3474,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3474,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3474,3,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3474,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3474,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3474,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3474,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3474,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3474,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3475,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3475,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3476,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
3476,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3476,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3476,4,Headache,Headaches NEC,Headaches,Nerv,N
3476,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3477,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3478,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3478,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3479,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
3479,2,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
3480,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3481,1,Oestradiol increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
3481,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3482,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3482,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3482,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3483,1,Migraine,Migraine headaches,Headaches,Nerv,N
3484,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3484,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3484,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3484,4,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3485,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3485,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3485,3,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3485,4,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3486,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3486,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
3486,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3486,4,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
3486,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3486,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3486,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3486,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3486,9,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3486,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3486,11,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3486,12,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
3487,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3488,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3489,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3489,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3489,3,Headache,Headaches NEC,Headaches,Nerv,N
3489,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3489,5,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3489,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3489,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3489,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3490,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3490,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3490,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3490,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3491,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3491,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
3491,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3491,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3491,5,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3491,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3491,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3492,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3493,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
3493,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
3494,1,Migraine,Migraine headaches,Headaches,Nerv,N
3494,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3494,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3495,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3496,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3497,1,Breast cancer stage I,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3497,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
3498,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3498,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3498,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3499,1,Acne,Acnes,Skin appendage conditions,Skin,N
3499,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3499,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3499,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3499,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3499,6,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3499,7,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3500,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
3500,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3500,3,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3501,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3502,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3502,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3503,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3503,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3503,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3504,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3504,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3505,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
3505,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3505,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3506,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3506,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3506,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3506,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3506,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3506,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3506,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3507,1,Breast engorgement,Breast signs and symptoms,Breast disorders,Repro,N
3507,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
3508,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3508,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3508,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3508,4,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3508,5,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3509,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3509,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3509,3,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3509,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3510,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3511,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3512,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
3512,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3512,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3513,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3514,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3514,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3514,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3514,4,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3514,5,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3514,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3515,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3515,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3516,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3516,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3516,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3516,4,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3517,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3517,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3517,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3517,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3518,1,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3518,2,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3519,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3519,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3519,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3519,4,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3519,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3520,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3520,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3520,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3521,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3521,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3522,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3523,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3524,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3525,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3525,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3525,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3525,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3525,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3525,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3526,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3526,2,Retracted nipple,Breast disorders NEC,Breast disorders,Repro,N
3527,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3527,2,Retracted nipple,Breast disorders NEC,Breast disorders,Repro,N
3528,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3528,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3529,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3530,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3531,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
3531,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3531,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3532,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3532,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3533,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3534,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3534,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3534,3,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3534,4,Headache,Headaches NEC,Headaches,Nerv,N
3535,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3535,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3535,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3535,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3536,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3536,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3536,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3537,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3537,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3538,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3539,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3539,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3539,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
3539,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3539,5,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3539,6,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
3540,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3541,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3542,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3543,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3544,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3544,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3544,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3545,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
3545,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3545,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3545,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
3545,5,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3545,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3546,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3546,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3546,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3546,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3546,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3547,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3547,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3548,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3549,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3549,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3549,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3549,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3549,5,Headache,Headaches NEC,Headaches,Nerv,N
3549,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3549,7,Vulvovaginal mycotic infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3550,1,Application site wound,Application site reactions,Administration site reactions,Genrl,N
3551,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3552,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3552,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3552,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3553,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3553,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3553,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3553,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3554,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3554,2,Bacterial diarrhoea,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3554,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3555,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3555,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3555,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3555,4,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3555,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3556,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
3557,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3557,2,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3558,1,Endometrial thickening,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3558,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3558,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3558,4,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
3558,5,Vaginal erosion,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3558,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3559,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3559,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3560,1,Migraine,Migraine headaches,Headaches,Nerv,N
3561,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3561,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3561,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3561,4,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
3561,5,Nipple swelling,Breast signs and symptoms,Breast disorders,Repro,N
3562,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3562,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3562,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3562,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3563,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3564,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3564,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3564,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3564,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3564,5,Headache,Headaches NEC,Headaches,Nerv,N
3564,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3565,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3565,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3566,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3566,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3566,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3566,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3567,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3568,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3569,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3569,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3569,3,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3569,4,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3569,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3570,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3570,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3570,3,Headache,Headaches NEC,Headaches,Nerv,N
3570,4,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3570,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3571,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3571,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3571,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3571,4,Dyschezia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3571,5,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3571,6,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
3571,7,Headache,Headaches NEC,Headaches,Nerv,N
3571,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3571,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3572,1,Acne,Acnes,Skin appendage conditions,Skin,N
3572,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3573,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3573,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3574,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3575,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3575,2,Depressive symptom,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3575,3,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3576,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3576,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3576,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3577,1,Gastric bypass,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3578,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3578,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3579,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3579,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3579,3,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3580,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3581,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3581,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3581,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3581,4,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3581,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3581,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3581,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3581,8,Visual field defect,Visual field disorders,Vision disorders,Eye,N
3582,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3582,2,Headache,Headaches NEC,Headaches,Nerv,N
3582,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3582,4,Migraine with aura,Migraine headaches,Headaches,Nerv,N
3582,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3582,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3582,7,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
3582,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3583,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3584,1,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
3584,2,Oral mucosal discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3584,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3585,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3585,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3586,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3586,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3586,3,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3586,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3587,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3587,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3588,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3588,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3588,3,Altered visual depth perception,Refractive and accommodative disorders,Vision disorders,Eye,N
3588,4,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3588,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3588,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3588,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3589,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3590,1,Basilar artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3590,2,Basilar artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3590,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3590,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3591,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
3591,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3591,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3591,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3592,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3592,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3593,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3593,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3593,3,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
3593,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3594,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3594,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3594,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3595,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3596,1,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3596,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3596,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3597,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3597,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3598,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3598,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3598,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3598,4,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3599,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3599,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3599,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
3599,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3599,5,Overlap syndrome,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
3599,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3599,7,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3600,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3601,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3602,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3602,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3602,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3603,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3604,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3604,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3604,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3605,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3606,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
3606,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3606,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3607,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3608,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3608,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3608,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3609,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3609,2,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
3609,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3609,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3609,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3609,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3609,7,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3609,8,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3610,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
3610,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3610,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3611,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3611,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3611,3,Muscle tone disorder,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
3612,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3612,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3612,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3613,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3613,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3614,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3614,2,Headache,Headaches NEC,Headaches,Nerv,N
3614,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3615,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3616,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
3617,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3617,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
3617,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3617,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3617,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3618,1,Breast cancer stage III,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3619,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3620,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3620,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3620,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3620,4,Application site scar,Application site reactions,Administration site reactions,Genrl,N
3621,1,Borderline personality disorder,Personality disorders with dramatic behaviour (Cluster B),Personality disorders and disturbances in behaviour,Psych,N
3621,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3621,3,Trans-sexualism,Sexuality issues,Gender related factors,SocCi,N
3622,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3622,2,Migraine,Migraine headaches,Headaches,Nerv,N
3623,1,Hormone receptor positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3624,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3625,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3625,2,Endometrial atrophy,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3625,3,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3626,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
3626,2,Administration site urticaria,Administration site reactions NEC,Administration site reactions,Genrl,N
3627,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3628,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3628,2,Intensive care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3629,1,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3629,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3629,3,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3630,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3630,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3631,1,Headache,Headaches NEC,Headaches,Nerv,N
3631,2,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
3632,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3632,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
3632,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3633,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3633,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3634,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3634,2,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
3635,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3635,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3635,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3635,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3636,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3636,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3636,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3636,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3636,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3637,1,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3638,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3639,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3639,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3640,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3640,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3640,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3640,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3640,5,Headache,Headaches NEC,Headaches,Nerv,N
3640,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3640,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3640,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3641,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3641,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3641,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3642,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3642,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3642,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3642,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3642,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3642,6,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3643,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
3643,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3644,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3644,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3645,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3645,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3645,3,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
3646,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3646,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3646,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3647,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3647,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3647,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3648,1,Migraine,Migraine headaches,Headaches,Nerv,N
3648,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
3648,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3649,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
3649,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3650,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3650,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3650,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3650,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3651,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3651,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3651,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3652,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3652,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3653,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3653,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3653,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3653,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3654,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
3654,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3655,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3655,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3655,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3655,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3656,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3656,2,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3657,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3657,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3658,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3659,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3659,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3659,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3660,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3661,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3661,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3661,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3661,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3661,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3662,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3663,1,Breast cancer stage II,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3664,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3665,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3665,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3665,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3665,4,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3665,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3666,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3666,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3667,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3667,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3667,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3668,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3668,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3668,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3668,4,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3669,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3670,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3671,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3671,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3671,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3671,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3671,5,Migraine,Migraine headaches,Headaches,Nerv,N
3671,6,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
3671,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3671,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3672,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3673,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3673,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3674,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3675,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3676,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3676,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3676,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3676,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3677,1,Headache,Headaches NEC,Headaches,Nerv,N
3677,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3678,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3678,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3678,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3678,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3678,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3678,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3678,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3679,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3679,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3679,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3679,4,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
3679,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3679,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3679,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3679,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3679,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3679,10,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3679,11,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
3679,12,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3680,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
3681,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3681,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3682,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3682,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3682,3,Product packaging confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3683,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3683,2,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3683,3,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3684,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3684,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3684,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3685,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3685,2,Blood zinc decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3685,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3685,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3685,5,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
3686,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3687,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3687,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3687,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3687,4,Overlap syndrome,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
3687,5,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3688,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3689,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3689,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3689,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
3689,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3689,5,Overlap syndrome,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
3689,6,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3690,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3690,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3690,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3690,4,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
3690,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3690,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3690,7,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3690,8,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3691,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3691,2,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
3691,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3691,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3692,1,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
3692,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3693,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3693,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3693,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3694,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3694,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
3695,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3695,2,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
3695,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3696,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3696,2,Headache,Headaches NEC,Headaches,Nerv,N
3696,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3696,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3696,5,Viral labyrinthitis,Viral infections NEC,Viral infectious disorders,Infec,N
3697,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3697,2,Headache,Headaches NEC,Headaches,Nerv,N
3697,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3697,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3697,5,Viral labyrinthitis,Viral infections NEC,Viral infectious disorders,Infec,N
3698,1,Gastric bypass,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3699,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3700,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3700,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3700,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
3701,1,Tachyphylaxis,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3702,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3703,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
3704,1,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
3704,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3705,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3706,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3706,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3706,3,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3707,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3708,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
3709,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3709,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3709,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3710,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3711,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3712,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3712,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3713,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3713,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3714,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3714,2,Acne,Acnes,Skin appendage conditions,Skin,N
3714,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3714,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3715,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3715,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3715,3,Urinary tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3715,4,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
3716,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3716,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3717,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3717,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3718,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3719,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3719,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
3719,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3720,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3721,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3722,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3723,1,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3724,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3725,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3726,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3726,2,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3726,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3726,4,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3726,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3727,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3728,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3728,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3728,3,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3728,4,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3728,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3729,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3729,2,Headache,Headaches NEC,Headaches,Nerv,N
3729,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3730,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3731,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3731,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3732,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3732,2,Vulvovaginal inflammation,Vaginal and vulval infections and inflammations,Female reproductive tract infections and inflammations,Repro,N
3733,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3733,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3733,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3733,4,Headache,Headaches NEC,Headaches,Nerv,N
3733,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3733,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3733,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3734,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3734,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3735,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3736,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3736,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3737,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3737,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3738,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3738,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3738,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3739,1,Genital burning sensation,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
3739,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3739,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3740,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3740,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3740,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3740,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3740,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3741,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3741,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3741,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3742,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3742,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3743,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3743,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3743,3,Headache,Headaches NEC,Headaches,Nerv,N
3743,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3744,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3744,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3745,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3745,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3745,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3745,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3745,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3745,6,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
3746,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3746,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3746,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3747,1,Headache,Headaches NEC,Headaches,Nerv,N
3747,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3748,1,Adnexa uteri pain,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3749,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3749,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3749,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3749,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
3749,5,Headache,Headaches NEC,Headaches,Nerv,N
3749,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3749,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3749,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3749,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3750,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3750,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3751,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3751,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3751,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3752,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3752,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3752,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3753,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3753,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3754,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3754,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3754,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3755,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3755,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3756,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3756,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3756,3,Migraine,Migraine headaches,Headaches,Nerv,N
3756,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3757,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3758,1,Migraine,Migraine headaches,Headaches,Nerv,N
3758,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3758,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3759,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3760,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3760,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3760,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3761,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3762,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3762,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3762,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3763,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3764,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3764,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3765,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3765,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3766,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3767,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3768,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3768,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3768,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3768,4,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
3768,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3768,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3768,7,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3769,1,Tachyphylaxis,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3770,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3771,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3771,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3771,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3772,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3773,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
3773,2,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
3773,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3774,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3775,1,Migraine,Migraine headaches,Headaches,Nerv,N
3776,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3777,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3778,1,Adenomyosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3779,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
3779,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3779,3,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3779,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3780,1,Hepatic adenoma,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
3780,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3780,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3781,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3781,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3781,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3782,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3782,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3782,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3782,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3782,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3783,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3783,2,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3783,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3784,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3784,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3784,3,Headache,Headaches NEC,Headaches,Nerv,N
3784,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3784,5,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3785,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3786,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3787,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3787,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3787,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3787,4,Headache,Headaches NEC,Headaches,Nerv,N
3788,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3788,2,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3788,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3788,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3788,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3789,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3790,1,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
3791,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3791,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3792,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3793,1,Headache,Headaches NEC,Headaches,Nerv,N
3793,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3793,3,Migraine,Migraine headaches,Headaches,Nerv,N
3793,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3794,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3794,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3794,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3794,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3795,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3796,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
3796,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3796,3,Headache,Headaches NEC,Headaches,Nerv,N
3796,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3796,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3796,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3797,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3797,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3797,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3797,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3797,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3797,6,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3797,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3798,1,Device dislocation,Device issues NEC,Device issues,Prod,N
3798,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3798,3,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
3798,4,Medical device discomfort,Complications associated with device NEC,Complications associated with device,Genrl,N
3799,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3800,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3800,2,Migraine,Migraine headaches,Headaches,Nerv,N
3801,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3801,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3801,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3802,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3803,1,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3804,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3804,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3804,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3804,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3804,5,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3805,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3805,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3805,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3805,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3806,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3807,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3807,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3807,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3807,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3808,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3808,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3808,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3808,4,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3809,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3810,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3810,2,Exposure via partner,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
3810,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3810,4,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3811,1,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3811,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3812,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3813,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3813,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3813,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3814,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3814,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3814,3,Headache,Headaches NEC,Headaches,Nerv,N
3814,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
3815,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3816,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
3817,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3817,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3818,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3818,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3818,3,Headache,Headaches NEC,Headaches,Nerv,N
3818,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3818,5,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3818,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3819,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3820,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3821,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3821,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3822,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3823,1,Hysteroscopy,Reproductive organ and breast imaging procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
3824,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3824,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3825,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3825,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3826,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3827,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3827,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3827,3,Tension headache,Headaches NEC,Headaches,Nerv,N
3827,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3828,1,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3828,2,Hyperaemia,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3829,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3829,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3829,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3829,4,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3830,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3831,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3831,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3831,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3831,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3831,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3831,6,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
3831,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3832,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3832,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3833,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3833,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3833,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3834,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3835,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3835,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3836,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3836,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3836,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3837,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3837,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
3838,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3838,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3838,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3838,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3838,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3838,6,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3839,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3839,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3839,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3839,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3839,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3840,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3840,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3840,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3840,4,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
3841,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
3842,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3842,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3842,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3842,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3842,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3842,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3842,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3842,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3842,9,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3842,10,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3842,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3843,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3844,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3844,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3844,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3844,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3845,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3845,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3845,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3845,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3846,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3846,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3846,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3847,1,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3847,2,Eyelid exfoliation,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
3847,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3848,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
3848,2,Headache,Headaches NEC,Headaches,Nerv,N
3848,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3848,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3849,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3849,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3849,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3849,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3850,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3851,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3852,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3852,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3852,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3853,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3853,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3853,3,Application site scar,Application site reactions,Administration site reactions,Genrl,N
3853,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3854,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3854,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3854,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3855,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3855,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3856,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
3857,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3858,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3858,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3858,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3858,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3859,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3860,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3861,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
3862,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3862,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3862,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3862,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3863,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3864,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3864,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3864,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3864,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3864,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3864,6,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3865,1,Dystrophic calcification,Trophic disorders,Tissue disorders NEC,Genrl,N
3865,2,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
3865,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3866,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3867,1,Headache,Headaches NEC,Headaches,Nerv,N
3867,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
3867,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3868,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3868,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3869,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3869,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3870,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
3870,2,Phyllodes tumour,Breast neoplasms unspecified malignancy,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3871,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3871,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3871,3,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3871,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3871,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3872,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3872,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3872,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3872,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3873,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3874,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3874,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3874,3,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
3875,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3876,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3876,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3876,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3876,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3877,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3877,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3878,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3878,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3878,3,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
3879,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3879,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
3879,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3879,4,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
3880,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3881,1,Abnormal withdrawal bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3881,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3882,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3882,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3882,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3882,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3882,5,Migraine,Migraine headaches,Headaches,Nerv,N
3883,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
3884,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3884,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3885,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3885,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3885,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3886,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3886,2,Vulvovaginal rash,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3887,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3888,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3888,2,Pelvic haemorrhage,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3888,3,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
3888,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3889,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
3889,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3889,3,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3889,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3890,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3891,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3892,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3893,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3894,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3895,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3895,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3896,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3896,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3896,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3896,4,Vascular graft,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
3897,1,Urethritis noninfective,Urethral infections and inflammations,Urethral disorders (excl calculi),Renal,N
3897,2,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3897,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3897,4,Vulvovaginal erythema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3897,5,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3898,1,Headache,Headaches NEC,Headaches,Nerv,N
3898,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3899,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3899,2,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3899,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3899,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3899,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3899,6,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
3899,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3899,8,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3899,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3899,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3900,1,Migraine,Migraine headaches,Headaches,Nerv,N
3901,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3902,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3902,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3902,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3902,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3903,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
3903,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3903,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3903,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3903,5,Headache,Headaches NEC,Headaches,Nerv,N
3903,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3903,7,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3903,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3903,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3903,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3904,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3905,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3905,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
3905,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3905,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3905,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3905,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3905,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3905,8,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3905,9,Myocardial strain imaging,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3905,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3905,11,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3905,12,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3905,13,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3905,14,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3905,15,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
3905,16,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3906,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3907,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3907,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3907,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3907,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3908,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3908,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
3909,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3909,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3909,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3909,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3910,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3911,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3911,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3911,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3911,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3911,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3911,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3911,7,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3911,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3911,9,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3912,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3913,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
3913,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
3913,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3913,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3913,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3914,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3914,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3914,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3914,4,Migraine,Migraine headaches,Headaches,Nerv,N
3914,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3915,1,Endometrial disorder,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3915,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3915,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3915,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3915,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3916,1,Migraine,Migraine headaches,Headaches,Nerv,N
3917,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3917,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3917,3,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3917,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3918,1,Endometrial disorder,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3918,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3918,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3918,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3918,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3919,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3919,2,Headache,Headaches NEC,Headaches,Nerv,N
3919,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3919,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3920,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3920,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3920,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3920,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3921,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3921,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3921,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3922,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3922,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3922,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3922,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3922,5,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3922,6,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3922,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3922,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3922,9,Headache,Headaches NEC,Headaches,Nerv,N
3922,10,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3922,11,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3922,12,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3922,13,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3922,14,Menopause,Age related issues,Age related factors,SocCi,N
3922,15,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3922,16,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3922,17,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3922,18,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3923,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3923,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3923,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3923,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3924,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3924,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3925,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3925,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3925,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3926,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3926,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3926,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3927,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3927,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3927,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3927,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3927,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3927,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3928,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3928,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3929,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3929,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3929,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3929,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3929,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3929,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3929,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3930,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3930,2,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
3930,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3930,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3930,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3930,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3931,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3931,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3931,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3931,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3931,5,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3931,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3932,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3932,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
3932,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3932,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3933,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3933,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3933,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3933,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3933,5,Headache,Headaches NEC,Headaches,Nerv,N
3933,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3933,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3933,8,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3933,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3933,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3933,11,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3933,12,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3933,13,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3933,14,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3934,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3934,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3934,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3934,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3934,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3934,6,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3934,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3935,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3936,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3936,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3936,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3936,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3937,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3937,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3937,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3937,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3937,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3938,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3938,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3938,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3938,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3939,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3939,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3939,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3939,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3939,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3940,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3940,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3940,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3940,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3940,5,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3940,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3941,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3941,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3941,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3941,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3942,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3942,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3942,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3942,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3942,5,Migraine,Migraine headaches,Headaches,Nerv,N
3942,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3943,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3943,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3943,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3943,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3943,5,Migraine with aura,Migraine headaches,Headaches,Nerv,N
3943,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3943,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3943,8,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3944,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3944,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3945,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
3945,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3945,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3946,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3946,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3946,3,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3946,4,Manufacturing product storage issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3946,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3946,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3947,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3947,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3948,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3948,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3948,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3948,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3948,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3948,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3948,7,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3948,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3949,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3949,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3949,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3949,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3949,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3949,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3949,7,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
3949,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3950,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3950,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3950,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3950,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3950,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3951,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3951,2,Menopause,Age related issues,Age related factors,SocCi,N
3951,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3952,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3952,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3952,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3952,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3952,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3952,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3952,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3953,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3953,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3953,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3953,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3953,5,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3953,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3953,7,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3953,8,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3953,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3954,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3954,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3954,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3954,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3954,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3954,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3954,7,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3954,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3954,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3954,10,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3955,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3955,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3955,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3955,4,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3956,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3956,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3956,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3956,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3956,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3956,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3956,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3957,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3957,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3957,3,Headache,Headaches NEC,Headaches,Nerv,N
3957,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3957,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3957,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3957,7,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3958,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3958,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3958,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3958,4,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3958,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3958,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3958,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3958,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3958,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3959,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3959,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3959,3,Headache,Headaches NEC,Headaches,Nerv,N
3959,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3959,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3960,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3960,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
3960,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3960,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3961,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3961,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3961,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3961,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3961,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3961,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3962,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3962,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3962,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3962,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3963,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3963,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3963,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3963,4,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3963,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3964,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3964,2,Headache,Headaches NEC,Headaches,Nerv,N
3965,1,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3966,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3966,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3966,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3966,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3966,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3967,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3967,2,Headache,Headaches NEC,Headaches,Nerv,N
3967,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3967,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3968,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3968,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3968,3,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3968,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3968,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3969,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3969,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3969,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3969,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3969,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3969,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3970,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3970,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3970,3,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3970,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3970,5,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3970,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3970,7,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3970,8,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3970,9,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3970,10,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3970,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3971,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3971,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3972,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3972,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3972,3,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3972,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3973,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3973,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3973,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3974,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3974,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3974,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3974,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3974,5,Porphyria non-acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
3975,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3975,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3975,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3975,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3975,5,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3975,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3975,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3976,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3976,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3976,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3976,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3976,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
3976,6,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3977,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3977,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3977,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3977,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3977,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3977,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3978,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3978,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3978,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3978,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3979,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3979,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3980,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3980,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3980,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3980,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3980,5,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
3980,6,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3980,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3980,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3980,9,Headache,Headaches NEC,Headaches,Nerv,N
3980,10,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3980,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3980,12,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3980,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3980,14,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3980,15,Menopause,Age related issues,Age related factors,SocCi,N
3980,16,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3980,17,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3980,18,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3980,19,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3981,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3981,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3981,3,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3982,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3982,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3982,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3982,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3983,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3983,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
3983,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3983,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3983,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3983,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3983,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3983,8,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3983,9,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3983,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
3983,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3983,12,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3983,13,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3983,14,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3984,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3984,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3985,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3985,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3985,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3986,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3986,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3986,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3986,4,Dyspareunia,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
3986,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3986,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3986,7,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3986,8,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3986,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3986,10,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3987,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3987,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3987,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3987,4,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3987,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3987,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3987,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3987,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3987,9,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3987,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3987,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3987,12,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3988,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3988,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3988,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3988,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3988,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3988,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3988,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3989,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3989,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3990,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3990,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3990,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3990,4,Headache,Headaches NEC,Headaches,Nerv,N
3990,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3990,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3991,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3991,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3991,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3992,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3992,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3992,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3992,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3993,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3993,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3993,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3993,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3993,5,Headache,Headaches NEC,Headaches,Nerv,N
3993,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3993,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3994,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3994,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3994,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3995,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3995,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3995,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3995,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3996,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3996,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3996,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3996,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3997,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3997,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3997,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
3997,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3997,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3998,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
3999,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3999,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3999,3,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
3999,4,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3999,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3999,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3999,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4000,1,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
4000,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
4000,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4000,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4001,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4001,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4001,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4001,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4001,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4002,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4002,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4002,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4002,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4002,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4002,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4003,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4004,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4004,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4004,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4004,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4004,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4004,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4004,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4005,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4005,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4006,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4006,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
4007,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4007,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4007,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4007,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4007,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4008,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4008,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4008,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4008,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4008,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4008,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4008,7,Migraine,Migraine headaches,Headaches,Nerv,N
4008,8,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4008,9,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4008,10,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4009,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4009,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4009,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4010,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
4010,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
4011,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4011,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4011,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4012,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4012,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4013,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4013,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4013,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4013,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4014,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4014,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4014,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4015,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4016,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4016,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4016,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4016,4,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4016,5,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4016,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4016,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4016,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4017,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4017,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4017,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4017,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4017,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4017,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
4018,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4018,2,Headache,Headaches NEC,Headaches,Nerv,N
4018,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4019,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4019,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4019,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4020,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4021,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4021,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4021,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4021,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4021,5,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4021,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4021,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4022,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4022,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4022,3,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4023,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4023,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4023,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4023,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4023,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4023,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4024,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4024,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4024,3,Dairy intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
4024,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4024,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4025,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4025,2,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4025,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4025,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4026,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4026,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4026,3,Headache,Headaches NEC,Headaches,Nerv,N
4026,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4026,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4026,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4026,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4026,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4026,9,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4026,10,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4026,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4026,12,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4027,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4027,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4027,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4027,4,Migraine,Migraine headaches,Headaches,Nerv,N
4027,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4028,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4028,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4028,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4028,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4028,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4028,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4028,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4028,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4028,9,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4028,10,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4028,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4029,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4029,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4029,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4029,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4030,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4030,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4030,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4030,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4030,5,Headache,Headaches NEC,Headaches,Nerv,N
4030,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4030,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4031,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4031,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4031,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4032,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4032,2,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4032,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4033,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
4033,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4033,3,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
4033,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4033,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4033,6,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
4033,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4034,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4034,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4034,3,Dairy intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
4034,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4034,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4035,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4035,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4036,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4036,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4036,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4037,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4037,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4037,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4037,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4037,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4037,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4037,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4037,8,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4037,9,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4038,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4038,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4038,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4039,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4039,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4039,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4039,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4039,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4039,6,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4039,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4039,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4040,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4040,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4040,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4040,4,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
4041,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4042,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4042,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4042,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4042,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4043,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4043,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4043,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4043,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4043,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4043,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4043,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4044,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4044,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4044,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4045,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4045,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4045,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4045,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4046,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4046,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4046,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4046,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4046,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4046,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4046,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4046,8,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4046,9,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4047,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4047,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4047,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4048,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4048,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4048,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4049,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4049,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4049,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4049,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4049,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
4049,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4049,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4049,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4049,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4050,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4050,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4051,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4051,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4051,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4051,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4052,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4052,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4052,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4052,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4052,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4052,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4053,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4053,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4053,3,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4054,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4054,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4055,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4055,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4055,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4056,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4056,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4057,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4057,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4057,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4057,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4057,5,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
4057,6,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4057,7,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4057,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4057,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4057,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4057,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4057,12,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
4058,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4059,1,Migraine,Migraine headaches,Headaches,Nerv,N
4060,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4060,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4060,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4060,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4060,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4060,6,Headache,Headaches NEC,Headaches,Nerv,N
4060,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4060,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
4060,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4060,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4060,11,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4061,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4061,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4061,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4061,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4062,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4062,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4062,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4062,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4062,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4062,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4063,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4063,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4063,3,Migraine,Migraine headaches,Headaches,Nerv,N
4064,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4064,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4064,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4064,4,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4064,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4064,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4064,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4064,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4064,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4064,10,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4064,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4064,12,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
4065,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4065,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
4065,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4065,4,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4066,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4066,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4066,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4066,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4067,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4067,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4067,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4067,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4067,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4068,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
4068,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
4068,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4069,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4069,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4069,3,Electrocardiogram ST-T segment abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4069,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4070,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4070,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4070,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4070,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4070,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4070,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4071,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4071,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4071,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4071,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4071,5,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4071,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4072,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4072,2,Headache,Headaches NEC,Headaches,Nerv,N
4073,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4073,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4073,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4073,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4074,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4074,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4074,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4074,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4074,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4074,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4074,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4074,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4074,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4075,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4075,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4075,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4076,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4076,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4076,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4076,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4076,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4076,6,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
4076,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4076,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4076,9,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4076,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4076,11,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4076,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4076,13,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4076,14,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4076,15,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
4076,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4076,17,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4076,18,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4077,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4078,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4078,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4079,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4079,2,Headache,Headaches NEC,Headaches,Nerv,N
4079,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4079,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4079,5,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4079,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4080,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4080,2,Vulvovaginal erythema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4080,3,Vulvovaginal rash,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4081,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4081,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4081,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4081,4,Headache,Headaches NEC,Headaches,Nerv,N
4081,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4081,6,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4081,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4082,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4082,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4082,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4082,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4082,5,Porphyria non-acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
4083,1,Migraine,Migraine headaches,Headaches,Nerv,N
4083,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
4084,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4085,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4086,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4086,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4086,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4086,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4086,5,Migraine,Migraine headaches,Headaches,Nerv,N
4086,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
4087,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4087,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4087,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4087,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4087,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4087,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4088,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4088,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4088,3,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4089,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4089,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4089,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4089,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4090,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4090,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4090,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4091,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4092,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4092,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4092,3,Migraine,Migraine headaches,Headaches,Nerv,N
4092,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4093,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4093,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4093,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4093,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4093,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4093,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4094,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4094,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4094,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4094,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
4095,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4095,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4095,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4095,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4095,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4095,6,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4095,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4096,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4096,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4096,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4096,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4096,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4096,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4096,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4097,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4098,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4098,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4098,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4098,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4098,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4099,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4099,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4099,3,Headache,Headaches NEC,Headaches,Nerv,N
4099,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4099,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4099,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4099,7,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4099,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4099,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4100,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4101,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4102,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
4102,2,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4102,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4102,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4102,5,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4103,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4104,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4104,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4104,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4104,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4104,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4104,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4104,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4104,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4105,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4105,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4105,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4105,4,Migraine,Migraine headaches,Headaches,Nerv,N
4106,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4106,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4106,3,Migraine with aura,Migraine headaches,Headaches,Nerv,N
4106,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4106,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4107,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4107,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4107,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4107,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4107,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4107,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4107,7,Dyschezia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4107,8,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4107,9,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4108,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4108,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4108,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4108,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4108,5,Migraine,Migraine headaches,Headaches,Nerv,N
4108,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4109,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4109,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4110,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4110,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4110,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4111,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4111,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4111,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4111,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4111,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4112,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
4113,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
4113,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4113,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4113,4,Headache,Headaches NEC,Headaches,Nerv,N
4113,5,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
4113,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4114,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4114,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4114,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4114,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4114,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4115,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4115,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4115,3,Headache,Headaches NEC,Headaches,Nerv,N
4115,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4115,5,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4116,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4117,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4118,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4118,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4118,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4118,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4118,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4119,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4120,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4120,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4120,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
4120,4,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
4121,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4122,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4123,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4123,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4123,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4123,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4123,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4124,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4125,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4125,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4126,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4126,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
4127,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4127,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4127,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4127,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4127,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4128,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4128,2,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
4128,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4128,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4128,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4128,6,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4128,7,Headache,Headaches NEC,Headaches,Nerv,N
4128,8,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4129,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
4130,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4130,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4130,3,Acne,Acnes,Skin appendage conditions,Skin,N
4130,4,Acne cystic,Acnes,Skin appendage conditions,Skin,N
4130,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4131,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4131,2,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
4131,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4131,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4131,5,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4131,6,Headache,Headaches NEC,Headaches,Nerv,N
4131,7,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4132,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4132,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4133,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4133,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4133,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4134,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
4135,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4135,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4135,3,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4135,4,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4136,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4136,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4137,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4137,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4137,3,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4137,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4137,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
4137,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4137,7,Uterine spasm,Uterine tone disorders,"Uterine, pelvic and broad ligament disorders",Repro,N
4137,8,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
4138,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4138,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4138,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4139,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4140,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4140,2,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
4140,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4141,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4142,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4142,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4142,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4142,4,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
4143,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4144,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4144,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4144,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4144,4,Respiratory symptom,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
4144,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4145,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4145,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4145,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4145,4,Headache,Headaches NEC,Headaches,Nerv,N
4145,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4146,1,Vulval oedema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4146,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4146,3,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4147,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4148,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4148,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4149,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4149,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4149,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4149,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4149,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4150,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4150,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4150,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4151,1,Migraine,Migraine headaches,Headaches,Nerv,N
4151,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
4152,1,Headache,Headaches NEC,Headaches,Nerv,N
4153,1,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
4154,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4155,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4155,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4155,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4156,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4156,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4157,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4157,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4157,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4158,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4158,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4159,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4159,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4159,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4159,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4159,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4159,6,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4159,7,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4159,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4160,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4160,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4161,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4162,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
4162,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4162,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4162,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4163,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4163,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4163,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4164,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4164,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4165,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4165,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4165,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4165,4,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4165,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4165,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4166,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4166,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4166,3,Headache,Headaches NEC,Headaches,Nerv,N
4166,4,Migraine,Migraine headaches,Headaches,Nerv,N
4166,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4166,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4166,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4166,8,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4167,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4167,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4168,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4168,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4168,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4168,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4168,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4169,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
4169,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4169,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
4169,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4169,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4169,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4170,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4171,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4171,2,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4172,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4172,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4173,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4173,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4173,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4173,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4173,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4174,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
4175,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4176,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4177,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4178,1,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4178,2,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
4178,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4178,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4179,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4180,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4180,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4180,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
4180,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
4181,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4181,2,Headache,Headaches NEC,Headaches,Nerv,N
4181,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4181,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4182,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4182,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4182,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4182,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4182,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4182,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4182,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4183,1,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4184,1,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
4185,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4185,2,Vulval ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4186,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4186,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4187,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4187,2,Headache,Headaches NEC,Headaches,Nerv,N
4187,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4187,4,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4187,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4187,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4187,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4187,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4188,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4188,2,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
4189,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4189,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4189,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
4189,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
4190,1,Bartholin's cyst,Vulvovaginal cysts and neoplasms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4190,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4191,1,Appendix cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4191,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4192,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4193,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4193,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4193,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4193,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4194,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4194,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4194,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4195,1,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
4195,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4195,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4195,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4195,5,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
4196,1,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
4197,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4197,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4197,3,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4197,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4197,5,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4197,6,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4197,7,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4198,1,Menopause,Age related issues,Age related factors,SocCi,N
4198,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4199,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4199,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4199,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4199,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4199,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4199,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4199,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4199,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4200,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4200,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4200,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4201,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4201,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4202,1,Medical device site laceration,Complications associated with device NEC,Complications associated with device,Genrl,N
4202,2,Vulvovaginal injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
4203,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4203,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4204,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4204,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4204,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4204,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4204,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4204,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4204,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4204,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4205,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4205,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4205,3,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4205,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4205,5,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4205,6,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4205,7,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4206,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4206,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4207,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4208,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4208,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4209,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4209,2,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
4210,1,Menopause,Age related issues,Age related factors,SocCi,N
4210,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4211,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4211,2,Histamine intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
4211,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4211,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4211,5,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4211,6,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4212,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4212,2,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4213,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4214,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4214,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4215,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4215,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4216,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4217,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4217,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4218,1,Ovarian hyperstimulation syndrome,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
4219,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4219,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
4219,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
4220,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4220,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4220,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4220,4,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4220,5,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4220,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4221,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4221,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4222,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4223,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4223,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4223,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4224,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4225,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4225,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4225,3,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4225,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4225,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4225,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4225,7,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4225,8,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4226,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4226,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4227,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4227,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4227,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4228,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4228,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4228,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4228,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4228,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4228,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4228,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4229,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4229,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4230,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4230,2,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
4231,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4231,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4231,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4231,4,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4232,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4232,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4232,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4232,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4233,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4233,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4233,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4234,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
4235,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4235,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4236,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4236,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4236,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4236,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4236,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4236,6,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4236,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4236,8,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4236,9,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4236,10,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4236,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4237,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
4237,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4237,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4238,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4239,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4239,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
4239,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
4240,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4241,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4241,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4242,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4242,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4242,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4242,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4242,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4242,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4242,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4243,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4244,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
4244,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4244,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4245,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4246,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4246,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4246,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4247,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4247,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4248,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4248,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4248,3,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4248,4,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4248,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4248,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4248,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4248,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4249,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4250,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4251,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4252,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4253,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4253,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4253,3,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4253,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4254,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4254,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4255,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4255,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4255,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4255,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4256,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4256,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4257,1,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
4257,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4257,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4257,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4257,5,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
4258,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
4259,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4260,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4260,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4260,3,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4261,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
4261,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4262,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4262,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4262,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4263,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4263,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4263,3,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4264,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4264,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4264,3,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4265,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4265,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4265,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4265,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4266,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
4266,2,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4266,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4266,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4266,5,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4267,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4267,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4267,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4267,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4267,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4268,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4268,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4268,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4268,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4268,5,Retinal migraine,Migraine headaches,Headaches,Nerv,N
4269,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4269,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4269,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4269,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4270,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4270,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4270,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4270,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4270,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4270,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4271,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4272,1,Headache,Headaches NEC,Headaches,Nerv,N
4272,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4273,1,Device effect variable,Device issues NEC,Device issues,Prod,N
4273,2,Oestradiol increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4274,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4274,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4274,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4274,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4274,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4274,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4274,7,Headache,Headaches NEC,Headaches,Nerv,N
4274,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4274,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4274,10,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
4275,1,Urge incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4276,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4276,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4276,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4277,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4277,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4277,3,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4277,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4277,5,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4277,6,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4277,7,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4278,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4278,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4278,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4278,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4279,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
4279,2,Device adhesion issue,Device issues NEC,Device issues,Prod,N
4279,3,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4279,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4279,5,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4280,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
4280,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4280,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4281,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4281,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4281,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4281,4,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4281,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4282,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4282,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4282,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4282,4,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4282,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4282,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4282,7,Headache,Headaches NEC,Headaches,Nerv,N
4282,8,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
4282,9,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
4282,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4282,11,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4282,12,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4282,13,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4282,14,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4282,15,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4282,16,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4282,17,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4283,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4284,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4284,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4285,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4285,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4286,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4286,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4286,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4286,4,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4286,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4286,6,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4286,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4286,8,Headache,Headaches NEC,Headaches,Nerv,N
4286,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4286,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4287,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4287,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4288,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4288,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4288,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4288,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4289,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4290,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4290,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4291,1,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4291,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4291,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4292,1,Histamine intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
4292,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4293,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4294,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4295,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4295,2,Genitourinary symptom,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
4296,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4296,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4296,3,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4296,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4297,1,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
4297,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4297,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4298,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4298,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4298,3,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4298,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4298,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
4298,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4298,7,Uterine spasm,Uterine tone disorders,"Uterine, pelvic and broad ligament disorders",Repro,N
4298,8,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
4299,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
4300,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4300,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4301,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4301,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4301,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4301,4,Headache,Headaches NEC,Headaches,Nerv,N
4301,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4301,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4301,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4301,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4302,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4303,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4303,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4304,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4304,2,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4305,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4305,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4305,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4306,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4306,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4306,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4306,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4306,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4306,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4306,7,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4306,8,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4307,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4307,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4307,3,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4307,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4307,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4308,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4308,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4309,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4309,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4310,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4310,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4310,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4310,4,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4310,5,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4310,6,Vaginal disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4311,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4311,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4311,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4311,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4311,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4311,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4311,7,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4311,8,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4312,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4312,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4312,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4312,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4313,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4314,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4314,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4314,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4314,4,Headache,Headaches NEC,Headaches,Nerv,N
4314,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4315,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4315,2,Headache,Headaches NEC,Headaches,Nerv,N
4315,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4315,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
4315,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4316,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4317,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4318,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4318,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4318,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4318,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4319,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4319,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
4319,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
4320,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
4321,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4322,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4322,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4322,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4322,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4322,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4323,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4323,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4323,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4323,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4324,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4324,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4324,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4324,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4324,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4324,6,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4324,7,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4324,8,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4325,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4325,2,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4325,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4325,4,Headache,Headaches NEC,Headaches,Nerv,N
4325,5,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4325,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4325,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4326,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4327,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4328,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4329,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4329,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
4329,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
4330,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
4331,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4331,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4331,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4331,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4332,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4332,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4333,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4333,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4333,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4333,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4334,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4334,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4335,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4335,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4336,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4336,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4337,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4337,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4338,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4339,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4340,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4340,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4340,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4340,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4340,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4340,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4340,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4340,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4341,1,Bladder discomfort,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4341,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4341,3,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
4341,4,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4341,5,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
4342,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4343,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4343,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4343,3,Headache,Headaches NEC,Headaches,Nerv,N
4343,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4343,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4343,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4343,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4344,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
4345,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4346,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4346,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4347,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4347,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4347,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4347,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4347,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4347,6,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4348,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4348,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4348,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4348,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4348,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4348,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4348,7,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4348,8,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4349,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
4350,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4351,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4352,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4353,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4353,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4354,1,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
4355,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4356,1,Acne,Acnes,Skin appendage conditions,Skin,N
4356,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
4356,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4356,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4356,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4356,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4356,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4356,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4356,9,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4356,10,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4356,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4357,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4358,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4358,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4358,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4358,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4359,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4359,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4359,3,Headache,Headaches NEC,Headaches,Nerv,N
4359,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4359,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4359,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4359,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4360,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4360,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4361,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4361,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4362,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4362,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4362,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4362,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4363,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4363,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4364,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4365,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
4365,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4365,3,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
4366,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4366,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4367,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4367,2,Headache,Headaches NEC,Headaches,Nerv,N
4368,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4368,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4368,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4368,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4368,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4368,6,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4369,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4369,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4370,1,Acne,Acnes,Skin appendage conditions,Skin,N
4370,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
4370,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4370,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4370,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4370,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4370,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4370,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4370,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4370,10,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4370,11,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4370,12,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4371,1,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
4372,1,Bladder discomfort,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4372,2,Cystitis interstitial,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
4372,3,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
4372,4,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
4372,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4372,6,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4373,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4373,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4373,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4373,4,Headache,Headaches NEC,Headaches,Nerv,N
4373,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4373,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4373,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4374,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4375,1,Headache,Headaches NEC,Headaches,Nerv,N
4376,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4376,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4376,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4376,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4377,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4378,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
4379,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
4379,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4379,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4380,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4380,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
4381,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4381,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4381,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4381,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4381,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4382,1,Uterine spasm,Uterine tone disorders,"Uterine, pelvic and broad ligament disorders",Repro,N
4383,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4383,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4384,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4384,2,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
4384,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
4385,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4385,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4385,3,Headache,Headaches NEC,Headaches,Nerv,N
4385,4,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4386,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4387,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4388,1,Headache,Headaches NEC,Headaches,Nerv,N
4389,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4389,2,Inflammatory pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4389,3,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4389,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4390,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4390,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4390,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4390,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4391,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
4392,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4392,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4392,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4392,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4393,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4393,2,Vascular purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
4394,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4394,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4394,3,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4394,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4394,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4394,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4394,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4394,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4394,9,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4394,10,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
4394,11,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4394,12,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4394,13,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4395,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4395,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4395,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4396,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4397,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
4397,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
4397,3,Pancreatic pseudocyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
4397,4,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4398,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4398,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4399,1,Idiopathic angioedema,Angioedemas,Angioedema and urticaria,Skin,N
4399,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4400,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4400,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4401,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4402,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4402,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4403,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4403,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4403,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4403,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4403,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4403,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4403,7,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4403,8,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4404,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4404,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4405,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4405,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4406,1,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4407,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4408,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4409,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4410,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4410,2,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4410,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4410,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4411,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4411,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4412,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4412,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4412,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4413,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4413,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4413,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4414,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
4414,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4415,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4415,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4415,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4415,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4416,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
4417,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4418,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4418,2,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
4418,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4418,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4419,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4420,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4421,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
4421,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4422,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4423,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4423,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4423,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4423,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4423,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4423,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4423,7,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
4423,8,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4423,9,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4424,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4424,2,Headache,Headaches NEC,Headaches,Nerv,N
4424,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4424,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4424,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4424,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4424,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4425,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
4425,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4426,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4426,2,Stent placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4427,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4427,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4428,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4428,2,Headache,Headaches NEC,Headaches,Nerv,N
4428,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4428,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4429,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4430,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4430,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4430,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4430,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4430,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4430,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4430,7,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
4430,8,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4430,9,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4431,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4431,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4432,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4432,2,Headache,Headaches NEC,Headaches,Nerv,N
4432,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4432,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4432,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4433,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4433,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4434,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4434,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4434,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4434,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4434,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4434,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4435,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4436,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4436,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4437,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
4437,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4438,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4438,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
4439,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
4439,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4439,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4439,4,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4439,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4439,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4440,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4440,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
4440,3,Migraine,Migraine headaches,Headaches,Nerv,N
4440,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4441,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4441,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4441,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
4442,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
4442,2,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4442,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4442,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4442,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4442,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4442,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4442,8,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4442,9,Urethral pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4442,10,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4443,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4443,2,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4443,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4443,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4444,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4445,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
4445,2,Exposure to toxic agent,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
4445,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4445,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4446,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4446,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4447,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4447,2,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4447,3,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4447,4,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4447,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4448,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4449,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4449,2,Headache,Headaches NEC,Headaches,Nerv,N
4449,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
4449,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4449,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4450,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4450,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4450,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4450,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4451,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4452,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
4452,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4452,3,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4453,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
4453,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4453,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4453,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4454,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
4454,2,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4454,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4454,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4454,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4454,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4454,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4454,8,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4454,9,Urethral pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4454,10,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4455,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
4455,2,Exposure to toxic agent,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
4455,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4455,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4456,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4457,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
4458,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4458,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4459,1,Headache,Headaches NEC,Headaches,Nerv,N
4459,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4460,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4460,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4460,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
4461,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4462,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
4462,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
4463,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4463,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4463,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4464,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4464,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4464,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
4464,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4464,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4464,6,Vulvovaginal erythema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4465,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4465,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4465,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4465,4,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4465,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4465,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4465,7,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
4465,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4465,9,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4465,10,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4465,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4465,12,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4465,13,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4466,1,Tanning,Social issues NEC,Lifestyle issues,SocCi,N
4467,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4467,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4468,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4469,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4469,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4469,3,Cerebral congestion,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
4469,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4469,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4469,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4469,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4469,8,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4470,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4470,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4470,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4470,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4470,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4470,6,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4471,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4471,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4472,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
4472,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4472,3,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4473,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4473,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4473,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4473,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4474,1,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4474,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4474,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4475,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4475,2,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4475,3,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4475,4,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4476,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4477,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4477,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4477,3,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4477,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4478,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4478,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4478,3,Headache,Headaches NEC,Headaches,Nerv,N
4478,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4478,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4478,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4478,7,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4478,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4478,9,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4479,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4479,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4479,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4479,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4479,5,Hyperphagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4479,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4479,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4479,8,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4479,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4479,10,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4480,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4480,2,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4480,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4480,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4480,5,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4480,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4480,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4480,8,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4481,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4482,1,Administration site reaction,Administration site reactions NEC,Administration site reactions,Genrl,N
4482,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4482,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4483,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4483,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4483,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4484,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4484,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4484,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4484,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4484,5,Headache,Headaches NEC,Headaches,Nerv,N
4484,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4484,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4484,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4484,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4485,1,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4486,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4487,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4487,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4488,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4488,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4488,3,Headache,Headaches NEC,Headaches,Nerv,N
4488,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4488,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4488,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4488,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4489,1,Vulvovaginal injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
4490,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4490,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4490,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4491,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4491,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4492,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
4492,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4493,1,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
4493,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4494,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4494,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4494,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4494,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4495,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4496,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4496,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4496,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4496,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4497,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4497,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4498,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4498,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4498,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4498,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4498,5,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4498,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4498,7,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4498,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4498,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4498,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4498,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4499,1,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4499,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4499,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4500,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4500,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4500,3,Migraine,Migraine headaches,Headaches,Nerv,N
4500,4,Migraine,Migraine headaches,Headaches,Nerv,N
4500,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4500,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4501,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4501,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4501,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4501,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4502,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4503,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4503,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4503,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4503,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4503,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4504,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
4505,1,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
4506,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4507,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4508,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4508,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4508,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4508,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4509,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4509,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4510,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4510,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4510,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4510,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4510,5,Headache,Headaches NEC,Headaches,Nerv,N
4510,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4510,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4511,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4511,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4511,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4511,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4511,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4511,6,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4511,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4511,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4512,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4512,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4513,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4513,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4514,1,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
4515,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4515,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4515,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4515,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4516,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
4516,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4517,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4517,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4517,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4517,4,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
4517,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4517,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4518,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
4518,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4518,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
4518,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4518,5,Application site rash,Application site reactions,Administration site reactions,Genrl,N
4518,6,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
4519,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4519,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4519,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
4519,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4519,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4520,1,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
4520,2,Intercepted accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
4521,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4521,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4522,1,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4522,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4523,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4524,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4525,1,Headache,Headaches NEC,Headaches,Nerv,N
4525,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4525,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4526,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4527,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4527,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4527,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4527,4,Headache,Headaches NEC,Headaches,Nerv,N
4527,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4527,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4527,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4528,1,Application site injury,Application site reactions,Administration site reactions,Genrl,N
4529,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4530,1,Menopause,Age related issues,Age related factors,SocCi,N
4531,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4531,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4531,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4532,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4532,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4532,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4532,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4532,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4532,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4533,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4533,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4533,3,Hormone replacement therapy,Hormonal therapeutic procedures NEC,Endocrine gland therapeutic procedures,Surg,N
4533,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4533,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4534,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4534,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4534,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4534,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4534,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4534,6,Headache,Headaches NEC,Headaches,Nerv,N
4534,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4534,8,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4534,9,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
4535,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4535,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4535,3,Headache,Headaches NEC,Headaches,Nerv,N
4535,4,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4535,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4535,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4535,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4535,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4536,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4536,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4536,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4536,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4536,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
4536,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4537,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
4537,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4537,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4537,4,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4537,5,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4537,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4537,7,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4538,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4539,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4539,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4540,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4540,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4540,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4540,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4541,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4541,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4541,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4541,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4541,5,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
4541,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4542,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4542,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4542,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4542,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4542,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4542,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4543,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4543,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4543,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4543,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4543,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4544,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4544,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4544,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4544,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4544,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4545,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
4545,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4545,3,Headache,Headaches NEC,Headaches,Nerv,N
4546,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4546,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4546,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4546,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4546,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4546,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4547,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4547,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4548,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4548,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4548,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4549,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
4549,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4550,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4550,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4550,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4550,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4550,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4550,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4550,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4551,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
4552,1,Dyspareunia,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
4553,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4553,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4553,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4553,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4553,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4554,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4554,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
4554,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4554,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4554,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
4554,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
4554,7,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4554,8,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4555,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4555,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4556,1,Headache,Headaches NEC,Headaches,Nerv,N
4557,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4557,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4558,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4558,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4558,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4558,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4559,1,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
4559,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4560,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4560,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4560,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4560,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4560,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4560,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4561,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4561,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4561,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4561,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4561,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4561,6,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
4561,7,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4561,8,Vaginal odour,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4561,9,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4562,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4562,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4562,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4563,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
4563,2,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
4563,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4564,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4564,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4564,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4564,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4564,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
4564,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4565,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
4565,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4566,1,Headache,Headaches NEC,Headaches,Nerv,N
4566,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4566,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4566,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4567,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
4568,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4569,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4569,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4570,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4570,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4570,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4570,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4571,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4571,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4571,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4571,4,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
4571,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4571,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4571,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4572,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4572,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4572,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4572,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4572,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4572,6,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
4573,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4574,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4574,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4574,3,Headache,Headaches NEC,Headaches,Nerv,N
4574,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4575,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4575,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4575,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4575,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4575,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4576,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4576,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4576,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4576,4,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4576,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4577,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4577,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4577,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4577,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4577,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4577,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4578,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4578,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4578,3,Migraine,Migraine headaches,Headaches,Nerv,N
4578,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4578,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4579,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4579,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4579,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4579,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4579,5,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4580,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4580,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4580,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4580,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4580,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4580,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4580,7,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4581,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4581,2,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
4581,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4581,4,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
4581,5,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
4581,6,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4581,7,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4582,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4582,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4582,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4582,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4583,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4583,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4583,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4584,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4584,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4584,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4584,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4584,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4585,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4585,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
4585,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4586,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4586,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4586,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4587,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4587,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4587,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4587,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4587,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4587,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4587,7,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4588,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4588,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4588,3,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
4588,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4588,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4589,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4589,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4589,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4589,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4589,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4590,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4590,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4591,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4591,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4591,3,Migraine,Migraine headaches,Headaches,Nerv,N
4592,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4592,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4592,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4592,4,Headache,Headaches NEC,Headaches,Nerv,N
4592,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4593,1,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4594,1,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
4595,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4595,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4595,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4595,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4595,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4596,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4596,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4596,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4597,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4597,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4597,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4597,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4598,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4598,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4598,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4598,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4599,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4599,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4599,3,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
4599,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4600,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4600,2,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4600,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4600,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4600,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4601,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4601,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
4601,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4601,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4601,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4601,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4601,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4601,8,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4601,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4601,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4602,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4602,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4602,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4602,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4602,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4602,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4602,7,Headache,Headaches NEC,Headaches,Nerv,N
4602,8,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4602,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4602,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4602,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4602,12,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
4602,13,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4603,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4603,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4603,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4603,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4603,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4603,6,Urethritis noninfective,Urethral infections and inflammations,Urethral disorders (excl calculi),Renal,N
4604,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4604,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4604,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4604,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4604,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4605,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4605,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4605,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4605,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4605,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4605,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4605,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4606,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4606,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
4607,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4607,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4607,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4608,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4608,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4608,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4609,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4609,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4609,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4609,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4610,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4610,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4610,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4610,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4610,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4611,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4611,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4611,3,Headache,Headaches NEC,Headaches,Nerv,N
4611,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4611,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4611,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4611,7,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4611,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4611,9,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4611,10,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4612,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4612,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4612,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
4612,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4612,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4613,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4613,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4613,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4613,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4613,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4613,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4613,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4613,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4613,9,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4613,10,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4613,11,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4614,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4614,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4614,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4614,4,Headache,Headaches NEC,Headaches,Nerv,N
4614,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4614,6,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
4614,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4614,8,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4614,9,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4615,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4615,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4615,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4615,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4615,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4615,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4615,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4615,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4615,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4615,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4615,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4615,12,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4615,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4615,14,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4615,15,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4616,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4617,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4617,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4617,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4617,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4617,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4617,6,Headache,Headaches NEC,Headaches,Nerv,N
4617,7,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4617,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4617,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4617,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4618,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4618,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4618,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4618,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4618,5,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4618,6,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4618,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4619,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4620,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4620,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4620,3,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4620,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4620,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4620,6,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4620,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4620,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4620,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4620,10,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4620,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4620,12,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4620,13,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4620,14,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4620,15,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4620,16,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4621,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4621,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4622,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4623,1,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4624,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4624,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4624,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
4624,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4624,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4625,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4625,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4625,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4626,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4626,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4626,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4626,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4626,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4626,6,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4626,7,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4626,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4626,9,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
4627,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4627,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4628,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4628,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4628,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4629,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4629,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4629,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4630,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4631,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4631,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4631,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4632,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4632,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4632,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4632,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4633,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4633,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4633,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4633,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4634,1,Headache,Headaches NEC,Headaches,Nerv,N
4634,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4634,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4634,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4635,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4635,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4636,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4637,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4637,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4637,3,Headache,Headaches NEC,Headaches,Nerv,N
4637,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4637,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4638,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4638,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4638,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4639,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4639,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4640,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4640,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4641,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4641,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4642,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4642,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4642,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4642,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4643,1,Migraine,Migraine headaches,Headaches,Nerv,N
4643,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4643,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4644,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4644,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4644,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4645,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4645,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4645,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4645,4,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4645,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4645,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4645,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4646,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4646,2,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
4646,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4646,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4647,1,Migraine,Migraine headaches,Headaches,Nerv,N
4647,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4647,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4648,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4649,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4649,2,Migraine,Migraine headaches,Headaches,Nerv,N
4649,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4649,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4650,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4651,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4651,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4652,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4652,2,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4653,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4653,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4653,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4653,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4653,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4653,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4653,7,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4653,8,Headache,Headaches NEC,Headaches,Nerv,N
4653,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4653,10,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4653,11,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4653,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4653,13,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4653,14,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4653,15,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4654,1,Headache,Headaches NEC,Headaches,Nerv,N
4654,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4655,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4655,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4655,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4655,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4655,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4655,6,Migraine,Migraine headaches,Headaches,Nerv,N
4655,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4655,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4655,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4656,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4657,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4657,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4657,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4657,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4658,1,Sinus headache,Headaches NEC,Headaches,Nerv,N
4659,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4659,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4660,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4660,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4660,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4660,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4660,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4661,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
4661,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
4662,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4662,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4662,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4662,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4663,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4663,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4663,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4664,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4664,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4664,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4665,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4665,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4665,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4666,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4666,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4666,3,Migraine,Migraine headaches,Headaches,Nerv,N
4666,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4667,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4667,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4667,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4667,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4668,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4668,2,Migraine,Migraine headaches,Headaches,Nerv,N
4668,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4668,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4669,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4669,2,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
4669,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4669,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4670,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
4670,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4670,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4670,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4671,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4671,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4671,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4671,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4672,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4672,2,Oligomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4672,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4672,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4673,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4673,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4673,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4674,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4674,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4674,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4674,4,Headache,Headaches NEC,Headaches,Nerv,N
4674,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4674,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4674,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4675,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4675,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4675,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4675,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4675,5,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
4675,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4676,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4676,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4676,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4677,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4677,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4677,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4677,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4677,5,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4678,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4678,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4678,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4678,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4679,1,Blood oestrogen increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4679,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4679,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4679,4,Headache,Headaches NEC,Headaches,Nerv,N
4680,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4680,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4680,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4680,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4681,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4681,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4681,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4681,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4681,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4682,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4682,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4682,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4682,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4683,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4683,2,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
4683,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4683,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4683,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4684,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4684,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4684,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4684,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4684,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4685,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4685,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4685,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4685,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4686,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4686,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4686,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4687,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4687,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4687,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4687,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4688,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4688,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4688,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4688,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4688,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4689,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4689,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4690,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4690,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4690,3,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
4690,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4690,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4691,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4691,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4692,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4692,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4692,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4692,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4693,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4694,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4695,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4696,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4696,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4696,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4696,4,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4696,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4696,6,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4697,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4697,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4698,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4698,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
4698,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4698,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4698,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4699,1,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4699,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4699,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4699,4,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4700,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4701,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4702,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4703,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4703,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4703,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4703,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4704,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4704,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4704,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4704,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4704,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4704,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4704,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4705,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4705,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4705,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4705,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4705,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4706,2,Migraine,Migraine headaches,Headaches,Nerv,N
4707,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4707,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4707,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4707,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4707,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4708,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4708,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4708,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4708,4,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4709,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4709,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4710,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4710,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4710,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4710,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4710,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4710,6,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4710,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4710,8,Product outer packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4710,9,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
4710,10,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4711,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4711,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4711,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4711,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4711,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4711,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4711,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4711,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4712,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4713,1,Menopause,Age related issues,Age related factors,SocCi,N
4714,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4714,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4714,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4715,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4715,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4716,1,Headache,Headaches NEC,Headaches,Nerv,N
4716,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4716,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4716,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4716,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4716,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4717,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4717,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4717,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4717,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4718,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4718,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4718,3,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4718,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4718,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4718,6,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4718,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4718,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4718,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4719,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4719,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4719,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4720,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4720,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4720,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4721,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4721,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4722,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4722,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4722,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4722,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4722,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4722,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4722,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4722,8,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4723,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4724,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4725,1,Headache,Headaches NEC,Headaches,Nerv,N
4725,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4725,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4726,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4726,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4726,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4727,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4727,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4729,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4729,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4729,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4730,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4730,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4731,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4732,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4733,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4733,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4733,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4733,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4733,5,Headache,Headaches NEC,Headaches,Nerv,N
4733,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4733,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4733,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4733,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4733,10,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4733,11,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4734,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4734,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4734,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4734,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4734,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4735,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4736,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4736,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4737,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4738,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4739,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4740,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4740,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4740,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4740,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4740,5,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4740,6,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4740,7,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4741,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4741,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4742,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4743,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4743,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4743,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4743,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4743,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4744,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4745,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4746,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4746,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4746,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4746,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4746,5,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
4746,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4746,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4746,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4747,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4748,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4748,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4749,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4749,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4750,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4750,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4750,3,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4751,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4751,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4752,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4753,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4753,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4753,3,Headache,Headaches NEC,Headaches,Nerv,N
4753,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4753,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4753,6,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4753,7,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4753,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4754,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4754,2,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4754,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4754,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4754,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4754,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4754,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4754,8,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
4754,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4755,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4756,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4757,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4758,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4759,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4760,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4761,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4761,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4762,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4762,2,Device adhesion issue,Device issues NEC,Device issues,Prod,N
4762,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4762,4,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4763,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4763,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4763,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4763,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4763,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4763,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4763,7,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
4764,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4764,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4765,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4765,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4765,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4765,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4765,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4766,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4766,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4767,1,Acne,Acnes,Skin appendage conditions,Skin,N
4767,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4767,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4767,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4767,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4767,6,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4768,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4768,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4769,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4769,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4769,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4769,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4769,5,Migraine,Migraine headaches,Headaches,Nerv,N
4769,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4770,1,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4770,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4771,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4771,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4772,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4772,2,Headache,Headaches NEC,Headaches,Nerv,N
4772,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4773,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4774,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4775,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4775,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4776,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4776,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4777,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4777,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4778,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4778,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4778,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4778,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4778,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4778,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4779,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4780,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4780,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4780,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4781,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4781,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4782,1,Migraine,Migraine headaches,Headaches,Nerv,N
4782,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4782,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4783,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4783,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4783,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4784,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4784,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4784,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4784,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
4784,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4784,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4784,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4785,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4786,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4787,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4787,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4787,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4787,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4787,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4788,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4789,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4789,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4789,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4789,4,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
4789,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4790,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4790,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4790,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4790,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4790,5,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
4790,6,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
4790,7,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4790,8,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4790,9,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4790,10,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
4790,11,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4791,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4792,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4793,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4793,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4793,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4793,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4793,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4793,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4793,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4794,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4795,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4795,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4795,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4795,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4795,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4795,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4796,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4796,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4797,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
4797,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4797,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4797,4,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4797,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4798,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4799,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4799,2,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4800,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4801,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4801,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4802,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4802,2,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4802,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4803,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4803,2,Headache,Headaches NEC,Headaches,Nerv,N
4803,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4803,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4803,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4803,6,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4804,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4805,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4806,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4806,2,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
4806,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4806,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4807,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4807,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4808,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4808,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4809,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4809,2,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4810,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4810,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4811,1,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4811,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4812,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4813,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4814,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4815,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4815,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4816,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4816,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4817,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4817,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4817,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4817,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4817,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
4818,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4818,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4819,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4820,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4820,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4820,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4820,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4821,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4821,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4821,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4822,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4823,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4823,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4823,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4823,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4823,5,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
4824,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4824,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4825,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4825,2,Atrophic vulvovaginitis,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4825,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4825,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4825,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4825,6,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4825,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4826,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4826,2,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4827,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4827,2,Headache,Headaches NEC,Headaches,Nerv,N
4827,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4828,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4829,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4829,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4829,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4829,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4829,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4829,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4829,7,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4830,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4830,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4830,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4830,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4830,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4830,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4830,7,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4831,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4832,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4832,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4832,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4832,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4832,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4832,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4832,7,Migraine,Migraine headaches,Headaches,Nerv,N
4832,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4833,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4834,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4835,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4835,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4835,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4835,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4835,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
4835,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4835,7,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4836,1,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4836,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4837,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4838,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4838,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4838,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4839,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4839,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4839,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4839,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4840,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4840,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4840,3,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4840,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4841,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4841,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4842,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4843,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4843,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4843,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4844,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4844,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4844,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4845,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4845,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4845,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4846,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4846,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4846,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4846,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4846,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4847,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4847,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4847,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4847,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4847,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4848,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4848,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4848,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4848,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4849,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4850,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4851,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4851,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4851,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4851,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4852,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4852,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4853,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4854,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4854,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4854,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4854,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4854,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4854,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4855,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4855,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4855,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4855,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4856,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4857,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4857,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4858,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4858,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4859,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4859,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4859,3,Migraine,Migraine headaches,Headaches,Nerv,N
4859,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4860,1,Headache,Headaches NEC,Headaches,Nerv,N
4861,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4861,2,Headache,Headaches NEC,Headaches,Nerv,N
4861,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4861,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4861,5,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4861,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4861,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4862,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4862,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4862,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4862,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4863,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4864,1,Sleep deficit,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
4864,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4865,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4865,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4866,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4866,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4866,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4866,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4867,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4867,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4868,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4868,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4868,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4868,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4869,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4869,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4869,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4869,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4869,5,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
4870,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4870,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4871,1,Product dispensing issue,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4871,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4872,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4872,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4872,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4873,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4873,2,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4873,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4873,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4874,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4874,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4874,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4874,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4875,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4875,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4875,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4875,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4875,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4876,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4876,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4877,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4877,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4877,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4877,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4877,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4878,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4878,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4878,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4878,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4878,5,Migraine,Migraine headaches,Headaches,Nerv,N
4878,6,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4879,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4879,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4879,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4879,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4879,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4880,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4880,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4880,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4880,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4881,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4881,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4881,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4882,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4882,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4882,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4882,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4883,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4883,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4883,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4884,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4884,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4885,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4885,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4886,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4886,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4887,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4887,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4887,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4887,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4887,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4888,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4889,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4889,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4889,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4889,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4889,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4889,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4890,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4890,2,Migraine,Migraine headaches,Headaches,Nerv,N
4891,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4891,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4891,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4892,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4892,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4892,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4893,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4893,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4894,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4894,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4894,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4894,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4895,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4895,2,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4896,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4897,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4897,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4898,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4898,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4898,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4899,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4899,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4899,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4899,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4899,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4900,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4900,2,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4900,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4901,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4901,2,Headache,Headaches NEC,Headaches,Nerv,N
4902,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4902,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4902,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4902,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4902,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4903,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4903,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4903,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4903,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4903,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4903,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4904,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4904,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4905,1,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4905,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4905,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4906,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4906,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4906,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4906,4,Headache,Headaches NEC,Headaches,Nerv,N
4906,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4907,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4907,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4907,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4907,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4907,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4908,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4908,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4908,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4908,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4908,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4908,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
4909,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4909,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4909,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4909,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4910,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4910,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4911,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4911,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4911,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4911,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4912,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4912,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4912,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4912,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4912,5,Headache,Headaches NEC,Headaches,Nerv,N
4912,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4912,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4912,8,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
4912,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4912,10,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4912,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4912,12,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4913,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4913,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4913,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4913,4,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4913,5,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4914,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4914,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4914,3,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4914,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4914,5,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4914,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4914,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4914,8,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
4914,9,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4914,10,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4914,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4914,12,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4915,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
4915,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4916,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4916,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4916,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4916,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4917,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4917,2,Atrophic vulvovaginitis,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
4917,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4917,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4917,5,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
4917,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4917,7,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4917,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4918,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4918,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4918,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4918,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4918,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4918,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4918,7,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4918,8,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4918,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4919,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4919,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4919,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4919,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4919,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
4919,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4919,7,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4920,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4920,2,Headache,Headaches NEC,Headaches,Nerv,N
4920,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4920,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4920,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4921,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4921,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4921,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4921,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4921,5,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4921,6,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
4921,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4921,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4921,9,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4921,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4921,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4922,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
4923,1,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4923,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4924,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4924,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4924,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4925,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4925,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4925,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4925,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4925,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4925,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4926,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4926,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4927,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4927,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4927,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4927,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4927,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4927,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4927,7,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4927,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4928,1,Headache,Headaches NEC,Headaches,Nerv,N
4928,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4928,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4929,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4929,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4929,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4929,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4929,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4929,6,Migraine,Migraine headaches,Headaches,Nerv,N
4929,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4929,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4930,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4930,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4931,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4931,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4931,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4931,4,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4931,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4931,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4931,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4931,8,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4931,9,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
4931,10,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4932,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4932,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4932,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4932,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4932,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4932,6,Migraine,Migraine headaches,Headaches,Nerv,N
4932,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4932,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4932,9,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4933,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4934,1,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
4935,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4936,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4936,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4936,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4936,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4936,5,Premenstrual dysphoric disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4937,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4938,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4939,1,Application site acne,Application site reactions,Administration site reactions,Genrl,N
4939,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
4939,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4939,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4940,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4940,2,Headache,Headaches NEC,Headaches,Nerv,N
4940,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4941,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4941,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4941,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4941,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4941,5,Headache,Headaches NEC,Headaches,Nerv,N
4941,6,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4941,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4942,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4942,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4942,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4943,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4943,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4944,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4944,2,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4944,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4945,1,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4946,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4946,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4946,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4946,4,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
4946,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4947,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4948,1,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
4948,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4949,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4949,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4950,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
4950,2,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
4950,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4951,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
4951,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4951,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4951,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4952,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4953,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4953,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4953,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4953,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4954,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4954,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4955,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4956,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4956,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4956,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4956,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4956,5,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
4956,6,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4957,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4957,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4957,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4957,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4957,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4958,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4958,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
4958,3,Headache,Headaches NEC,Headaches,Nerv,N
4958,4,Migraine,Migraine headaches,Headaches,Nerv,N
4959,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4959,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4959,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4959,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4959,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4960,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4960,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4960,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4961,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4961,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4961,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4961,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4961,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4961,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4962,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4962,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4962,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4962,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4963,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4963,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4963,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4963,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4963,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4963,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4963,7,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4964,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4964,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4964,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4964,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4964,5,Migraine,Migraine headaches,Headaches,Nerv,N
4964,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4965,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4965,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4965,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4965,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4966,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4966,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4967,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4967,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4967,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4967,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4967,5,Headache,Headaches NEC,Headaches,Nerv,N
4967,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4967,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4967,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4967,9,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4968,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4968,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4968,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4968,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4968,5,Headache,Headaches NEC,Headaches,Nerv,N
4968,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4968,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4969,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4969,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4970,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4970,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4970,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4971,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4971,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4972,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4972,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4973,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4973,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4973,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4974,1,Blood oestrogen increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4974,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4974,3,Headache,Headaches NEC,Headaches,Nerv,N
4975,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4975,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4976,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4976,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4976,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4976,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4977,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4977,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4977,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4978,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4978,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4978,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
4978,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4979,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4980,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4980,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4981,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4981,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4981,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4981,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4981,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4982,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4982,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4982,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4982,4,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
4983,1,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4983,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4984,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4984,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4984,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4985,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4985,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4985,3,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4985,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
4985,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4986,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4986,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4986,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4986,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4987,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4987,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4987,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4987,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4988,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4988,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4988,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4988,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4989,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4989,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4989,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4989,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4990,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4990,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4990,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4991,1,Oestriol abnormal,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
4991,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4991,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4992,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4992,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4992,3,Headache,Headaches NEC,Headaches,Nerv,N
4992,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4992,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4992,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4992,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4993,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4993,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4993,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4994,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4994,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4995,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4995,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4995,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4995,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4996,1,Migraine,Migraine headaches,Headaches,Nerv,N
4997,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4998,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4998,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4998,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4999,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4999,2,Dermal absorption increased,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4999,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4999,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4999,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4999,6,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5000,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5000,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5000,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5000,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5000,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5001,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5001,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5001,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5001,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5001,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5001,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5001,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5002,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5002,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5002,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5002,4,Headache,Headaches NEC,Headaches,Nerv,N
5002,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5002,6,Manufacturing materials issue,Manufacturing materials issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5002,7,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5003,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5003,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5003,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5004,1,Headache,Headaches NEC,Headaches,Nerv,N
5005,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5005,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5005,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5005,4,Migraine,Migraine headaches,Headaches,Nerv,N
5005,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5006,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5006,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5006,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5006,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5007,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5007,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5007,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5007,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5007,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5007,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5008,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5008,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5008,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5008,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5008,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5008,6,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5008,7,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5008,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5009,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5009,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5009,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5009,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5009,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5009,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5010,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5010,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5011,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5011,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5011,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5011,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5011,5,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5011,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5011,7,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5012,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5012,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5012,3,Migraine,Migraine headaches,Headaches,Nerv,N
5012,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5012,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5013,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5013,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5013,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5014,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5014,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5014,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5014,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5015,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5015,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
5016,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5016,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5016,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5017,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
5017,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5018,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5019,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5019,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5019,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5020,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5020,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5021,1,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5021,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5021,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5022,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5022,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5022,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5022,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5023,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5023,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5023,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5024,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5024,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5024,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5024,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5024,5,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5024,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5025,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5025,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5025,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5025,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5025,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5026,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5026,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5026,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5026,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5026,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5026,6,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5026,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5027,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5027,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5027,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5028,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5028,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5029,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5029,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5029,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5029,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5030,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5030,2,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
5030,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5030,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5030,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5031,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5031,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5031,3,Headache,Headaches NEC,Headaches,Nerv,N
5031,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5032,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5032,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5033,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5033,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5034,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5034,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5035,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5035,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5035,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5035,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5035,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5036,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5036,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5036,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5037,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5037,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5037,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5038,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5038,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5038,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5039,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5039,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5039,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5039,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5040,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5040,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5040,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5040,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5040,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5040,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5041,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5041,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5042,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5042,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5043,1,Migraine,Migraine headaches,Headaches,Nerv,N
5043,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5044,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5044,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5045,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5045,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5045,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5046,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5046,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5046,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5046,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5046,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5046,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5046,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5047,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5047,2,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5048,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5048,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5049,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5049,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5049,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5049,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5049,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5049,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5050,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5050,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5050,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5051,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5051,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5052,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5052,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5052,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5052,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5052,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5052,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5053,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5054,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5054,2,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5054,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5055,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5055,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5055,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5056,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5056,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
5056,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5056,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5057,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5057,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5057,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5057,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5058,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5058,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5059,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5059,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5059,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5060,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5060,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5060,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5061,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5061,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5061,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5061,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5061,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5061,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5061,7,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5062,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5062,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5062,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5062,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5062,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5063,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5063,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5063,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5063,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5063,5,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5063,6,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5064,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5064,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5065,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5065,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5065,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5065,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
5065,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5066,1,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
5066,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5066,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5066,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5067,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5067,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5068,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5068,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5068,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5069,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5069,2,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
5069,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5069,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5069,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5070,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5070,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5070,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5070,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5070,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5071,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5071,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5071,3,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
5071,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5072,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5072,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5072,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5072,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5073,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5073,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5073,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5073,4,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
5074,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5074,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5074,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5074,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5074,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5074,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5075,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5075,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5075,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5075,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5075,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5076,1,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
5076,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5076,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5076,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5077,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5077,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5078,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5078,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5078,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5079,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5079,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5079,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5079,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5079,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5079,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5079,7,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5079,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5080,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5080,2,Migraine,Migraine headaches,Headaches,Nerv,N
5080,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5081,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5081,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5081,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5082,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5082,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5083,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5083,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5083,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5083,4,Headache,Headaches NEC,Headaches,Nerv,N
5083,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5083,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5083,7,Sleep deficit,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
5083,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5084,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5084,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5085,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5086,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5087,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5087,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5087,3,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5087,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5088,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5088,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5088,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5088,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5088,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5089,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5089,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5089,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5090,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5090,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5090,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5090,4,Upper-airway cough syndrome,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5091,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5091,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5091,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5091,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5091,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5092,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5093,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5094,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5094,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5094,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5095,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5095,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
5095,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5095,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5095,5,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5095,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5096,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5096,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5096,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5096,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5096,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5096,6,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5096,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5096,8,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5097,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5097,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5097,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5098,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5099,1,Acne,Acnes,Skin appendage conditions,Skin,N
5099,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5099,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5100,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5100,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5100,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5101,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5102,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5103,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5103,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5104,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5104,2,Headache,Headaches NEC,Headaches,Nerv,N
5104,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5105,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
5105,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5105,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5105,4,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
5106,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5107,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5107,2,Headache,Headaches NEC,Headaches,Nerv,N
5107,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5107,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5108,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5108,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5109,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
5110,1,Migraine,Migraine headaches,Headaches,Nerv,N
5111,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5111,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5112,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5113,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5113,2,Headache,Headaches NEC,Headaches,Nerv,N
5113,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5113,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5113,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5113,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5114,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5114,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5115,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5115,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5115,3,Headache,Headaches NEC,Headaches,Nerv,N
5115,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5115,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5116,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5116,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5116,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5116,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5116,5,Migraine,Migraine headaches,Headaches,Nerv,N
5116,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5116,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5116,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5116,9,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5117,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5117,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5118,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5118,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5118,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5119,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5119,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5120,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5120,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5120,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5121,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5121,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
5121,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5121,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5122,1,Headache,Headaches NEC,Headaches,Nerv,N
5122,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5122,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5123,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5123,2,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5124,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5124,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5124,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5125,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5125,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5125,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5125,4,Headache,Headaches NEC,Headaches,Nerv,N
5125,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5126,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
5126,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5127,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5127,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5127,3,Headache,Headaches NEC,Headaches,Nerv,N
5127,4,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5127,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
5127,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5128,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5128,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5128,3,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5129,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5129,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5130,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5130,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5130,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5130,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5130,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5130,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5130,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5131,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5131,2,Headache,Headaches NEC,Headaches,Nerv,N
5132,1,Absence of immediate treatment response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5132,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5132,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5132,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5133,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5133,2,Headache,Headaches NEC,Headaches,Nerv,N
5133,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5134,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5134,2,Anhedonia,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5134,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5134,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5134,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5134,6,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5134,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
5135,1,Migraine,Migraine headaches,Headaches,Nerv,N
5135,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5136,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5136,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5136,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5136,4,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
5137,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5137,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5137,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5137,4,Menopause,Age related issues,Age related factors,SocCi,N
5138,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5138,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5139,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
5140,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5140,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5140,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5141,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5141,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5141,3,Migraine,Migraine headaches,Headaches,Nerv,N
5141,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5141,5,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5142,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5142,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5143,1,Sinonasal obstruction,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5144,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5144,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5144,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5144,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5144,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5144,6,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5144,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5144,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5144,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5144,10,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5144,11,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5145,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5145,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5146,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5146,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5147,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5148,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
5149,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5149,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5149,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5149,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5149,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5149,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5149,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5150,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5150,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5150,3,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5151,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5151,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5151,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5151,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5151,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5151,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5151,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
5151,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5152,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5152,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5152,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5152,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
5152,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5152,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5152,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5152,8,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
5152,9,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5152,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5152,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5152,12,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5152,13,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5152,14,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5152,15,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5152,16,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5152,17,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
5152,18,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5153,1,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5153,2,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
5154,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5154,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5155,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5155,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5155,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5155,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5155,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5156,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5156,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5156,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5156,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5157,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5157,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5157,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5158,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5158,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5158,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5158,4,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
5159,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5160,1,Headache,Headaches NEC,Headaches,Nerv,N
5160,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5160,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5160,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5161,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5161,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5162,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5162,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5162,3,Headache,Headaches NEC,Headaches,Nerv,N
5162,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5162,5,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5163,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5164,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5165,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5165,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5165,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5165,4,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5165,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5165,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5166,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5167,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5167,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
5168,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5168,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5169,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5169,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5169,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5170,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5170,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5171,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5171,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5171,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5171,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5171,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5171,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5172,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
5173,1,Headache,Headaches NEC,Headaches,Nerv,N
5173,2,Headache,Headaches NEC,Headaches,Nerv,N
5173,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5174,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5174,2,Atrophic vulvovaginitis,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5174,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5174,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5174,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5174,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5175,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5175,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5175,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5176,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
5176,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5176,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
5176,4,Vulvovaginal injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
5176,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5177,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5177,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5178,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5178,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5179,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5179,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5180,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5180,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
5180,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5180,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5180,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5180,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5180,7,Headache,Headaches NEC,Headaches,Nerv,N
5180,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5180,9,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5181,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
5182,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5183,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5184,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5184,2,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5185,1,Administration site discomfort,Administration site reactions NEC,Administration site reactions,Genrl,N
5185,2,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
5186,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
5187,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
5188,1,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
5189,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5190,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5190,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5190,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5191,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5191,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5192,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5192,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5192,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5193,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5193,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5193,3,Headache,Headaches NEC,Headaches,Nerv,N
5193,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5193,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5193,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5193,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5193,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5194,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5194,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5195,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5195,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5195,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5195,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5195,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5195,6,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5195,7,Headache,Headaches NEC,Headaches,Nerv,N
5195,8,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5196,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5196,2,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
5196,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5196,4,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5196,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5197,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5197,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5197,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5197,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5197,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5197,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5197,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5198,1,Expulsion of medication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5198,2,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
5199,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5199,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5199,3,Headache,Headaches NEC,Headaches,Nerv,N
5199,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5200,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5200,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5200,3,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5201,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5201,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5201,3,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5201,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5202,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5203,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5204,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
5205,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5205,2,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
5206,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5206,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5206,3,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5207,1,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5207,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5207,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5207,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5207,5,Vaginal prolapse,Pelvic prolapse conditions,"Uterine, pelvic and broad ligament disorders",Repro,N
5208,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
5208,2,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
5208,3,Genital injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
5208,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5209,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5210,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5211,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5212,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5212,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
5212,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5213,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5213,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5214,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5214,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5214,3,Genital paraesthesia,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
5214,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5214,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5214,6,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5214,7,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5214,8,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5214,9,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5215,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5215,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5216,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5217,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5217,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5217,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5218,1,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5219,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5219,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5219,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5220,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5221,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5221,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5221,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5221,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5221,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5221,6,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5221,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5222,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5222,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5223,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5223,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5223,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5223,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5223,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5223,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5223,7,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
5223,8,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5223,9,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5224,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5225,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5225,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5226,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
5226,2,Headache,Headaches NEC,Headaches,Nerv,N
5226,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5227,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5227,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5228,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5228,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5229,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5229,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5229,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5229,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5229,5,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
5229,6,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5229,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5229,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5229,9,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5230,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5231,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5231,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5231,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5231,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5231,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5232,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5232,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5232,3,Headache,Headaches NEC,Headaches,Nerv,N
5232,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5232,5,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5233,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5233,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5233,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5233,4,Headache,Headaches NEC,Headaches,Nerv,N
5233,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5234,1,Pulmonary venous thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5235,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5235,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5236,1,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5236,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5236,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5236,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5237,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5238,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5239,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5239,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5240,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5240,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5241,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
5241,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5242,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
5242,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5242,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5242,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5242,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5243,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5243,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5244,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5245,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5245,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5246,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5246,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5246,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5247,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5247,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5247,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5248,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5248,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5248,3,Migraine,Migraine headaches,Headaches,Nerv,N
5248,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5248,5,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5249,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
5249,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5249,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5249,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5249,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5249,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5249,7,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5249,8,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5249,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5250,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5251,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5252,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5252,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5253,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5253,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5253,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5254,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5254,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5254,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5255,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5255,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5255,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5256,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5256,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5256,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5257,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5257,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5257,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5257,4,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
5257,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5257,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5257,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5257,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5257,9,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
5257,10,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
5257,11,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5257,12,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5258,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5258,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5258,3,Oestrogen deficiency,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
5258,4,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5258,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5258,6,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5259,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5259,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5260,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5260,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5260,3,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
5260,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5260,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5261,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5261,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5261,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5262,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5263,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5263,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5264,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5264,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5264,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5265,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5266,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5267,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5267,2,Sticky skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5268,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5268,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5268,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5268,4,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
5268,5,Migraine,Migraine headaches,Headaches,Nerv,N
5268,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5268,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5268,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5269,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5270,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5271,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5271,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5272,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,Y
5273,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5274,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5274,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5274,3,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
5274,4,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5274,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5275,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5275,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5275,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5275,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5275,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
5276,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5277,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5277,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5278,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5278,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5279,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5279,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5279,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5279,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5279,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5279,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5279,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5280,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5280,2,Headache,Headaches NEC,Headaches,Nerv,N
5280,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5280,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5280,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
5281,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5281,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5281,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5282,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5282,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5282,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5282,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5282,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5282,6,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5283,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5283,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5283,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5283,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5283,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5284,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5284,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5284,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5284,4,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
5284,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5284,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5284,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5284,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5284,9,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
5284,10,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
5284,11,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5284,12,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5285,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5286,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5286,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5286,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5286,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5286,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5286,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5287,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5287,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5287,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5287,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5288,1,Lacunar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5289,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5289,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5290,1,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5291,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
5291,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5291,3,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
5291,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5291,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5291,6,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5292,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5292,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5292,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5292,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5292,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5293,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5293,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5294,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
5294,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5294,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
5294,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5295,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5295,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5296,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5296,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5296,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5296,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5296,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5297,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5297,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5298,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5298,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5298,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5298,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5298,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5298,6,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5299,1,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
5299,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5299,3,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
5299,4,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5300,1,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5301,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5302,1,Degeneration of uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
5302,2,Myomectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
5303,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5303,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5303,3,Migraine with aura,Migraine headaches,Headaches,Nerv,N
5303,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5304,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5304,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5304,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5305,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5305,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5305,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5305,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5305,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5305,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5305,7,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5306,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5306,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5306,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5306,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
5306,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5306,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5307,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5307,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5308,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
5308,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5309,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5309,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5309,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
5310,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
5310,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5310,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5311,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5311,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5311,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5311,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5311,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5311,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5311,7,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5312,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5312,2,Headache,Headaches NEC,Headaches,Nerv,N
5312,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5312,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5313,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5313,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5313,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5313,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5313,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5313,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5314,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
5314,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5314,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5314,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5315,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5316,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5316,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5316,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5317,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5317,2,Product outer packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5317,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5318,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
5318,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5318,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5319,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5319,2,Headache,Headaches NEC,Headaches,Nerv,N
5320,1,Blood oestrogen increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5321,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5321,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5321,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5321,4,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
5321,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5321,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5322,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5322,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5322,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5322,4,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5323,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5323,2,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
5324,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5324,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5325,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5325,2,Headache,Headaches NEC,Headaches,Nerv,N
5325,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5325,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5326,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
5326,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5326,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
5326,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5327,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5327,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5327,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5327,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5327,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5327,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5327,7,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5327,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5328,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5328,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5328,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5329,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5329,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5329,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5329,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5330,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5330,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5330,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5330,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5330,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5331,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5331,2,Headache,Headaches NEC,Headaches,Nerv,N
5331,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5331,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5331,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5332,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5332,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5333,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5333,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5333,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5333,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5333,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
5333,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5334,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5334,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5334,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5334,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5334,5,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
5334,6,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5334,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5334,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5334,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5334,10,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
5335,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5335,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5335,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5336,1,Device placement issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5337,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5338,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5338,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5338,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5338,4,Headache,Headaches NEC,Headaches,Nerv,N
5338,5,Headache,Headaches NEC,Headaches,Nerv,N
5338,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5338,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5338,8,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5338,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5338,10,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5339,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5340,1,Migraine,Migraine headaches,Headaches,Nerv,N
5340,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
5340,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5341,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5341,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
5341,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5342,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5343,1,Eye haematoma,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
5344,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5344,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5345,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5345,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5346,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5346,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5346,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5346,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5347,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5347,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5347,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5348,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5348,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5348,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5349,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5349,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5349,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5350,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5350,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5350,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5351,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5351,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5351,3,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5351,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5351,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5351,6,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5351,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5351,8,Headache,Headaches NEC,Headaches,Nerv,N
5351,9,Heart alternation,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5351,10,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5351,11,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5351,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
5351,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5351,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5351,15,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5351,16,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
5351,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5351,18,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5351,19,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5351,20,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5352,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5352,2,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5353,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5353,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5353,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5354,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5354,2,Headache,Headaches NEC,Headaches,Nerv,N
5355,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5356,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5356,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5357,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5357,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5358,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5359,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5360,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5361,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5361,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5362,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5362,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5362,3,Headache,Headaches NEC,Headaches,Nerv,N
5362,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5363,1,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5363,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5364,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5365,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5365,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
5366,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5366,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5366,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5367,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5368,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5368,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5368,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5369,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5369,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5369,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5370,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5370,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5370,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5370,4,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
5371,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5372,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5373,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5373,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
5373,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5373,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5373,5,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5373,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5374,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5375,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5376,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5376,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5377,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5377,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5378,1,"Sleep disorder due to general medical condition, insomnia type",Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5379,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5379,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5379,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5380,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5380,2,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5381,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5381,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5381,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5381,4,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5382,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5383,1,Acne,Acnes,Skin appendage conditions,Skin,N
5383,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5383,3,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
5384,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5384,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5384,3,Bedridden,Disability issues,Lifestyle issues,SocCi,N
5384,4,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5384,5,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
5384,6,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
5384,7,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
5384,8,Madarosis,Alopecias,Skin appendage conditions,Skin,N
5384,9,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5384,10,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5384,11,Skin laxity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5384,12,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5385,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5385,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5385,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5385,4,Headache,Headaches NEC,Headaches,Nerv,N
5385,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5385,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5385,7,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5385,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5385,9,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5386,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5387,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5388,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5388,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5388,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5388,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5388,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5388,6,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5388,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5389,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5389,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5389,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5389,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5390,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5391,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5392,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5393,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5393,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5393,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5393,4,Headache,Headaches NEC,Headaches,Nerv,N
5393,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5393,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5393,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5393,8,Product dispensing issue,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5393,9,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5393,10,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5393,11,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5394,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5395,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5396,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5396,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5396,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5396,4,Product container seal issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5396,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5396,6,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5397,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5397,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5397,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5397,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5397,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5397,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5397,7,Tinea infection,Tinea infections,Fungal infectious disorders,Infec,N
5398,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5399,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5399,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5399,3,Headache,Headaches NEC,Headaches,Nerv,N
5400,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5400,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5400,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5400,4,Migraine,Migraine headaches,Headaches,Nerv,N
5400,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5401,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5401,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5401,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5402,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5402,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
5402,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5402,4,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5403,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5403,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5403,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5403,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5403,5,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5403,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5403,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5403,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5403,9,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5403,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5403,11,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5403,12,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5403,13,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5403,14,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5404,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5404,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5405,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5405,2,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5406,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5406,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5406,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5407,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5408,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5409,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5409,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5409,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
5410,1,Bacterial vaginosis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5411,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5411,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5411,3,Product appearance confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5412,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
5412,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5412,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5412,4,Headache,Headaches NEC,Headaches,Nerv,N
5412,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5412,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5412,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5413,1,Oestrogen deficiency,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
5413,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5414,1,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
5414,2,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5414,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5414,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5414,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5415,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
5416,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5417,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5418,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5419,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5419,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5419,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5420,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
5420,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5421,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5421,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5421,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5421,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5421,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5421,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5421,7,Tinea infection,Tinea infections,Fungal infectious disorders,Infec,N
5422,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5422,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5422,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5422,4,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5422,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5422,6,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5423,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5423,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5424,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5424,2,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
5424,3,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5424,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5424,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5424,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5425,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5425,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5425,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5425,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5425,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
5426,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5427,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5427,2,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5428,1,Deafness,Hearing losses,Hearing disorders,Ear,N
5428,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5428,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5428,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5429,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5429,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5429,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5429,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5429,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5430,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5430,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5430,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5431,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5431,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5431,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5431,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5432,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5432,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5432,3,Product appearance confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5433,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5433,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5433,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
5434,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5435,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5436,1,Oestrogen deficiency,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
5436,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5437,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5437,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5437,3,Headache,Headaches NEC,Headaches,Nerv,N
5438,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5438,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5438,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5438,4,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
5438,5,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5438,6,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5439,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5440,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
5440,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5441,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5441,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5441,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5442,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5442,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5443,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5443,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5443,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5444,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5444,2,Headache,Headaches NEC,Headaches,Nerv,N
5444,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5444,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5445,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5446,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5446,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5447,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5447,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
5448,1,Headache,Headaches NEC,Headaches,Nerv,N
5449,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5449,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5449,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5449,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5450,1,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5450,2,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5451,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5451,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5451,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5451,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5452,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5453,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5454,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5455,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5456,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5456,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5457,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5457,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5457,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5457,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5457,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5457,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5457,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5457,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5457,9,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5458,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5459,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5459,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5459,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5459,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5459,5,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5460,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5460,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5460,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5460,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5460,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5460,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5460,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5460,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5461,1,Headache,Headaches NEC,Headaches,Nerv,N
5461,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5461,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5461,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5462,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5462,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5462,3,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5462,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5462,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5462,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5462,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5462,8,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5462,9,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5462,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
5462,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5462,12,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5462,13,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5463,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5463,2,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5463,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
5463,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5464,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5465,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5466,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
5467,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5467,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5467,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5467,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5467,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5467,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5467,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5467,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5468,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5468,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5468,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5468,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5469,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5469,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5469,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5469,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5470,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5471,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5472,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5472,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5472,3,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5472,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5473,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5473,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5474,1,Manufacturing issue,Manufacturing issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5474,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5475,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5475,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5475,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5475,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5475,5,Histrionic personality disorder,Personality disorders with dramatic behaviour (Cluster B),Personality disorders and disturbances in behaviour,Psych,N
5475,6,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
5475,7,Pigmentation lip,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5475,8,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5475,9,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5475,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5475,11,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
5475,12,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5475,13,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5475,14,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5476,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5476,2,Headache,Headaches NEC,Headaches,Nerv,N
5476,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5476,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5477,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
5477,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5477,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5477,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5478,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5478,2,Headache,Headaches NEC,Headaches,Nerv,N
5478,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5478,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5478,5,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5478,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5479,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5480,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5481,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5482,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5482,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5482,3,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5482,4,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5482,5,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5483,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5483,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5483,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5483,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5483,5,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5484,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5485,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5485,2,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5485,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
5485,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5486,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5486,2,Headache,Headaches NEC,Headaches,Nerv,N
5486,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5486,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5487,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5487,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5487,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5487,4,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5488,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5488,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5488,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5489,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5489,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5489,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5489,4,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5490,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5490,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5491,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
5491,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5491,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5491,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5492,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5492,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5492,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5492,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5492,5,Histrionic personality disorder,Personality disorders with dramatic behaviour (Cluster B),Personality disorders and disturbances in behaviour,Psych,N
5492,6,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
5492,7,Pigmentation lip,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5492,8,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5492,9,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5492,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5492,11,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
5492,12,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5492,13,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5492,14,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5493,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5493,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5493,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5494,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
5494,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5494,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5494,4,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5495,1,Vulvovaginal mycotic infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5496,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5496,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5496,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5496,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5497,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5497,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5497,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5497,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5498,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5498,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5498,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5498,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5499,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5499,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5499,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5500,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5500,2,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5500,3,Headache,Headaches NEC,Headaches,Nerv,N
5500,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5500,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5500,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5500,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5500,8,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5500,9,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5501,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5501,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5502,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5502,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5502,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5503,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5503,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5503,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5503,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5503,5,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5504,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5504,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5504,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5504,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5504,5,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5504,6,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5504,7,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5504,8,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5504,9,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5504,10,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5505,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5505,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5506,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5506,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5506,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5507,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5507,2,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
5508,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5509,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5509,2,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5509,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5509,4,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5510,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5510,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5510,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5511,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5511,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5512,1,Vulvovaginal mycotic infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5513,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5513,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5514,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5514,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5514,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5514,4,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5514,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5514,6,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5514,7,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5514,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5515,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5515,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5515,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
5515,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5515,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5516,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5517,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5518,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5518,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5519,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5519,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5519,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5519,4,Headache,Headaches NEC,Headaches,Nerv,N
5519,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5520,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5520,2,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
5521,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5521,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5521,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5521,4,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5521,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5521,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5522,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5522,2,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5522,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5522,4,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5523,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5523,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5523,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5523,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5524,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5525,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5526,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5527,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
5528,1,Acne,Acnes,Skin appendage conditions,Skin,N
5529,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5530,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5530,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5531,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5531,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5531,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5531,4,Headache,Headaches NEC,Headaches,Nerv,N
5531,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5531,6,Product outer packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5532,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5533,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5534,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5534,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5534,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5534,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5534,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5534,6,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5534,7,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5535,1,Agitation neonatal,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5535,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5535,3,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5535,4,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5535,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
5536,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5536,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5537,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
5537,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5537,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5537,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5537,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5537,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5537,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5537,8,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5538,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5539,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5539,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5539,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5540,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5541,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5542,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5542,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
5542,3,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5543,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5543,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
5543,3,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5544,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5544,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5544,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5545,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5546,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5546,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5546,3,Infant irritability,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5546,4,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5546,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5547,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5548,1,Agitation neonatal,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5548,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5548,3,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5548,4,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5548,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
5549,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5550,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5550,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
5550,3,Manufacturing issue,Manufacturing issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5550,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5551,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
5552,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5553,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5554,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5554,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5554,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5554,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5555,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5555,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5556,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5557,1,Drug dose titration not performed,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5557,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5557,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5557,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5557,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
5557,6,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5557,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5558,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5558,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5558,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5558,4,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
5559,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5559,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5560,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5561,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
5561,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
5561,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5561,4,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
5561,5,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5561,6,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5561,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5562,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5563,1,Endometrial thickening,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
5563,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5563,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5563,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5563,5,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5563,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5564,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5564,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5564,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5565,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5565,2,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5565,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5566,1,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
5567,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5567,2,Headache,Headaches NEC,Headaches,Nerv,N
5568,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5568,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5568,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
5568,4,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
5568,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5568,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5568,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5568,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5569,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5570,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5570,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5570,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5570,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
5570,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5571,1,Headache,Headaches NEC,Headaches,Nerv,N
5572,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5572,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5572,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5572,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5572,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5572,6,Headache,Headaches NEC,Headaches,Nerv,N
5572,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5572,8,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5572,9,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5573,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
5573,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5574,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5574,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5574,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
5574,4,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
5574,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5574,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5574,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5574,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5575,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5575,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
5575,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5575,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5575,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
5575,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5575,7,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
5575,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5575,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5575,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5575,11,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5575,12,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5575,13,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5575,14,Tendon discomfort,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
5575,15,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
5575,16,Uterine pain,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
5575,17,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
5576,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5576,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5576,3,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5576,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5577,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5577,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5577,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
5577,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5577,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5577,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5577,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5577,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5578,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5578,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5578,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5578,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5578,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5578,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5578,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5578,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5578,9,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5578,10,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5579,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5579,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5580,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5580,2,Bladder discomfort,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5580,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5581,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5581,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5581,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5581,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5582,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5582,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5582,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5582,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5582,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5582,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5582,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5582,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5582,9,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5582,10,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5583,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5583,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5584,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5584,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5584,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5584,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5585,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5585,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5586,1,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5586,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5586,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5587,1,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
5587,2,Splenic thrombosis,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5588,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5589,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5589,2,Endometrial thickening,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
5589,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5589,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5589,5,Pelvic congestion,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
5589,6,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5590,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5590,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5590,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5591,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5592,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
5592,2,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5592,3,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
5592,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5593,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5593,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5593,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5594,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5594,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5595,1,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
5595,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5595,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5595,4,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5595,5,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5595,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5596,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5596,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5597,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5597,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5597,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5597,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5598,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5598,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5598,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
5598,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5598,5,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5598,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5599,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5600,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
5600,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5601,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5602,1,Blood pressure measurement,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5603,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5603,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5604,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5604,2,Bladder discomfort,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5604,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5605,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5606,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5606,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5606,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5606,4,Migraine,Migraine headaches,Headaches,Nerv,N
5607,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5608,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5608,2,Device issue,Device issues NEC,Device issues,Prod,N
5608,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
5608,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5609,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5610,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5610,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5611,1,Milk allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5612,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5613,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5613,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5613,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5613,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5613,5,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5614,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5614,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5614,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5614,4,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5615,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5615,2,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
5615,3,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
5615,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5615,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5615,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5615,7,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5616,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5616,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5616,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5616,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5616,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5617,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5617,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5618,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5619,1,Family stress,Family and partner issues,Family issues,SocCi,N
5619,2,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5619,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5619,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
5619,5,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5619,6,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5620,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5620,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5620,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5620,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5620,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5620,6,Uterine spasm,Uterine tone disorders,"Uterine, pelvic and broad ligament disorders",Repro,N
5621,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5622,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5622,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5623,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5624,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5624,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5625,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5625,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5625,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5626,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5626,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5627,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5627,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5627,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5627,4,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5628,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5628,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5629,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5629,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5629,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5629,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5630,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5630,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5630,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5630,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5631,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5631,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
5631,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5632,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5632,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5632,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5632,4,Migraine,Migraine headaches,Headaches,Nerv,N
5633,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5633,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5634,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
5635,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5636,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5637,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5637,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5637,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5637,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5637,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5637,6,Uterine spasm,Uterine tone disorders,"Uterine, pelvic and broad ligament disorders",Repro,N
5637,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5638,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5639,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5639,2,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5639,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5639,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5639,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5640,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5640,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5641,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5641,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5642,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
5642,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5642,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5642,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5642,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5642,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5642,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5642,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5642,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5642,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5643,1,Bipolar I disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
5644,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5645,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5645,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5645,3,Product packaging confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5645,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5645,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5645,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5646,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5646,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5646,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5646,4,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5646,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5646,6,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5647,1,Ovulation disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
5648,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5648,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5649,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5650,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5651,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5651,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5652,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5652,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5653,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
5653,2,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
5653,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5653,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5653,5,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5653,6,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
5653,7,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
5653,8,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5653,9,Vulvovaginal erythema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5653,10,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5653,11,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5654,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5655,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5655,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5656,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5657,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5658,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
5658,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5658,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5659,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5659,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
5659,3,Application site mass,Application site reactions,Administration site reactions,Genrl,N
5659,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5659,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5659,6,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
5659,7,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5660,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5661,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5661,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5661,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5661,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5661,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5662,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5662,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5662,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5662,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5663,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5664,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5664,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
5664,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5664,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
5664,5,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5665,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5665,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
5665,3,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
5665,4,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5666,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5666,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5666,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5666,4,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5667,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5667,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5667,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5668,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
5669,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5669,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5669,3,Product packaging confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5669,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5669,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5669,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5670,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5670,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5671,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5671,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5671,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5672,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5673,1,Ovulation disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
5674,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5675,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5676,1,Bipolar I disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
5676,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5676,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5676,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
5676,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5676,6,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5676,7,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
5677,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
5677,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5677,3,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
5677,4,Headache,Headaches NEC,Headaches,Nerv,N
5677,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5677,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5677,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5677,8,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5677,9,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
5677,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5677,11,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5677,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5678,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5679,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5679,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5679,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5679,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5679,5,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5680,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5681,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5682,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5682,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5683,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5683,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5683,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5683,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5683,5,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5683,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5683,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5683,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5683,9,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
5683,10,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5683,11,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5683,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5684,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
5684,2,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
5684,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5684,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5684,5,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5684,6,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
5684,7,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
5684,8,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5684,9,Vulvovaginal erythema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5684,10,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5684,11,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5685,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5686,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5686,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5686,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5686,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5686,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5687,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5688,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5688,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5689,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
5690,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
5691,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5692,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5693,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
5694,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5694,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5694,3,Migraine,Migraine headaches,Headaches,Nerv,N
5694,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5695,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
5695,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5695,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5695,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5695,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5695,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5695,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5696,1,Vascular purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
5697,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5697,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5697,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5697,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5697,5,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5698,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5698,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5698,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5698,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5698,5,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5699,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5699,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5699,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5699,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5700,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5701,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5702,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5703,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5703,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5704,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5705,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5706,1,Tension headache,Headaches NEC,Headaches,Nerv,N
5707,1,Drug delivery system issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5707,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5707,3,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5707,4,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5708,1,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
5709,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5709,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5709,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5709,4,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5710,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5710,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5710,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5710,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5710,5,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5711,1,Administration site discomfort,Administration site reactions NEC,Administration site reactions,Genrl,N
5711,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5711,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
5712,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5712,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5713,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
5713,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5714,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5714,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5714,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5715,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
5715,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
5716,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
5716,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5716,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5716,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5716,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5716,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5716,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5717,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5718,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5718,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5718,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5718,4,Headache,Headaches NEC,Headaches,Nerv,N
5718,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5718,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5719,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5719,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5720,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5720,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5720,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5720,4,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
5720,5,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5720,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5720,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5721,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5722,1,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5723,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5724,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5724,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5724,3,Migraine,Migraine headaches,Headaches,Nerv,N
5724,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5725,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5726,1,Vascular purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
5727,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5727,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5727,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5728,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5729,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5729,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5730,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5731,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5731,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5731,3,Tension headache,Headaches NEC,Headaches,Nerv,N
5732,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5732,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5732,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5732,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5732,5,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5733,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5734,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5734,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5734,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5734,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5735,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5736,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5737,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5738,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
5738,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5738,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5739,1,Administration site discomfort,Administration site reactions NEC,Administration site reactions,Genrl,N
5739,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5739,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
5740,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5740,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5740,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5740,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5741,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5742,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5742,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
5742,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5742,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5742,5,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
5742,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5743,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5744,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5745,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5746,1,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5747,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5747,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5747,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5747,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5747,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5747,6,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
5747,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5747,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5747,9,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5748,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5748,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5748,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5748,4,Headache,Headaches NEC,Headaches,Nerv,N
5748,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5748,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5748,7,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5749,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5750,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5751,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5751,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5752,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5752,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5753,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5754,1,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5755,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5756,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5756,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5756,3,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5757,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5758,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5759,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5759,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5759,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5759,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5760,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5761,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5762,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5762,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5762,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5763,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5764,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5764,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5765,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
5765,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5765,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5765,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5766,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5767,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5767,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
5767,3,"Sleep disorder due to general medical condition, insomnia type",Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5768,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5768,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5768,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5768,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5769,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5770,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5771,1,Migraine,Migraine headaches,Headaches,Nerv,N
5771,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5772,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5773,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5773,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5773,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5773,4,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
5773,5,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5773,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5773,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5774,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5774,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5775,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5776,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5776,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5776,3,Migraine,Migraine headaches,Headaches,Nerv,N
5777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5777,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
5777,3,"Sleep disorder due to general medical condition, insomnia type",Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5778,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5778,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5778,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5778,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5778,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5779,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5779,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5779,3,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5779,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5779,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5779,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5779,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5779,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5779,9,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
5779,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5779,11,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5779,12,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5780,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5780,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5781,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5782,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5782,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
5783,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5784,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5785,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5786,1,Blood pressure measurement,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5787,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
5787,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5787,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5787,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5788,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5788,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5788,3,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5789,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5789,2,Headache,Headaches NEC,Headaches,Nerv,N
5789,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5789,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5790,1,Headache,Headaches NEC,Headaches,Nerv,N
5790,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5790,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5791,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5792,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5793,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5794,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5794,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5794,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5794,4,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5795,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5795,2,Cartilage injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
5795,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5795,4,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
5795,5,Ligament sprain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
5795,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5795,7,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5795,8,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5795,9,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5796,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5796,2,Migraine,Migraine headaches,Headaches,Nerv,N
5797,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5798,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5798,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5799,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5800,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5800,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5800,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5801,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5801,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5801,3,Migraine,Migraine headaches,Headaches,Nerv,N
5802,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5803,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
5804,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5805,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5805,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5805,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5806,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5806,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5806,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5807,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5808,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5808,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5808,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5809,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5809,2,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
5810,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5810,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5811,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5811,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5812,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5812,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5812,3,Bone contusion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5812,4,Catheter placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5812,5,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
5812,6,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5812,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5812,8,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
5812,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5812,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5812,11,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5812,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5812,13,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
5812,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5812,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5812,16,Piloerection,Pilar disorders NEC,Skin appendage conditions,Skin,N
5812,17,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5812,18,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5812,19,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5812,20,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5812,21,Thoracic vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5813,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5813,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5813,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5813,4,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5813,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5814,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
5815,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
5816,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5816,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
5816,3,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5817,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5817,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5817,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5817,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5817,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5817,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5817,7,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5818,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5818,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5819,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5819,2,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5820,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
5821,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5821,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5821,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5821,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
5822,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5822,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5822,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5823,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5823,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5824,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5825,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5825,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5825,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5825,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5825,5,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5825,6,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5825,7,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5825,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5825,9,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5825,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5825,11,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5825,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5825,13,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5825,14,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5825,15,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5825,16,Marital problem,Family and partner issues,Family issues,SocCi,N
5825,17,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5825,18,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5825,19,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5825,20,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5825,21,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5825,22,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5825,23,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5825,24,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5826,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5826,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5826,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5826,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5827,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
5827,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5828,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5829,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5829,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5829,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5830,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5831,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5831,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5832,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5833,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5833,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5834,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5834,2,Headache,Headaches NEC,Headaches,Nerv,N
5835,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5836,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5836,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5837,1,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5838,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
5839,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5839,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5839,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5840,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5841,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5841,2,Vulval ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5842,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5842,2,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5843,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5843,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5843,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5844,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
5845,1,Headache,Headaches NEC,Headaches,Nerv,N
5845,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5846,1,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5847,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5847,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5847,3,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
5847,4,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5848,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5848,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5848,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5849,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5849,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5849,3,Headache,Headaches NEC,Headaches,Nerv,N
5849,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5849,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
5849,6,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5849,7,Malabsorption from administration site,Administration site reactions NEC,Administration site reactions,Genrl,N
5849,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5849,9,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5849,10,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5849,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5850,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5851,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5851,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5851,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5852,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
5852,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
5853,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5853,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5853,3,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5853,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5854,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5855,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5855,2,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5855,3,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
5855,4,Large intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5855,5,Reperfusion injury,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
5855,6,Vasculitis gastrointestinal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
5856,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5856,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5856,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5857,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5858,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5858,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5858,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5859,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5860,1,Headache,Headaches NEC,Headaches,Nerv,N
5860,2,Heat exhaustion,Heat injuries (excl thermal burns),Injuries by physical agents,Inj&P,N
5860,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5860,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5861,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5861,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5862,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5863,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5863,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5864,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5864,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5864,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5865,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5865,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5866,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
5866,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5867,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5867,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5867,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5867,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5868,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5869,1,Application site injury,Application site reactions,Administration site reactions,Genrl,N
5869,2,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5869,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5869,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5870,1,Headache,Headaches NEC,Headaches,Nerv,N
5871,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5872,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5872,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5872,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5872,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5873,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5873,2,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
5873,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5873,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5873,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5873,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5873,7,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5874,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5874,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5874,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5874,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5875,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5876,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5877,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5877,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
5877,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5877,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5878,1,Migraine,Migraine headaches,Headaches,Nerv,N
5879,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
5879,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5879,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5879,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5879,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5880,1,Tension headache,Headaches NEC,Headaches,Nerv,N
5881,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
5882,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5883,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5884,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5884,2,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5884,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5885,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5886,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5887,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5888,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
5888,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5889,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
5889,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5890,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
5890,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
5890,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5890,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5891,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5891,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5892,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5892,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5892,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5892,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5892,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5892,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5892,7,Headache,Headaches NEC,Headaches,Nerv,N
5892,8,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
5892,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5892,10,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5892,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5892,12,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5892,13,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5893,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5893,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5894,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5894,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5894,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5894,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5894,5,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5895,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5896,1,Tension headache,Headaches NEC,Headaches,Nerv,N
5897,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5898,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5899,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5900,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5901,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5902,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5903,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5904,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5905,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5905,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5906,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5906,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5907,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5907,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5907,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5907,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
5908,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5908,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5908,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5909,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5909,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
5910,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5910,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5911,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5912,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5912,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5913,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5914,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5914,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5914,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5915,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5916,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5916,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5916,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5917,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5917,2,Wrong strength,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5918,1,Histamine intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
5918,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
5918,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5919,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5919,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5920,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5920,2,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
5921,1,Migraine,Migraine headaches,Headaches,Nerv,N
5922,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5922,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5923,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5924,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
5924,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5924,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5924,4,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5924,5,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
5924,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5924,7,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5924,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5924,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5925,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
5925,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5925,3,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
5925,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5925,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5925,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5925,7,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5925,8,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
5925,9,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5925,10,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5925,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5925,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5925,13,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5926,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5926,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5927,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
5927,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5928,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5929,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5929,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5930,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5930,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5931,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5931,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
5931,3,Oestradiol abnormal,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5931,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5931,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5932,1,Administration site exfoliation,Administration site reactions NEC,Administration site reactions,Genrl,N
5932,2,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
5932,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5932,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5932,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5933,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5933,2,Feelings of worthlessness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5933,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5933,4,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5933,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5933,6,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5934,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5934,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5935,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5935,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
5936,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5936,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5936,3,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5936,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5937,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5938,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5939,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
5939,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5939,3,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5940,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5941,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5942,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
5942,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5943,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5944,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5944,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5944,3,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5944,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5945,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5946,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5947,1,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
5947,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
5947,3,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5948,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5949,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5950,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5950,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5950,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5951,1,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
5952,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5952,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5952,3,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
5953,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
5953,2,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5954,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5954,2,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
5954,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5954,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5955,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5956,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5956,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5956,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5957,1,Menopause,Age related issues,Age related factors,SocCi,N
5958,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5959,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5959,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5960,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5960,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5960,3,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5961,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5961,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5962,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5962,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5962,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5963,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5963,2,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
5964,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5964,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5964,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5965,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5966,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5967,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5967,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5967,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5968,1,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
5969,1,Abnormal uterine bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5969,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5970,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5970,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5970,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5970,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5971,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5971,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5972,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5972,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5972,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5972,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5972,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5972,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5973,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5973,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5974,1,Joint laxity,Joint related disorders NEC,Joint disorders,Musc,N
5975,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5976,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5977,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5977,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
5978,1,Headache,Headaches NEC,Headaches,Nerv,N
5979,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5979,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5979,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5980,1,Headache,Headaches NEC,Headaches,Nerv,N
5981,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5982,1,Headache,Headaches NEC,Headaches,Nerv,N
5983,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5983,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5983,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5983,4,Merycism,Eating disorders NEC,Eating disorders and disturbances,Psych,N
5983,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5983,6,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5983,7,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5983,8,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5983,9,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
5983,10,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
5984,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5985,1,Headache,Headaches NEC,Headaches,Nerv,N
5986,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5986,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5986,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5986,4,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5986,5,Vaginal disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5987,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5987,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5987,3,Deformity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5987,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5987,5,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5987,6,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
5987,7,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
5988,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
5988,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5988,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5988,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5989,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5990,1,Uterine contractions abnormal,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
5991,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5991,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5991,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5991,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5991,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5991,6,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5991,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5991,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5992,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5993,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5993,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
5993,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
5993,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5994,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5994,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5995,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5996,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5996,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5996,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5996,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5997,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5998,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5998,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5999,1,Headache,Headaches NEC,Headaches,Nerv,N
5999,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6000,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6000,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6001,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6002,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6002,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6002,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6003,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6003,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6003,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6003,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6003,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6004,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6004,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6004,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6004,4,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6005,1,Headache,Headaches NEC,Headaches,Nerv,N
6006,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6007,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6007,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6007,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6007,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6008,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6008,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6008,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6008,4,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
6008,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6008,6,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6009,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6009,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6010,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6011,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
6011,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6012,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
6012,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6013,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6013,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6013,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6014,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6014,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6014,3,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6015,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6015,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
6015,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6015,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6015,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6016,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
6016,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
6016,3,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6016,4,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6016,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6016,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6016,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6016,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6016,9,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6017,1,Migraine,Migraine headaches,Headaches,Nerv,N
6018,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6019,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6019,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6019,3,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
6019,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6019,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6019,6,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6020,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6021,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6021,2,Supraventricular extrasystoles,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6021,3,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
6022,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
6023,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6024,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
6024,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6025,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6025,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6026,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6027,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6028,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6029,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6029,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
6029,3,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6030,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6031,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6031,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6031,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6032,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6032,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6032,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6032,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6033,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6034,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6034,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6034,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6034,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6035,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6036,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6036,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6036,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6036,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6037,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6037,2,Menometrorrhagia,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6038,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6039,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6039,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6039,3,Product dose confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6039,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6040,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6041,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6041,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6041,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6042,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6043,1,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6044,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6044,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6044,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6044,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
6045,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6045,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
6045,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6045,4,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6045,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6045,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6045,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6045,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6045,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6045,10,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
6045,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6045,12,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6045,13,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6046,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6046,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6046,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6047,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6048,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6049,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6050,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6050,2,Genital discomfort,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
6050,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6051,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6052,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6052,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
6052,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6053,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6054,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6055,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6056,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6057,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6057,2,Migraine,Migraine headaches,Headaches,Nerv,N
6057,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6057,4,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
6058,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6058,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6059,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6059,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6060,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6061,1,Blood immunoglobulin A increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
6061,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6062,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6062,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6063,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6064,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6065,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6065,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6066,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
6066,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6066,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6067,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6068,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6068,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6068,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6068,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6069,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6069,2,Menometrorrhagia,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6070,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6071,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6071,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6072,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
6073,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6073,2,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
6073,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6073,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6074,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6074,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6075,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6075,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6075,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6076,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6077,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6078,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6079,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6080,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6080,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6081,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6082,1,Nipple disorder,Breast disorders NEC,Breast disorders,Repro,N
6082,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6083,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6083,2,Migraine,Migraine headaches,Headaches,Nerv,N
6084,1,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
6084,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6085,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6086,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6086,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6087,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6087,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
6088,1,Endometrial disorder,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6088,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6089,1,Headache,Headaches NEC,Headaches,Nerv,N
6089,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6089,3,Thunderclap headache,Headaches NEC,Headaches,Nerv,N
6089,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6090,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6090,2,Vertebrobasilar insufficiency,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
6091,1,Severe cutaneous adverse reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
6092,1,Migraine,Migraine headaches,Headaches,Nerv,N
6093,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6094,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6094,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6094,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6095,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6096,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6097,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6097,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6098,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6098,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6098,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6099,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6100,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
6101,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6101,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6102,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
6103,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6103,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6104,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6105,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6105,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6105,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6105,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6106,1,Adnexa uteri pain,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6107,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6107,2,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
6107,3,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6107,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6108,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
6108,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6109,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6110,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6110,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6110,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6111,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6111,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6111,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6111,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6111,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6112,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6112,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6112,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
6112,4,Headache,Headaches NEC,Headaches,Nerv,N
6112,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6112,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6113,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6113,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6114,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6115,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6115,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6116,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
6116,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6117,1,Device failure,Device issues NEC,Device issues,Prod,N
6118,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6119,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6119,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6120,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6120,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6121,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6121,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6121,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6121,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
6121,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6121,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6122,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6123,1,Headache,Headaches NEC,Headaches,Nerv,N
6123,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6123,3,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6124,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6124,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6124,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6124,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6124,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6124,6,Headache,Headaches NEC,Headaches,Nerv,N
6124,7,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
6124,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6124,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6124,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6125,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6125,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6126,1,Exposure via direct contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
6126,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
6127,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6127,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6128,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
6129,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6129,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6130,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6131,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6131,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6131,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6131,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6131,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6131,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6131,7,Headache,Headaches NEC,Headaches,Nerv,N
6131,8,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
6131,9,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6131,10,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6131,11,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6131,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6131,13,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6132,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6133,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6134,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6135,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6135,2,Vulvovaginal inflammation,Vaginal and vulval infections and inflammations,Female reproductive tract infections and inflammations,Repro,N
6136,1,Migraine,Migraine headaches,Headaches,Nerv,N
6136,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6136,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6137,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
6137,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6137,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
6137,4,Application site papules,Application site reactions,Administration site reactions,Genrl,N
6137,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6138,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6138,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
6139,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6139,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6139,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6139,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6139,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6140,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6140,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6141,1,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6141,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6142,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6143,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6143,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6143,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6144,1,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6144,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6144,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6145,1,Migraine,Migraine headaches,Headaches,Nerv,N
6145,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6146,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
6146,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
6146,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6146,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6146,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6146,6,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6146,7,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6146,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6146,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6147,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6147,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6148,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6149,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6149,2,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6150,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6150,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6151,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6151,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6151,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6151,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6152,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6152,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6152,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6153,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6154,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6155,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6155,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6156,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6157,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6158,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6159,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6159,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6159,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6159,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6159,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6159,6,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6160,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6160,2,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6161,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6161,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6161,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6161,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6161,5,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6162,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6163,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6164,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6164,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6165,1,Device leakage,Device issues NEC,Device issues,Prod,N
6166,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6166,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6166,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
6166,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
6166,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6166,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6167,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6168,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
6169,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6170,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6171,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
6172,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6172,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6172,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6173,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6174,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6174,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6174,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6174,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6174,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6175,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
6176,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6176,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6177,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
6177,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6178,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
6179,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6179,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
6179,3,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6180,1,Acne,Acnes,Skin appendage conditions,Skin,N
6181,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6181,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6182,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
6182,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6183,1,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
6183,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6184,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6184,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6185,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6186,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6187,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6188,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6188,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6188,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6189,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6189,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6189,3,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6189,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6189,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6189,6,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6189,7,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6189,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6190,1,Headache,Headaches NEC,Headaches,Nerv,N
6191,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6191,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6192,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6193,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6194,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6194,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
6195,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6196,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6196,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6197,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6197,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6197,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6197,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6197,5,Headache,Headaches NEC,Headaches,Nerv,N
6197,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6197,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6197,8,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6197,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6198,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6198,2,Application site injury,Application site reactions,Administration site reactions,Genrl,N
6198,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6198,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6198,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
6198,6,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6199,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6199,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6199,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6200,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
6201,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6202,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6202,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6203,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6203,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6204,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6204,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6204,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6204,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6205,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6205,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
6206,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6206,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
6207,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6208,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6208,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6208,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6209,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6209,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6209,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6210,1,Vulvitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
6211,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6211,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6211,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6211,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6211,5,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
6211,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6211,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6212,1,Application site nodule,Application site reactions,Administration site reactions,Genrl,N
6213,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6213,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6213,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6213,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6214,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6214,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6215,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6216,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6217,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
6217,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6217,3,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6218,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
6219,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6219,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6219,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6220,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6221,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6222,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6222,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6222,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6222,4,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6223,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6224,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
6224,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6224,3,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
6224,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6225,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6225,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6225,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6226,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
6226,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6226,3,Vulvovaginal mycotic infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
6227,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6228,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6229,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6229,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6230,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6231,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6231,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6231,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6231,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6232,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6232,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6233,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6233,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6234,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6235,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6236,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6236,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6236,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6237,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
6237,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6237,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6237,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6237,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6238,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
6238,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6238,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
6238,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6239,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6240,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
6240,2,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
6240,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6240,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6240,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
6240,6,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6241,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6241,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6242,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6242,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6242,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6243,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6243,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6243,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6243,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6244,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
6244,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6244,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6245,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6245,2,Headache,Headaches NEC,Headaches,Nerv,N
6245,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6245,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6245,5,Mental fatigue,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
6245,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
6246,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6247,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6248,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6248,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6248,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6248,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6248,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
6248,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6248,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6249,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6249,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6250,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6250,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6250,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6250,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6250,5,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6250,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6251,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
6252,1,Cerebral artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6252,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6253,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6253,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6254,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6254,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6254,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6255,1,Migraine,Migraine headaches,Headaches,Nerv,N
6256,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6256,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
6256,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6256,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6256,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6256,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6256,7,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6256,8,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6256,9,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6256,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6257,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6258,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6258,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6259,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6260,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6261,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6261,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6262,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6263,1,Headache,Headaches NEC,Headaches,Nerv,N
6263,2,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
6263,3,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
6264,1,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6265,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6265,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6265,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
6266,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6267,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6268,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6268,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6268,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6268,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6269,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6270,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6271,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6271,2,Endometrial hypoplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6271,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6271,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
6271,5,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6271,6,Vaginal cyst,Vulvovaginal cysts and neoplasms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6272,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
6272,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6272,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6272,4,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6272,5,Menometrorrhagia,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6272,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6273,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
6273,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6273,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6274,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6274,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6274,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6274,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6274,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6274,6,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6274,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6275,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
6275,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6275,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6276,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
6277,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6277,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6278,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6278,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6279,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6280,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
6280,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6280,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6281,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6281,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6281,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6281,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6282,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6282,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
6283,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6283,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6283,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6283,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6284,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
6284,2,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
6284,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6284,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6285,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
6286,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
6286,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6286,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6287,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6288,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6289,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6290,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
6291,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6291,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6292,1,Migraine,Migraine headaches,Headaches,Nerv,N
6293,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6293,2,Product shape issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6293,3,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
6293,4,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6294,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6295,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6295,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6296,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
6296,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6297,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
6297,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6298,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6299,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6299,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6299,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6300,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6300,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6300,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6300,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6301,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6301,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6301,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
6301,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6301,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6301,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6302,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6302,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6302,3,Thoracic outlet syndrome,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
6303,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6304,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6305,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
6306,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6306,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6306,3,Headache,Headaches NEC,Headaches,Nerv,N
6306,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6306,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6307,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6308,1,Bladder irritation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6308,2,Bladder irritation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6308,3,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6308,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6308,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6309,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6309,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6309,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6310,1,Headache,Headaches NEC,Headaches,Nerv,N
6311,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6311,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6311,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
6312,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6313,1,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6314,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6315,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6316,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6317,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6318,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6319,1,Headache,Headaches NEC,Headaches,Nerv,N
6319,2,Histamine level,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
6319,3,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6320,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6321,1,Migraine,Migraine headaches,Headaches,Nerv,N
6322,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6322,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6322,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6322,4,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6322,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6322,6,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6322,7,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6322,8,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6322,9,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6322,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6322,11,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6322,12,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6322,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6322,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6322,15,Headache,Headaches NEC,Headaches,Nerv,N
6322,16,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6322,17,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6322,18,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6322,19,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6322,20,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
6322,21,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6322,22,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6322,23,Myalgia,Muscle pains,Muscle disorders,Musc,N
6322,24,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6322,25,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6322,26,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
6322,27,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6322,28,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6322,29,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6322,30,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6322,31,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6323,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6323,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6324,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6325,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6325,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6325,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6326,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6327,1,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6327,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6327,3,Migraine,Migraine headaches,Headaches,Nerv,N
6327,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6327,5,Oestrogen deficiency,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
6327,6,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6327,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6328,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6329,1,Headache,Headaches NEC,Headaches,Nerv,N
6329,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6330,1,Wrong patient,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6331,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6331,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6332,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6332,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6332,3,Migraine,Migraine headaches,Headaches,Nerv,N
6332,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6333,1,Haemangioma of liver,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
6334,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6335,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6335,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
6335,3,Headache,Headaches NEC,Headaches,Nerv,N
6335,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6335,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6335,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6335,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6335,8,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6336,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6337,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6338,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6338,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6338,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6338,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6338,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6339,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6340,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6340,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6341,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6341,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6342,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6342,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6343,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6343,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
6343,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6344,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6344,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6344,3,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6344,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6344,5,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6344,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6344,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6344,8,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6345,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6345,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6345,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6346,1,Headache,Headaches NEC,Headaches,Nerv,N
6347,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6347,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
6347,3,Headache,Headaches NEC,Headaches,Nerv,N
6347,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6348,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6349,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6350,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6351,1,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
6351,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6351,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6352,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6353,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
6353,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6354,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
6354,2,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
6354,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6354,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6354,5,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6354,6,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6354,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6355,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6356,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6356,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6356,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6356,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6356,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6356,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6356,7,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6356,8,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
6356,9,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6357,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6357,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6357,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6357,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6357,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
6357,6,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6357,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6358,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6358,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6359,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6359,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6359,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6359,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6360,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6360,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6360,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6360,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6360,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6361,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6361,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6361,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6362,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6362,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6363,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6363,2,Headache,Headaches NEC,Headaches,Nerv,N
6364,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
6364,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6364,3,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
6364,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6364,5,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6364,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6365,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6365,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6366,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6367,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6367,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6367,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6367,4,Headache,Headaches NEC,Headaches,Nerv,N
6367,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6367,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6367,7,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6368,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6369,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6370,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6371,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
6372,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
6372,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
6373,1,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6373,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6373,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6374,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6374,2,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6374,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
6374,4,Headache,Headaches NEC,Headaches,Nerv,N
6374,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6374,6,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6374,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6374,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6374,9,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6375,1,Genital injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
6376,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
6376,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6376,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6377,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6377,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
6377,3,Headache,Headaches NEC,Headaches,Nerv,N
6377,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6377,5,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6377,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6377,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6377,8,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6378,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6378,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
6378,3,Headache,Headaches NEC,Headaches,Nerv,N
6378,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6378,5,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6378,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6378,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6378,8,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6379,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6379,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6379,3,Endometrial hyperplasia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6379,4,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
6379,5,Headache,Headaches NEC,Headaches,Nerv,N
6379,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6379,7,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6379,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6379,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6379,10,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6380,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6380,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6381,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6382,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6382,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6382,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6383,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6384,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6384,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6385,1,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
6386,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6386,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6386,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6386,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6386,5,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6387,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6387,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6388,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6388,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6388,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6389,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6390,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6391,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6392,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6392,2,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6393,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6394,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6394,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6394,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6395,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6396,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6396,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
6396,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6396,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6397,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6398,1,Acne,Acnes,Skin appendage conditions,Skin,N
6399,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6399,2,Headache,Headaches NEC,Headaches,Nerv,N
6399,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6400,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6401,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6402,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6403,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6403,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6403,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
6403,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6404,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6405,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6405,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6406,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6406,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6407,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6407,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6407,3,Headache,Headaches NEC,Headaches,Nerv,N
6408,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6409,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6409,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6410,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6410,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6410,3,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
6410,4,Tension headache,Headaches NEC,Headaches,Nerv,N
6411,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6412,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6412,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6412,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6412,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6413,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6413,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6414,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6415,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6415,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6416,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
6416,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6416,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6417,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6417,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6418,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6418,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6419,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6419,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6419,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6419,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6419,5,Migraine with aura,Migraine headaches,Headaches,Nerv,N
6419,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6419,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6420,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
6420,2,Headache,Headaches NEC,Headaches,Nerv,N
6420,3,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6421,1,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
6421,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6422,1,Blood oestrogen increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6422,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6423,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6423,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6423,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6423,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6423,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6423,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6423,7,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
6423,8,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6423,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6423,10,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
6423,11,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6423,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6424,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
6424,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6424,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
6424,4,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6424,5,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6424,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6425,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6425,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6425,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
6425,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6425,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
6426,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6426,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6426,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6427,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6427,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6427,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6428,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6429,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
6429,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6429,3,Headache,Headaches NEC,Headaches,Nerv,N
6429,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6430,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6430,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6431,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6431,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6431,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6432,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6433,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6433,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
6433,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
6434,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6434,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6435,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6435,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6435,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6435,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6435,5,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6435,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6435,7,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6436,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6436,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6437,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6438,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6438,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6439,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6439,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6440,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6440,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6440,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6441,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6441,2,Vaginal disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6442,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6443,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6444,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6444,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6445,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6446,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6446,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6446,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6446,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6447,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
6447,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6447,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6447,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6447,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6448,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6449,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6449,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6449,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6450,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6450,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6450,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
6450,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6450,5,Headache,Headaches NEC,Headaches,Nerv,N
6450,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
6450,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6451,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6452,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6452,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6452,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6453,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6453,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6454,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6454,2,Headache,Headaches NEC,Headaches,Nerv,N
6454,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
6454,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6454,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6454,6,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6454,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6455,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6456,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6456,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6457,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6458,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6458,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6458,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6458,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6459,1,Incorrect dosage administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6459,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6460,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6460,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6461,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
6461,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6461,3,Manufacturing issue,Manufacturing issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6461,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6461,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6461,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6461,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6462,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6462,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6462,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6463,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6464,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6465,1,Genital injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
6466,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6467,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6467,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6467,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6467,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6467,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6468,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
6469,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
6469,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6470,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6470,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6470,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6470,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6470,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6471,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6472,1,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6473,1,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
6474,1,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6475,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6475,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6475,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6476,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6476,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6477,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6477,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6477,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
6477,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6477,5,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6478,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6478,2,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
6479,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6480,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6481,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6481,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6481,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6481,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6482,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6482,2,Drug dose titration not performed,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6482,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6482,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6482,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6483,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6483,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6483,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6484,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6484,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6484,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6484,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6484,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6485,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6485,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6485,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6486,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6486,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6486,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6486,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6486,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6487,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6488,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6488,2,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6488,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6488,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6489,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6489,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6489,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6490,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6490,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6491,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6492,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6493,1,Rectal discharge,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
6494,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6495,1,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6495,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6496,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6496,2,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
6496,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6497,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6497,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6497,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6498,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
6499,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6500,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
6500,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6500,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6500,4,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
6501,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6502,1,Headache,Headaches NEC,Headaches,Nerv,N
6502,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6503,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6503,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6504,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6504,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6504,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6504,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6504,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6504,6,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6505,1,Migraine,Migraine headaches,Headaches,Nerv,N
6505,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6505,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6505,4,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6506,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6506,2,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6507,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6507,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6507,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6508,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6508,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6508,3,Migraine,Migraine headaches,Headaches,Nerv,N
6508,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6509,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6509,2,Vulvovaginal rash,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6510,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6510,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6511,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6512,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
6513,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6513,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6514,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6514,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6515,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6515,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6516,1,Headache,Headaches NEC,Headaches,Nerv,N
6516,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6516,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6517,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
6518,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
6519,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6519,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
6520,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6521,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6521,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6522,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6523,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6523,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6523,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6523,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6524,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6524,2,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6524,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6525,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6526,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
6527,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6527,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6527,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6528,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6529,1,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
6529,2,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
6530,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6530,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6531,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6531,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6532,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
6532,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6532,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6532,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6532,5,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
6533,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6534,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6534,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6534,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6535,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6535,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6535,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6535,4,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6536,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6536,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6536,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6537,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6537,2,Menopause,Age related issues,Age related factors,SocCi,N
6538,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6538,2,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
6539,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6539,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6539,3,Product dispensing issue,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6539,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6540,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6541,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6541,2,Headache,Headaches NEC,Headaches,Nerv,N
6542,1,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
6543,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6543,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6544,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6545,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6546,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6547,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6548,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6548,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6548,3,Headache,Headaches NEC,Headaches,Nerv,N
6549,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6549,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6549,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6549,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6549,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6550,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6550,2,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6550,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6551,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6551,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6552,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6552,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6552,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6552,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6553,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6553,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6553,3,Migraine,Migraine headaches,Headaches,Nerv,N
6553,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6554,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6555,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6555,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6556,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6556,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6556,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6557,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6558,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6559,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6559,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6560,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6560,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6560,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6560,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6561,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6561,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6561,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
6561,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6561,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6561,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6562,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6563,1,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6564,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6564,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6565,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6566,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6566,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6567,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6568,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
6568,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6568,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6568,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6568,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6569,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6569,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6569,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6570,1,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6571,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6571,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6572,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6572,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6572,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6572,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6572,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6573,1,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6574,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
6574,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6575,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6575,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
6576,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6577,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6577,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6577,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
6578,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6579,1,Acne,Acnes,Skin appendage conditions,Skin,N
6579,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6579,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6579,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6579,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6579,6,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6579,7,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6579,8,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6580,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6580,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6581,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6581,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6581,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6581,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6581,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6582,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6582,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6582,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6582,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6582,5,Headache,Headaches NEC,Headaches,Nerv,N
6582,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6583,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6583,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6583,3,Product dispensing issue,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6583,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6583,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6583,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6584,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
6584,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6585,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6586,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6586,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6586,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6586,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6586,5,Headache,Headaches NEC,Headaches,Nerv,N
6586,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6586,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6586,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6586,9,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
6586,10,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6587,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6587,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6587,3,Headache,Headaches NEC,Headaches,Nerv,N
6587,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6587,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6587,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6587,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6588,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6589,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
6589,2,Headache,Headaches NEC,Headaches,Nerv,N
6589,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
6589,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6589,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6590,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6590,2,Headache,Headaches NEC,Headaches,Nerv,N
6590,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6590,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6590,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6590,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6591,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6591,2,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6591,3,Vulvovaginal inflammation,Vaginal and vulval infections and inflammations,Female reproductive tract infections and inflammations,Repro,N
6591,4,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6592,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6592,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6592,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6592,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6592,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6593,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6593,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6593,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6593,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6593,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6593,6,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6593,7,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6593,8,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6593,9,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6594,1,Headache,Headaches NEC,Headaches,Nerv,N
6595,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6595,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6595,3,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
6595,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6595,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
6596,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6597,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6598,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6598,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6599,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6600,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
6601,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6602,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6602,2,Headache,Headaches NEC,Headaches,Nerv,N
6602,3,Menopause,Age related issues,Age related factors,SocCi,N
6602,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6603,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6603,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6604,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
6604,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6605,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6605,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6605,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6605,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6605,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6606,1,Menopause,Age related issues,Age related factors,SocCi,N
6607,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6607,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6607,3,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
6607,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
6607,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6607,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6607,7,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6607,8,Vulvovaginal mycotic infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
6608,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
6609,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6610,1,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
6611,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6612,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6613,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6614,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6614,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
6614,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6615,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6615,2,Menopause,Age related issues,Age related factors,SocCi,N
6616,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6616,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6617,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6618,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6619,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
6619,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6619,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6619,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6619,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6619,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6619,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6619,8,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
6620,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6620,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6621,1,Headache,Headaches NEC,Headaches,Nerv,N
6621,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6622,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6623,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6624,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6624,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6625,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6625,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6626,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6626,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6626,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6626,4,Headache,Headaches NEC,Headaches,Nerv,N
6626,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6626,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6627,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6628,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
6629,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6629,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
6629,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6629,4,Drug dose titration not performed,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6629,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6629,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6630,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6630,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
6630,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6630,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6631,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6631,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6632,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
6633,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6633,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
6633,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6633,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6633,5,Migraine,Migraine headaches,Headaches,Nerv,N
6633,6,Packaging design issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6634,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6634,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6634,3,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6634,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6635,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6635,2,Headache,Headaches NEC,Headaches,Nerv,N
6635,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6635,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
6635,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6636,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6636,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6636,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6637,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6637,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6637,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6638,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6638,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6638,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6638,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6638,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6639,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6639,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6639,3,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
6639,4,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6639,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6639,6,Tension headache,Headaches NEC,Headaches,Nerv,N
6640,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6640,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6640,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6640,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6640,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6641,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6642,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6642,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6643,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6644,1,Device dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6644,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6644,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6645,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6646,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6646,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6647,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6647,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6647,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6647,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6647,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6647,6,Product dosage form issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6647,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6647,8,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6648,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6648,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6648,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6648,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6648,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6649,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
6650,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6651,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6652,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6652,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6652,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6652,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6653,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6653,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6654,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6655,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6656,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6657,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6657,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6658,1,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6659,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6659,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6660,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6660,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6660,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
6660,4,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
6661,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6662,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6662,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6663,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
6663,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6663,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
6663,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6663,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6663,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6663,7,Headache,Headaches NEC,Headaches,Nerv,N
6663,8,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
6663,9,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6663,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6663,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6663,12,Personal relationship issue,Social issues NEC,Lifestyle issues,SocCi,N
6663,13,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6664,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6664,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6665,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6665,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6665,3,Intertrigo,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6665,4,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
6665,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6665,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6665,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6666,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6667,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6667,2,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6668,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6669,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6670,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6670,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6670,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6670,4,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6671,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6671,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6671,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6671,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6671,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6672,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6672,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6672,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6672,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6673,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6673,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6673,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6674,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6674,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6674,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6674,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6675,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6675,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6675,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6676,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6676,2,Headache,Headaches NEC,Headaches,Nerv,N
6676,3,Menopause,Age related issues,Age related factors,SocCi,N
6676,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6676,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6677,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6677,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
6678,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6678,2,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
6679,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6679,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6680,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6681,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6681,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6681,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6681,4,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
6681,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6681,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6681,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6682,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
6683,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6683,2,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
6683,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6684,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6684,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6684,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
6685,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6685,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6686,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6686,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6686,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6687,1,Menopausal depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6687,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6688,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6688,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6688,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6688,4,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6688,5,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6689,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6690,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6690,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6690,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6691,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6691,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6692,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6692,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6692,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6692,4,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6692,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6692,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6693,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6693,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6693,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6693,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6693,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6694,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6694,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6694,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6694,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
6694,5,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6694,6,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6694,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6694,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6694,9,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6695,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6695,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6695,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6695,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6695,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6696,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6696,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6696,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6696,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6696,5,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6697,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6698,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6698,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6698,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
6698,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6698,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6699,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
6700,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6700,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6700,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6701,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6701,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6701,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6702,1,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6702,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6703,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
6703,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6703,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6703,4,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6703,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6703,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6703,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6704,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6704,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6704,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6704,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6704,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6704,6,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6705,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6705,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6705,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6706,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6707,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6707,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6707,3,Headache,Headaches NEC,Headaches,Nerv,N
6707,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6708,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6709,1,Headache,Headaches NEC,Headaches,Nerv,N
6709,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6709,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6710,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6710,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6711,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6712,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6712,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6712,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6712,4,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6712,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6713,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6714,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6714,2,Migraine,Migraine headaches,Headaches,Nerv,N
6714,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6714,4,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
6715,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6715,2,Headache,Headaches NEC,Headaches,Nerv,N
6715,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6716,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6716,2,Autoinflammatory disease,Autoinflammatory diseases,Immune disorders NEC,Immun,N
6716,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6716,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6716,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6717,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6717,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6717,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6717,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6717,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6718,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6719,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
6720,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6720,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6720,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6721,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
6721,2,Application site scab,Application site reactions,Administration site reactions,Genrl,N
6721,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6721,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
6721,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6722,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6723,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6723,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6723,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6724,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6724,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6724,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6724,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6724,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6724,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6725,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6726,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6727,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
6728,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
6728,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6728,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6729,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6729,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6730,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6730,2,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
6730,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6730,4,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6731,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6732,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
6732,2,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
6732,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6733,1,Cold urticaria,Urticarias,Angioedema and urticaria,Skin,N
6733,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6733,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6734,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6734,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6735,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6736,1,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
6737,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6737,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6737,3,Faeces hard,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
6737,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6737,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6738,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6739,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6739,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6740,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6741,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6741,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6742,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6742,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6743,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
6743,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6744,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
6745,1,Device dislocation,Device issues NEC,Device issues,Prod,N
6745,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
6746,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6746,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6746,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6746,4,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6746,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6747,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6747,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6748,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6748,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6748,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6749,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6749,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6749,3,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6749,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6749,5,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6749,6,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
6749,7,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6750,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6750,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6751,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6751,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6751,3,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
6751,4,Headache,Headaches NEC,Headaches,Nerv,N
6751,5,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6751,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6751,7,Palatal swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6752,1,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
6753,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6754,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6755,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6755,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6756,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
6756,2,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6756,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6756,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6756,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6757,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6757,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6757,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6757,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6757,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6757,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6757,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6757,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6757,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6757,10,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6757,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6757,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6757,13,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6757,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6757,15,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6758,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6759,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6759,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6759,3,Headache,Headaches NEC,Headaches,Nerv,N
6759,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
6759,5,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6759,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6759,7,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6759,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6759,9,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6759,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6759,11,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6759,12,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6760,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6760,2,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
6760,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
6760,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6760,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6761,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6762,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6763,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
6764,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6765,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6765,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6765,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6765,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6766,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6766,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
6766,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6767,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6767,2,Menopause,Age related issues,Age related factors,SocCi,N
6768,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6768,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6769,1,Abnormal menstrual clots,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6769,2,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6770,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6770,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6771,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6772,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6772,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6772,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6772,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6773,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6773,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6774,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6774,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6774,3,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6775,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6776,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6777,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6777,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
6778,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
6778,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6778,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6778,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6779,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
6780,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6780,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6780,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6780,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6780,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6780,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
6781,1,Migraine,Migraine headaches,Headaches,Nerv,N
6781,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6781,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6781,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6782,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6782,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
6782,3,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6783,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6783,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6783,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
6783,4,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6784,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
6784,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6785,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6786,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6786,2,Device issue,Device issues NEC,Device issues,Prod,N
6786,3,Genital injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
6787,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6788,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6788,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6789,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6789,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6789,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6790,1,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6791,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6791,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6791,3,Vulval haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6792,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6792,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6792,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6793,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6793,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6794,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6794,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6794,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6794,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6795,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6795,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6795,3,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6795,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6795,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6796,1,Malabsorption from application site,Application site reactions,Administration site reactions,Genrl,N
6796,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6797,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6797,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6797,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6797,4,Migraine,Migraine headaches,Headaches,Nerv,N
6797,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
6798,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6799,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6800,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6800,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6801,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6801,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6801,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6801,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6802,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6802,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6802,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6802,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6803,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6803,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6803,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6803,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6803,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6804,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6804,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6804,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6804,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6805,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6806,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6806,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6807,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6807,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
6807,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6807,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6808,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6808,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6809,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6809,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6809,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6809,4,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6809,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6810,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6810,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6811,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6811,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6812,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6813,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6814,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6815,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6816,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
6817,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
6817,2,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6817,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6818,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6819,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6820,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6821,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6822,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
6823,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6823,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6824,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6825,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6826,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6826,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6827,1,Migraine,Migraine headaches,Headaches,Nerv,N
6828,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6828,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6828,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6829,1,Unhealthy lifestyle,Social issues NEC,Lifestyle issues,SocCi,N
6830,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6830,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6830,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6831,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6831,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6831,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6832,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6832,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6833,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6834,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6835,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6836,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6837,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
6838,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6838,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6838,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
6838,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6839,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6840,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6841,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6842,1,Blood oestrogen increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6842,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
6843,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6843,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6843,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6843,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6843,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6843,6,Multiple allergies,Allergic conditions NEC,Allergic conditions,Immun,N
6843,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6843,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6843,9,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6843,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6843,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6844,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6844,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6844,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6845,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6846,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6846,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6846,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6847,1,Application site injury,Application site reactions,Administration site reactions,Genrl,N
6847,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6848,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6848,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6848,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6848,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6849,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6849,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6849,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6849,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
6849,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6849,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6849,7,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6849,8,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6849,9,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6849,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6850,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6850,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6851,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6852,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6853,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6853,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6853,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6854,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6854,2,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6854,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6855,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6855,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6855,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6855,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6855,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
6855,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6855,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6855,8,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6856,1,Breast disorder,Breast disorders NEC,Breast disorders,Repro,N
6857,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6857,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6857,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6857,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6857,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6857,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6857,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6857,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6857,9,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
6857,10,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6857,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6857,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6857,13,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6857,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6857,15,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6858,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6859,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
6859,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6859,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6859,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6859,5,Migraine,Migraine headaches,Headaches,Nerv,N
6859,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
6859,7,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6859,8,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6860,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6861,1,Headache,Headaches NEC,Headaches,Nerv,N
6861,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6862,1,Acne,Acnes,Skin appendage conditions,Skin,N
6863,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6864,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6865,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6865,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6865,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6865,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6865,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6866,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
6866,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6866,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6866,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6866,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6867,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6868,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6868,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6868,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6868,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6868,5,Menstrual clots,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6868,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6869,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6869,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
6870,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
6870,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
6870,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6871,1,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6871,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6871,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6872,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6872,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6873,1,Acne,Acnes,Skin appendage conditions,Skin,N
6873,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
6873,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6874,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6874,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6874,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6875,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
6875,2,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6875,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6875,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6875,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6876,1,Cervical polyp,Cervix neoplasms,Cervix disorders (excl infections and inflammations),Repro,N
6876,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6877,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6878,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6879,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6879,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6879,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6879,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6879,5,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6879,6,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6879,7,Headache,Headaches NEC,Headaches,Nerv,N
6879,8,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6879,9,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
6879,10,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6880,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
6880,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6881,1,Acne,Acnes,Skin appendage conditions,Skin,N
6882,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6882,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6882,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6882,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6882,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6882,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6882,7,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
6883,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6883,2,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6884,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6884,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6884,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6884,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6884,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6885,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
6886,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6886,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
6886,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6887,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6888,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6889,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6889,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6890,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6891,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6891,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6891,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6892,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6892,2,Renal embolism,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
6893,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
6894,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6894,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6894,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6895,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6895,2,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6895,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6895,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6895,5,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6895,6,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6896,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6896,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6896,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6896,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6896,5,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6896,6,Headache,Headaches NEC,Headaches,Nerv,N
6896,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6896,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6897,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6898,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6898,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6898,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6899,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6900,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6901,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6902,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6902,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6902,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6903,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
6904,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
6905,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6905,2,Headache,Headaches NEC,Headaches,Nerv,N
6905,3,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
6906,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
6907,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6907,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6907,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6908,1,Migraine,Migraine headaches,Headaches,Nerv,N
6909,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6909,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
6909,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6909,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6909,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6910,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6911,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6911,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6912,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6913,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6914,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
6915,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6916,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6917,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6918,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6919,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6919,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6919,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6919,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6920,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6921,1,Precancerous lesion excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6921,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6922,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6922,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6923,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6923,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6924,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
6925,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6925,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6925,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6925,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6925,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6925,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6925,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6925,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6925,9,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6925,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6925,11,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6925,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6925,13,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6926,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6926,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6927,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6927,2,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6927,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6928,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6928,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6928,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6928,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6928,5,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6929,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6929,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6929,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6929,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6929,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6930,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6930,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6930,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6930,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6931,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6931,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
6931,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6931,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6932,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6932,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6932,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6932,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6932,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6932,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6933,1,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6933,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6933,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6933,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6934,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6934,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6935,1,Headache,Headaches NEC,Headaches,Nerv,N
6936,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6936,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6937,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6938,1,Administration site papule,Administration site reactions NEC,Administration site reactions,Genrl,N
6938,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6939,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6939,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6940,1,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6941,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6941,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6941,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
6942,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6942,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6942,3,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6942,4,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
6943,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6943,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
6943,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6944,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6944,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6944,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6945,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
6945,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
6945,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6945,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6946,1,Oestradiol increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6947,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6948,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6949,1,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6950,1,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6951,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6952,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6953,1,Rheumatic disorder,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6953,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
6954,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6954,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6954,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6954,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6954,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6954,6,Lip pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6954,7,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6954,8,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6954,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6954,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6954,11,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
6954,12,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6954,13,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6954,14,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6954,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6954,16,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
6955,1,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6956,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6956,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6956,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6956,4,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6956,5,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
6956,6,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6956,7,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6956,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6957,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
6957,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6957,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6957,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6958,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6959,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6959,2,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
6960,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
6961,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6962,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
6962,2,Application site mass,Application site reactions,Administration site reactions,Genrl,N
6962,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6962,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6962,5,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6962,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6963,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6963,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6963,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6963,4,Headache,Headaches NEC,Headaches,Nerv,N
6963,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6963,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6964,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6964,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6964,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6965,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6966,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
6967,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6968,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6969,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
6969,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6969,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
6969,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6969,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6970,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6971,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6971,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6972,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6973,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6974,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6975,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6975,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
6975,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6975,4,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
6976,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6976,2,Headache,Headaches NEC,Headaches,Nerv,N
6976,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6977,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6977,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6977,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
6977,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6978,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6978,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6978,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6978,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6979,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6980,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6981,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
6982,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6983,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
6984,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6985,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6985,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6985,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6985,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6985,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6985,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6985,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6985,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6985,9,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6985,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
6985,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6985,12,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6985,13,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6985,14,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
6986,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
6986,2,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6987,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6987,2,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
6987,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
6988,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
6989,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6989,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6989,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6990,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
6991,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6992,1,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
6992,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6993,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6993,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6993,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6993,4,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6994,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6995,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6995,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6996,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6997,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6997,2,Vascular purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
6998,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6998,2,Endometrial thickening,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
6998,3,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
6998,4,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
6998,5,Migraine,Migraine headaches,Headaches,Nerv,N
6998,6,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
6999,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
6999,2,Migraine,Migraine headaches,Headaches,Nerv,N
6999,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
6999,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6999,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6999,6,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7000,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7001,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7001,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7002,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7002,2,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7002,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7003,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7004,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7005,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7005,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
7005,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
7005,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7006,1,Headache,Headaches NEC,Headaches,Nerv,N
7006,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7006,3,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7007,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7008,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7008,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
7009,1,Drug delivery system issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7009,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
7009,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7010,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
7011,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7011,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7011,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7012,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7013,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7013,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7013,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7013,4,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
7014,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
7015,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7015,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7016,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7016,2,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
7016,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7017,1,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
7018,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
7018,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
7018,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
7018,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7019,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7020,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7020,2,Migraine,Migraine headaches,Headaches,Nerv,N
7021,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
7022,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
7022,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
7022,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
7023,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7024,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7025,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
7025,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
7026,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7026,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
7026,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7026,4,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7026,5,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7026,6,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7026,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7027,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7028,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
7029,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
7029,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7029,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
7029,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7030,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
7030,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7030,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7031,1,Uterine spasm,Uterine tone disorders,"Uterine, pelvic and broad ligament disorders",Repro,N
7031,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7032,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7032,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7032,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7033,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7034,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
7035,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7036,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7036,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
7036,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
7037,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7037,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7038,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
7039,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7039,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7039,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
7039,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7040,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
7040,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
7040,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
7041,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7041,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7042,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
7043,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
7043,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
7043,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
7043,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
7043,5,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
7044,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7045,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7046,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
7046,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7047,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
7047,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
7048,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
7048,2,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7048,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
7048,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7049,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
7050,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
7050,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
7050,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
7050,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7050,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7051,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7051,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7051,3,Migraine,Migraine headaches,Headaches,Nerv,N
7051,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7051,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7052,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
7052,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
7052,3,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
7052,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
7052,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
7052,6,Application site rash,Application site reactions,Administration site reactions,Genrl,N
7052,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7053,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7054,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7054,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
7054,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7054,4,Withdrawal bleed,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
7055,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
7056,1,Acne,Acnes,Skin appendage conditions,Skin,N
7056,2,Ophthalmic migraine,Migraine headaches,Headaches,Nerv,N
7056,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7056,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7057,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7057,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
7058,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
7059,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
7059,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
7060,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
7061,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7061,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7062,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
7063,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
7063,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7063,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
7064,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7065,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7066,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7067,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
7067,2,Migraine,Migraine headaches,Headaches,Nerv,N
7067,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7067,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7068,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
7068,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7068,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
7068,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7068,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7069,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
7070,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
7071,1,Acne,Acnes,Skin appendage conditions,Skin,N
7072,1,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7072,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7073,1,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7073,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7074,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
7074,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7074,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7074,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7075,1,Burns first degree,Thermal burns,Injuries by physical agents,Inj&P,N
7075,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7076,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7076,2,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
7077,1,Blood oestrogen decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
7078,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7079,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7080,1,Cerebral vasoconstriction,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
7081,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
7081,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7082,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
7082,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7083,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7083,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7083,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7083,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7083,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7084,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7085,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7086,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
7086,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
7086,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7087,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
7088,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7089,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
7089,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7089,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
7089,4,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
7090,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7091,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7091,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
7091,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7091,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7091,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7092,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
7092,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
7093,1,Headache,Headaches NEC,Headaches,Nerv,N
7093,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7094,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7094,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7095,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
7095,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7095,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7095,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7095,5,Headache,Headaches NEC,Headaches,Nerv,N
7095,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
7095,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
7096,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7096,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7096,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7096,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7096,5,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7096,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7096,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7097,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7097,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
7097,3,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
7097,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
7097,5,HER2 positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7097,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7097,7,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7097,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7097,9,Paget's disease of nipple,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7097,10,Product dosage form issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7097,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7098,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
7098,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7098,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7098,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7098,5,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7098,6,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7098,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
7098,8,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7098,9,Intrusive thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
7098,10,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
7098,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7098,12,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
7098,13,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7098,14,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7098,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7098,16,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
7098,17,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7098,18,"Sleep disorder due to general medical condition, insomnia type",Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
7098,19,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7099,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7099,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7100,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
7100,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
7100,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
7100,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
7100,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7101,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
7101,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7102,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7102,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7102,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
7102,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7102,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7103,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7103,2,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
7103,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7104,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7105,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7105,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
7105,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7105,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7106,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
7106,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7106,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7107,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
7107,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7107,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7108,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7109,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7110,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7110,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7110,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7111,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7112,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
7112,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7113,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
7113,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
7113,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
7114,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
7114,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
7114,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
7115,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7115,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7115,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7115,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7115,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7116,1,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7116,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7116,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7117,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
7117,2,Migraine,Migraine headaches,Headaches,Nerv,N
7117,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7118,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7118,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7118,3,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7118,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7118,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
7118,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
7119,1,Migraine,Migraine headaches,Headaches,Nerv,N
7120,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7120,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7120,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7120,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7120,5,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
7120,6,Headache,Headaches NEC,Headaches,Nerv,N
7121,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7121,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7121,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7122,1,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7122,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7123,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
7124,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
7125,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7125,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
7125,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
7126,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
